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LSRPI Parameter (here LS) as calculated by the BioDent™ RPI, [p. 313].
LSPM Parameter as recalculated by Peter Mauer, [p. 313].
LScross Parameter in cross-sectional testing direction, [p. 210].
LSperi Parameter in periosteal testing direction, [p. 210].
1O is commonly pronounced “Kleene’s O”. This symbol was chosen because of its adequate shape in
relation to cycles. Furthermore, imO Kleene deserves a parameter for the alternative proof (Kleene, 1952)
of the Gödel’s incompleteness theorems (Gödel, 1931) (which itself proved the famous Hilbert’s program as
impossible).
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Abstract
Osteoporosis is “a skeletal disorder characterised by compromised bone strength predis-
posing to an increased risk of fracture” (NIH, 2001). Every second woman and every fifth
man will suffer an osteoporotic fracture (Kanis et al., 2000). Of all people that suffer an
age-related fracture, the current gold standard of osteoporosis diagnosis, DEXA scanning,
misclassifies 80% of them to be non-osteoporotic (Sanders et al., 2006). Bone quantity is
easily measured, however, bone strength is an interplay of bone quantity and quality —
and the latter is hard to determine. More reliable clinical methods to diagnose osteoporosis
are needed as well as widening of our understanding of the underlying mechanisms and of
treatment options. Exploring these were the goals of this thesis.
This work used cortical bones from an ovariectomized (OVX) sheep model to study the
effects of estrogen depletion and zoledronic acid (ZOL) on bone quality. The usability of
Magnet Resonance Imaging (MRI) with novel contrast agents and submillimeter Reference
Point Indentation (RPI) to determine parameters of bone quality were explored.
Observation of microcrack propagation showed decreased strength and resistance to frac-
ture of OVX bone. The mechanical properties of individual OVX osteons in respect to
their age were not different from CON tissue. Novel MRI contrast agents labelled outer
and inner surfaces of bone — but microcracks were not detected with the limited reso-
lution. OVX periosteal bone showed increased brittleness and easier crack propagation
with RPI, while ZOL reversed properties towards control. Improvements were addressed
to increase the clinical applicability.
In conclusion, this work illustrates the importance of microstructure in the strength of cor-
tical bone as well as the use of clinically applicable submillimeter techniques.
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1. Introduction
“Everything has been said but not everyone has said it (yet).” Morris King Udall
1. Hierarchical Structure of Bone
Stability, shape and movement of vertebrates are enabled by the muscoskeletal system.
Endoskeletal bones were so effective in withstanding forces that vertebrates became the
biggest animals on land, in water and in the air1. 600 million years of evolution of bones
resulted in a highly sophisticated, multi-scale, hierarchical composite material (Fratzl &
Weinkamer, 2007). This hierarchy applies through every size level as shown in Figure 1.1.
Beginning at single collagen molecules that intertwine, embed mineral crystals, array into
fibrils and fibre patterns of lamellar layers, to Basic Multicellular Units (BMU) like osteons
to structural architectures of osteonal cortical bone or trabecular networks up to the organ
level of entire bones. The bones interact with joints, tendons, ligaments, muscles, nerves
and the bloodstream to build the entire muscoskeletal system that enables load bearing and
deliberate and precise motion.
“Form follows function” is a main principle for shapes in nature (Thompson, 1992). In
bone this reflects for example in bone adaptation towards light and stress distributing tra-
becular structures as well as in the shape of entire bones (Frost, 2003). These adaptations
are enabled by constant tissue remodelling and adaptation throughout life.
1The endoskeletons in the vertebrates enabled increasing brain complexity, which often gives Homo
Sapiens an illusory of evolutionary superiority. Exoskeletons, on the other hand, such as in insects, spiders or
lobsters, do exhibit certain mechanical benefits over bones (Taylor, 2011). However, the trade-off is regular
shedding and relative small brain size, which both seem to limit the absolute size of exoskeleton animals.
These small animals are highly diverse and make up for 80% of animal species on planet earth.
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Figure 1.1.: The structure of bone. A: Morphology at the millimeter range. From Gray’s
Anatomy (2005). B: Hierarchy from protein to organ level. From Ritchie et al. (2009).
1.1. Bone Development, Cells and Remodelling
Although bone is a hard tissue, it is far from being static and is continuously modelled
and remodelled. Bones develop early in foetal life, most of them through a process called
endochondral ossification as calcifications build in hyaline cartilage agglomeration models.
Some plate like bones, such as the skull, develop through intramembranous ossification
with accumulations of bone building cells independently from cartilage areas.
Most bone cells originate from Mesenchymal Stem Cells (MSCs). They can differentiate
into a variety of cells, such as chondrocytes that build the cartilage layers of joints, and
into osteoprogenitor cells that differentiate further into osteoblasts and finally osteocytes.
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Figure 1.2.: A: Osteocyte with emerging processes. SEM image with etched bone matrix
from Pajevic (2009), bar: 5 µm. The diameter of canaliculi are ≈250–300 nm (Bonewald,
2007). B: Three dimensional view onto the thin osteocyte side. Confocal microscope
image from Sharma et al. (2012), bar: 10 µm. People say god can be seen in nature. In bone you can see the Flying Spaghetti Monster.
Osteoblasts are responsible for all bone modelling. They lay down ≈1.5µm/d of primary
osteoid collagen matrix (Frost, 1969). The osteoid mineralizes subsequently with crystal-
lization of hydroxyapatite, aligned with the collagen direction (Wang et al., 2012). Some
osteoblast get embedded during the deposition of new bone and differentiate into osteo-
cytes (Fig. 1.2), which make up 90–95% of bone cells (Bonewald, 2011). They stay buried
in individual lacunae for the rest of their lives, Frost (1966) estimated their half-life to 25
years. The oval shaped osteocytes stay connected to their neighbours through a network of
cell processes placed in canaliculi. This network enables cells in deeper layers to exchange
nutrients and waste products with their neighbours actively and passively towards the blood
stream (Wehrli & Fernández-Seara, 2005). Osteocytes are actively involved in calcium and
phosphate homoeostasis of the body by removal and deposition of minerals with osteocytic
osteolysis (Teti & Zallone, 2009; Wysolmerski, 2013). Osteocytes have some endocrine
functionality and influence distant organs (Bonewald, 2011). On the mechanical side, they
are the principal sensors for mechanical loading, initiate bone resorption by osteoclasts and
regulate bone formation by osteoblasts (Schaffler & Kennedy, 2012). Osteocytes detect
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damage and initiate bone remodelling to replace old tissue with new tissue. The processes
of damage detection are not fully understood (Webster et al., 2013), there are indications
that osteocytes respond to shear stress induced damage on their processes (Taylor et al.,
2003; Dooley et al., 2012), to tissue strain (Stern & Nicolella, 2013) and fluid flow (Han
et al., 2004). Signals from damaged and apoptotic osteocytes spread into the surrounding
bone tissue and initiate bone removal by osteocytes (Kennedy et al., 2012a; Jilka et al.,
2012). Bone resorption is performed by Basic Cellular Units (BMUs) (Fig. 1.3) that dig
tubular tunnels into cortical bone with a speed of ≈40µm/d (Martin & Ishida, 1989) that
are filled up by osteoblasts with new bone in the wake, leaving a blood vessel in the centre.
Figure 1.3.: Basic Cellular Units remove bone at the tip and place new bone in the rear.
From Taylor et al. (2007).
1.2. Bone Competence and Failure
The primary function of bone is to carry loads for a lifetime. In general, a material fails if
the load is higher than the strength. There are two main cases of failure of bone. The first
case of failure of bone is due to sudden high impact loads. No matter how weak or strong
a bone is, there can always be a higher load than its strength and a bone may break. The
bone parts will fuse together and heal within three to four months (Einhorn, 1998).
The second case of bone failure are repetitive loads that are higher than the fatigue strength
of the material. Due to weight restrictions in moving organisms, the development of
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local damage of bone material due to fatigue must be accepted and therefore cared for
by remodelling (Martin, 2003). The repetitive loads of daily life cause microcracks with a
size of 5–500µm in the bone matrix (Schaffler et al., 1995; O’Brien et al., 2003). The spe-
cific fibre reinforced structure of bone in the size range of microcracks enables the required
time for removal and replacement of damaged material (Taylor & Lee, 2003).
There are two different circumstance when bone fatigue can become an issue, firstly, with
bones of “normal” strength exposed to high loads over prolonged time one can suffer so-
called stress fractures. This phenomenon occurs in individuals who start excessive amounts
of training, such as racehorses (Parkin et al., 2006), make up 5%–15% of all injuries of
athletes and especially runners (Fredericson et al., 2006) and occur in 5–20% of military
recruits (Välimäki et al., 2005; Cosman et al., 2013).
The second case of fatigue failure occurs at “normal loads” when the bone is insufficiently
strong. These fragility fractures happen mostly in elderly people with osteoporosis (OP)
and are covered in the next section.
2. Osteoporosis
The WHO (1994) defines osteoporosis as “a disease characterised by low bone mass and
microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a
consequent increase in fracture risk”. Reports of frail bones date back to ancient Egypt
(Patlak & Teitelbaum, 2001), the first reports regarding a relation of old age and fractures
were done in the late 1790s by Paston Cooper (1824). Further early work was performed
around 1820 by Jean Lobstein (Schapira & Schapira, 1992), who noticed larger holes in
bone and subsequently coined the word osteoporosis literally meaning “porous bones” in
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French. A century later Albright et al. (1940) attributed the holes and bone loss to a post-
menopausal drop in estrogen levels. With the development of antibiotics, better hygiene
and nutrition in the last century2, humans in the industrialized countries increased in age
dramatically and osteoporosis skyrocketed from a rare disease (Lozano et al., 2012) to a
substantial age-related disease (Lopez et al., 2006).
Osteoporosis is a condition in which bone is unable to maintain the necessary strength to
withstand normal loads without fracture. Bone strength is an interplay of quantity and
quality — in OP both are diminished and the bones become prone for fracture.
One of the most striking changes in early OP is a rise in bone remodelling rates by a
factor of three on average (Recker et al., 2004), which can vary significantly with the
anatomical location (Allen & Burr, 2010). Not each of the additional turnover sites is
refilled adequately, leaving bigger central canals, increasing the porosity on the long run
and decreasing the amount of bone. The bone surface itself contributes to its own remodel-
ling resulting in a continual decrease of bone mass (Bui et al., 2013). The mineralization
of bone decreases on the global level of the entire skeleton, but increases locally on the
micrometer range, leading to a more brittle behaviour that is less competent to stop micro-
damage. Healthy bone adapts its size and shape to functional demands (Roux, 1881), in
osteoporotic bone, however, the removal surpasses the rebuilding and the healthy adapta-
tion is out of balance. Structural changes include the increase of osteonal bone and porosity,
the thinning and vanishing of trabeculae, an increase in trabeculae distance and decreasing
connectivity. The diminishing strength, mainly of cortical bone (Zebaze et al., 2010), leads
2Osteoporosis is an evolutionary young phenomenon: Let the age of the universe represent a year, the
Big Bang on New Year, by May our sun system accumulated, by June the first organisms appeared. On
December 15th the notochord was the first rudimentary spine, on 21st the first vertebrates conquered land,
early Homo species appeared on the 31st, 22:25. Homo Sapiens emerged at 23:54, mastered agriculture 30s
before midnight and the term “osteoporosis” was coined 400ms ago — a mere eye blink in evolution.
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to bone fracture. Among the factors that contribute to osteoporotic fractures are the history
and risk of falls (Edwards et al., 2013), the incidence of earlier fractures (Omsland et al.,
2012), drinking (Eleftheriou et al., 2012) and smoking (Taes et al., 2010), lack of physical
activity in early life (Rideout et al., 2006) and throughout life (Greendale et al., 1995),
nutrition (Pearce et al., 2010; Hiramatsu et al., 2013), obesity (Armstrong et al., 2012),
anorexia (Hiramatsu et al., 2013), depression (Rizzoli et al., 2012; Rabenda et al., 2012),
poverty (Crandall et al., 2012; Karlamangla et al., 2013), sex (Seeman, 2003) and genetic
factors (Li et al., 2005a).
2.1. Fracture Risk
The life-time fracture risk related in relation to OP is 30–50% for women and 15–20%
for men (Kanis et al., 2000) and may be even higher (Pasco et al., 2006). The world-wide
number of hip fractures is estimated to quadruple from 1.7 million in 1990 to 6.3 million
in 2050 (Sambrook & Cooper, 2006). OP fractures themselves are normally not lethal,
however, the mortality rates related to OP fractures — in the first 12 months after a fracture
— are high (Johnell et al., 2004). Hip fracture patients have a 5- to 8-fold increased risk
for all-cause mortality within 3 months (Haentjens et al., 2010), respectively an absolute
mortality rate of 14.7% and 24.3% within 12 and 24 months (Kim et al., 2012). This
accounts for 1.5% of all deaths in the population >50 years (Kanis et al., 2003). Female
hip fracture patients die on average 4 years earlier, men 5 years earlier (Frost et al., 2013).
2.2. Medical Intervention
There are numerous attempts to increase bone strength. This begins with changes in life-
style, nutrition and awareness of risk factors (Curry & Hogstel, 2001). Vitamin D helps to
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absorb calcium from the diet and supplements may help if combined with additional cal-
cium (Chan, 2001). Hormone replacements, as suggested by Albright et al. (1940), were
popular with 20–50% of post-menopausal women (Brixen et al., 2005) until the end of
the last century, however, they increased the risk of breast cancer (Beral, 2003). Raloxi-
fene is not associated with breast cancer but with stroke and blood clots (Barrett-Connor
et al., 2006) and its effects accounted for only 4 % of reduction in fracture risk (Sarkar
et al., 2002). For 40 years bisphosphonates (BPs) have been used (Russell, 2011) and have
been “extremely successful in reducing fracture risk” (Allen & Burr, 2010; Alves et al.,
2012). In OP bone is lost through an increased number of bone remodelling units and a
negative balance of bone removal and replacement from each remodelling event (Allen &
Burr, 2010). BPs suppress the initiation of osteoclast activity (Russell et al., 2008). Sub-
sequently, osteoclastic bone removal and the remodelling rate are reduced and the loss of
bone material is decelerated with BPs. On the other hand, bone remodelling is the mainte-
nance mechanism to remove microdamage. With the suppression of a majority of remodel-
ling, microdamage is insufficiently repaired and can accumulate. Combination therapies of
bone modelling parathyroid hormone (PTH) plus BPs are potentially more effective (Liu
et al., 2006; Gallacher & Dixon, 2010). Zoledronic acid (ZOL), which was used in this
study as well, is a third generation BP of high efficiency that enables once yearly intra-
venous administration with positive effects on bone mass, still visible 5 years later (Grey
et al., 2012). Among the disadvantages of BP are the risks of developing osteonecrosis of
the jaw (ONJ) (Pautke et al., 2012) and of atypical femoral fractures (AFFs) (Park-Wyllie
et al., 2011; Compston, 2011; Jamal et al., 2011; Ettinger et al., 2013), where the debate is
still ongoing, if BPs do cause AFFs (Franceschetti et al., 2013) or not (Trotter et al., 2011;
Rizzoli et al., 2011) and if microdamage accumulation is the main reason (Abrahamsen &
Einhorn, 2012).
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Overall, the benefit-to-risk ratio of BPs is still good and BPs are the recommended pharma-
cological OP prevention (Body, 2011; Alves et al., 2012; Giannini et al., 2013) — with
AFFs being about 100 times less common than OP related proximal femoral fractures
(Audran et al., 2011). OP medications are expensive and normally only cost-effective in
patients at high risk of bone fracture (Kanis, 2002) and if the medications are taken regu-
larly (Hiligsmann et al., 2010; Wade et al., 2012), which around 40% of patients actually do
(Curtis et al., 2013). The pure treatment costs for an osteoporotic fracture are e800–3100
(Gutiérrez et al., 2012), prevention of a single fracture costse23,000 for women aged > 80
years, but is not cost-effective for women of 50–59 years with e125,000 per prevented
fracture (Sanders et al., 2006). For alendronate the costs are e9200 per quality adjusted
life year (QALY), sequential teriparatide and alendronate therapy e125,000/QALY (Liu
et al., 2006), zoledronic acid, vitamin D plus calcium is cost saving in some countries
withe19,000–22,300/QALY and comparable to generic alendronate, while branded alen-
dronate adds e11,000/QALY (Akehurst et al., 2011). Zoledronic acid prevents more frac-
tures than other antiosteoporotic treatments at lower cost (Fardellone et al., 2010).
3. Bone Quality and Quantity
Bone strength, its ability to withstand daily loading without failure, is determined by bone
quantity and quality. Bone quantity can be described with factors like volume, bone density
or mineral content. Bone quality, on the other hand, is more complex and involves numer-
ous factors that are more vague, intertwined and overlapping. The particular shape at the
organ level influences the stress distribution and strength, as does the microstructure and
-architecture, the local tissue stiffness, age and mineralization level of BMUs, elevated or
declined rates of remodelling, the specific configuration of collagen and non-collagenous
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proteins (NCP), the mineral crystal composition as well as the sizes and size distributions of
structures from the mineralized collagen fibrils to lamellae and osteons (Bouxsein, 2003).
3.1. Microdamage
Microdamage is fracture of bone on the micrometer scale. Microcracks appear through
normal daily loading and a normal amount is principally no issue in healthy terrestrials.
However, elevated levels of microdamage, insufficient removal of microdamage and a
decreased resistance to crack propagation can lead to bone fracture (Schaffler et al., 1995).
The amount, size and behaviour of microdamage is a factor of bone quality. Histology is
the most common technique for the detection of microdamage in bone (Chapurlat & Del-
mas, 2009). Frost (1960) introduced Basic Fuchsin to detect microdamage in bone by using
an en bloc staining technique. Basic Fuchsin is non-specific to microcracks and has to be
applied in ethanol solution because of its low water solubility. In the past decade, water
soluble, chelating agents were found to label microdamage in bone (Lanyon et al., 1982;
Lee et al., 2000b; O’Brien et al., 2002). Their sequential application has since improved
the understanding of crack morphology and propagation (O’Brien et al., 2003; Zarrinkalam
et al., 2005; Voide et al., 2009). However, fluorescent contrast agents allow only a limited
number of snapshots in time (Rost, 1995). A limited number of contrast agents are non-
toxic (Lee et al., 2003; Pautke et al., 2010) and only members of the tetracycline family
are approved for human use (Arlot et al., 2005; Land et al., 2007). Furthermore, the nature
of any fluorescent contrast agent — water soluble or not — requires a method to excite
and measure fluorescing light at the microdamage site. Most common is epifluorescence
microscopy on histological slices of 40–150µm thickness (Frost, 1958; Burr & Hooser,
1995; Lee et al., 2000b). This is close to the size of microcracks, which appear to be
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roughly elliptically shaped parallel to the long axis of the bone and with dimensions of
≈400×100×5µm (Lee et al., 2000b). Confocal laser scanning microscopy may also be
used (Zioupos & Currey, 1994), it enhances contrast and suppresses out-of-focus light,
but it still requires processed ex vivo samples. Therefore, fluorescence-based, histological
techniques for microdamage detection are mainly used in scientific research but are not
readily applicable in the clinic.
In osteoporosis, the normal balance between microdamage, its removal and replacement
with an adequate amount of tissue is disturbed. This leads to steady bone loss, increasing
the risk of fractures. The most common medical intervention against this quantitative bone
loss is the administration of bisphosphonates, which interfere with bone resorption (Rus-
sell, 2011). However, when resorption is stopped, the relatively constant amount of damage
can accumulate, reduce bone quality and contribute to failure of skeletal structures (Burr
et al., 1998; Chapurlat & Delmas, 2009). Prolonged use of bisphosphonates is associated
with an accumulation of microdamage and with atypical fractures (Shane et al., 2010).
As microdamage can be measured only ex vivo, the European Society of Biomechanics
identified the development of a clinical in vivo method to quantify bone microdamage as
a research priority (Prendergast & McCormack, 2002). There is a clinical need for more
precise estimations of an individual’s fracture risk, to ensure better targeted drug therapy
and better monitoring of disease progression. There are several approaches to measure
microdamage — and other features of bone quality — with non-harmful techniques.
3.2. Mechanical Testing
The best way to give predictions about fracture of materials is to measure their strength.
Unfortunately, measuring the failure strength requires a) a certain amount of material and
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b) access or removal of the material and c) the destruction of the material. All three points
are usually not possible while a creatures is alive. Most techniques (e. g. DEXA) deter-
mine proxies of bone strength: parameters that are known to be correlated somehow with
strength or fracture risk, but that are not a direct measure of strength.
A novel, potent technique to directly measure bone strength in vivo (Randall et al., 2009;
Diez-Perez et al., 2010) was applied in one chapter of this thesis.
3.3. Dual X-ray Absorptiometry (DEXA)
Dual X-ray Absorptiometry (DEXA) is easy to apply clinically, cheap and results in a
single number describing bone quantity, the Bone Mineral Density (BMD). DEXA is based
on the absorption of permeating x-ray radiation in hard tissue. BMD is linked to fracture
risk (Fig. 1.4) and thus was defined as the gold standard in clinical osteoporosis diagnosis
by the World Health Organization (WHO, 1994).
Bone mineral density measures the amount of mineral per given area in g/cm2. The average
BMD of young white adult women is defined as normal, from there the standard deviations
are computed and called T-scores. The WHO (1994) defines patients with T-scores up to
−1.0 as normal, between−1.0 to−2.5 as osteopenic and below−2.5 as osteoporotic. The
so-called Z-score is different from the T-score in that it is compared to an age, sex and
ethnicity matched normal curve. Z-scores can be used in cases of severe osteoporosis, in
premenopausal women, men under the age of 50 and in children.
The benefits of DEXA is that it is easy to apply and to compare. However, there are
disadvantages in DEXA measurements as well. There is an ongoing debate how useful
BMD measurements are in terms of diagnosing osteoporosis, determining a real fracture
risk and monitoring disease progression and drug effects. The main point is, that BMD and
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Figure 1.4.: Remaining life-time risk of hip fracture for 50 year old women in relation to
BMD and T score values. The T-score of 0 represents the average bone mass of young
women. From Kanis (2002).
strength and fracture risk are somehow related — but they are not at all the same and it is
difficult to draw conclusions from one to the other. Patients do not have problems with low
BMD, they have problems with broken bones (Robb-Nicholson & Schatz, 2004). Not every
woman with low BMD will break a bone and on the other hand, not every woman who is
classified as not being osteoporotic will not break a bone. Classification by DEXA misses a
significant portion of people who are not classified as osteoporotic T <−2.5, but do sustain
an age-related fracture. These numbers are estimated to be 80% of women between 50–59
years (Sanders et al., 2006), the “majority” of all age-related fractures (with only 15% of
fracture patients being classified as osteoporotic) according to Pasco et al. (2006) and even
up to an overpowering of 96% of fractures would arise in women “without” osteoporosis
(which means, that only 4% of women that broke a bone were previously classified as
osteoporotic) as estimated by Kanis et al. (2002). BMD measurements do have a relative
13
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low sensitivity to detect positive patients that will actually break a bone — and, on the
contrary, will “rule out” a lot that will actually break a bone. Because of its low sensitivity,
BMD measurements are even not3 recommended by the WHO (1994) to be used as a
widespread population-based screening (Kanis, 2002; Kanis et al., 2008).
BMD somehow measures the quantity of bone, however, studies also showed up to 60 %
of specimens with high porosity exhibited normal BMD — while being mechanically infe-
rior (Zebaze et al., 2010). Figure 1.4 demonstrates, that the risk of bone fracture is of
course highest when classified as osteoporotic by BMD, however, the risk of fracture in
osteopenia is nearly as high and the risk with normal bone (based on BMD) is not zero.
Together with the definition of T-scores as a deviation from the normal comes, that the
absolute amount of women with T <−2.5 are small and thus, the amount of fractures in
“osteoporotic by BMD”-classified women is a minority of all age-related fractures. DEXA
is also said to be erroneous (Bolotin, 2007) and that DEXA scans can underestimate or
overestimate bone mineral density by 20–50% (Järvinen et al., 2008). Even if “normal”,
untreated bone might be comparable with BMD, this does not necessarily apply for bone
under different circumstances, such as drug treated bone and an increase in BMD does not
necessarily correlate with fracture risk. Cummings et al. (2002) found, that an increase in
BMD from alendronate only accounted for 16 % of the decrease in fracture risk, for teri-
paratide BMD accounted for 30–41% (Chen et al., 2006). Last but not least, DEXA uses
ionizing radiation, which can alter DNA and cause cancers in a minority of cases.
There are attempts to increase the predictive value of DEXA, such as inclusion of the shape
of bones measured during DEXA scans (Goodyear et al., 2012).
3The WHO (1994) of course recommends that women at increased fracture risk, e. g. after a first age-
related fracture, should be screened — but they do not recommend screening every old woman.
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In conclusion, BMD does not measure the strength of bone and not even the quality, it is
a mere proxy for the quantity of bone — and as such, it is far away from being a perfect
predictor of fracture risk. Techniques with better predictive value than the current gold
standard technique DEXA are needed.
3.4. Computed Tomography (CT)
The second method to gain BMD values is Computed Tomography (CT). Benefits of CT
over DEXA are the measurement of three dimensional data, the ability to provide trabecular
architecture parameters and overall an improved discrimination of individuals with fragility
fractures (Link, 2012).
The ability of CT to determine architectural parameters emerged in the last decade with
improved hardware and software and has since been used in small studies to identify
patients with increased fracture risk (Milovanovic et al., 2011).
The use of CT in bone quality and quantity assessment is restricted by the maximum reso-
lution, which is currently around 82 µm for peripheral scans of outer extremities such as
the ankle (Boutroy et al., 2005) and at around 250×250×400µm for whole body scans.
Software-sided improvements e. g. in motion distortion prevention improve the resolution
slightly (Pialat et al., 2011).
There are some disadvantages with the use of CT to determine bone quantity and
quality. CT measures predominantly the quantity of bone and gives little insight about
the materials’ quality (Sievänen, 2010). The biggest downside of CT scans, however, is
the amount of ionizing radiation exposure. X-rays can alter DNA (Mitelman et al., 2011),
which can initiate cancer (Brenner et al., 2003). The radiation exposure per CT scan is rela-
tive high with a radiation dose around 15 mSv (Brenner & Hall, 2007). A single CT scan
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therefore already exposes the patient to a multiple of the natural annual radiation exposure
of 2.4 mSv (UNSCEAR, 2008). A single pelvic CT scan exposes the patient to more than
the annual allowed radiation exposure of workers in nuclear power plants (20 mSv/a) (World
Nuclear Association, 2011) and more than people in the vicinity of Chernobyl are expected
to experience during their whole life (14 mSv/70a) (Brenner & Hall, 2007). The 19,500 CT
scans per day in the US alone are estimated to cause 29,000 new cancer cases and 14,500
deaths per year (Berrington de González et al., 2009). One in 270 women and 1 in 600
men undergoing CT coronary angiography will develop cancer from this CT scan (Smith-
Bindman et al., 2009). Still the associated risks of CT-based diagnosis are outweighed by
its benefits in diagnosis — at least in heart related issues.
Further advances in resolution of CT scanners are only possible for dead tissue and can be
performed with microCT (or µCT) scanners. Resolution in the micrometer range enable
more precise determination of architectural parameters. For example OP bone exhibits
thinner trabeculae (Gabet & Bab, 2011) and increased porosity (Kennedy et al., 2009a).
Also, with the resolution of µCT scanners of 20 µm to 1 µm (Phan et al., 2006), micro-
cracks could be visible — with or without contrast agents. Still, there are concerns with
the reliability of µCT derived BMD values (Entezari et al., 2011). Synchrotron radiation
scanners enable resolutions below 1µm. For example Brock et al. (2013) used a resolution
of 10 nm to find indications that microdamage in bone starts at the lacunae.
3.4.1. Contrast Agents
The crux of computed tomography is its restriction to measure the volume and density of
a material — which are only partly related with the quality of the material. Detecting the
individual microcracks with µCT scanners either requires high resolution in the range of
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1–5µm and / or compounds that increase the contrast. Bone contrast agents have been
developed in the past decade (Parkesh et al., 2006b; Wang et al., 2007; Zhang et al., 2010).
One group of contrast agents, is based on precipitation of heavy elements in great amount
in the microdamage voids. Both uranyl acetate UO2(CH3COO)2 (Schaffler et al., 1994;
Tang & Vashishth, 2007) and barium sulfate BaSO4 (Landrigan et al., 2011; Turnbull et al.,
2011) can be used. These compounds fill all voids with high density material, which makes
them a) usable for density-based CT and b) unusable for in vivo work. Resolutions of 10 µm
were sufficient to identify areas of high damage with BaSO4 precipitation, but not enough
to resolve single cracks (Leng et al., 2008; Landrigan et al., 2011).
The second group of microdamage contrast agents for µCT are functionalized to chemically
bind to either proteins or minerals on the surface of exposed microdamage. Examples are
iodinated agents (Lee et al., 2003; Parkesh et al., 2006a) and gold nanoparticles (Zhang
et al., 2010; Ross & Roeder, 2011; Ross et al., 2012). However, they bear the principle
disadvantage, that chemical binding can form only one molecular layer of contrast agents
on a surface. The real surface of bone microdamage is unknown4. In the simplest case,
a crack can be assumed to consist of only two main surfaces. The thickness of a single
layer of contrast agent molecules can be estimated to be the diameter of the molecule
of 1–5 nanometers (Li et al., 2009). Microcracks, however, have a thickness of 3–15
micrometers (O’Brien, 2000; Voide et al., 2009). Functionalized, surface binding contrast
agents can be estimated to fill ≈1h of the volume of a microcrack. µCT scanners pick
up density differences. In a three dimensional voxel of 10×10×10µm of bone (density
≈ 2.5 g/cm3) with a flat microcrack spanning through the entire voxel 10×10µm with a
4Mathematicians call this the coastline paradox: the closer a coastline is zoomed in, the longer it mea-
sures. The closer one looks at microdamage in bone, the less it will appear as two distinct surfaces but a
myriad network of crazed material in several layers.
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thickness of 3 µm, covered on two surfaces with a constant 1 nm thick layer of contrast
agent would, in order to increase the density of the voxel by detectable 5 %, require a
contrast agent with a density around 25000 g/cm3 5. As such materials were not mentioned
in the synthesis of Parkesh et al. (2006a) and Ross et al. (2012), neither were able to
detect a density increase that was caused by microdamage labelled with contrast agent
with a normal µCT scanner. Despite lacking visibility, both approaches are believed to
have a functional binding ability towards bone. There is currently no proven contrast agent
application to visualize bone microdamage with CT below a resolution of 10×10×10µm
(Ritman, 2011; Anton & Vandamme, 2014; Lusic & Grinstaff, 2013) and research should
therefore be focussed elsewhere (Cleese et al., 1970). Nevertheless, with three magnitudes
higher resolutions around 1×1×1µm, microcracks are detectable as water filled voids of
lower density than the mineral phase.
3.5. Other Techniques to Determine Fracture Risk
There is a number of techniques to determine fracture risk. The most notably is the FRAX
algorithm that offers the computation of fracture risk based on 10 different patient para-
meters (Kanis et al., 2008) and a patient database (Lapi et al., 2012). Despite the popula-
rity of FRAX, it also gained critique for not being the tool of choice in all cases (Andrews,
2010), as well as predicting fracture not better than simpler screening tools (Rubin et al.,
2013). Other screening tools require as few as one factor to give an impression of osteo-
porotic fracture risk and to indicate necessary treatment (Kung et al., 2007; Rubin et al.,
2013). One important non-clinical factor for example is the probability to fall (McClung
5This is 2000× the density of lead. If individual layers would be up to 2.5 nm thick (Li et al., 2009)
and crack sides not a flat surface but a craze network 40 layers of exposed surfaces in depth, then a density
still 20 times that of lead is required (≈ density of the centre of the sun) — plus a not yet included, utopian
surface coverage of 100 %.
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et al., 2001): whereas low BMD is associated with less than 20% of fractures (sec. 3.3),
over 90% of hip fractures are associated with falling (Järvinen et al., 2008).
A number of individual techniques can be used to examine bone quality and quantity.
Some techniques require the removal of bone, such as scanning electron microscopy (SEM)
(Wise et al., 2005; Brennan et al., 2011c), transmission electron microscopy (TEM) (Rubin
et al., 2003), atomic force microscopy (AFM) (Hassenkam et al., 2005; Milovanovic et al.,
2012), nanoindentation (Oyen & Cook, 2009; Brennan et al., 2011c), acoustic emission
(Muller et al., 2006) and the majority of mechanical testing methods. These techniques
all require some bioincompatible treatment such as specially prepared small samples sizes,
toxic solvents and contrast agents or high radiation and none of them are applicable in vivo.
Some techniques do not require the extraction of bone per se and could be applied non-
destructively, such as FTIR and Raman spectroscopy (Sahar et al., 2005; Boskey, 2006;
Bauer & Link, 2009; Bonnier et al., 2011; Raghavan et al., 2012). However, for larger ani-
mals there is the technical difficulty of bringing an imaging probe directly onto an exposed
bone surface in vivo, which has not yet been done (Boskey, 2006). Application of FTIR
to bone through the covering skin was achieved, however, in mice (Draper et al., 2005).
As well, Lambers et al. (2013) measured bone resorption and modelling in mouse tails
with fluorescent markers. Utilizing several techniques to the same sample provides more
discriminatory information (Raghavan et al., 2012). None of the biocompatible techniques
is far beyond research status or small clinical trials yet.
Biomarker detection in blood serum is rapidly expanding in the past years for many dis-
eases. In bone, osteoblast and osteoclast specific proteins can be used to estimate resorp-
tion and remodelling (Corrigan, 2011). Calcium kinetic studies are able to indicate rapid
bone turnover changes due to interventions (Shahnazari et al., 2010). However, systemic
19
CHAPTER 1. INTRODUCTION
markers are unspecific to individual bone sites and may over- or underestimate the remodel-
ling activity (Allen & Burr, 2010). As well, current modelling or remodelling activity does
not reflect on the actual quality of the existing bone.
Ultrasound techniques, such as calcaneal quantitative ultrasound (QUS), are used to deter-
mine structural parameters of bone. From acoustic parameters such as the reflectance or
speed of sound, conclusions about bone stiffness and trabecular structure can be made
(Muller et al., 2006; Zacharias et al., 2009). The benefit of ultrasound techniques is the
non-harmfulness and ease of clinical application.
Positron Emission Tomography (PET) is a three dimensional imaging technique, based on
radioactive positron decay of tracer substances. PET images are mostly connected to the
functionality of the tissue and an increased uptake of radioactively labelled contrast agents
in certain locations. Its main use is the localization of cancer tissues by their increased
uptake of glucose and other nutrients. Labelling recent bone microdamage and remodelling
can be done with a sodium fluoride tracer with the radioactive 18F isotope. Li et al. (2005b)
demonstrated this successfully in loaded mice forearms, Silva et al. (2006) in rats and Li
et al. (2011) in a PET/CT combination scanner in high resolution. The drawbacks of
PET detection of microdamage is any area with exposed bone mineral may be labelled
(Turnbull, 2013). Furthermore, a single PET radiation dose is 5–7mSv, the almost always
combined CT results in additional doses of 25 mSv (Brix et al., 2005). Such doses induce
one cancer per 3000 examinations. Imaging techniques with low risks are desirable.
Magnetic Resonance Imaging (MRI) is a three dimensional imaging technique, based on
the electromagnetic configurations within certain atoms. X-ray based techniques (x-ray
imaging, DEXA and CT) are limited by their amount of ionizing radiation and the asso-
ciated cancer risk. MRI on the other hand is non-ionizing and limited in resolution and
20
CHAPTER 1. INTRODUCTION
exposure time only by the induction of thermal energy from flipping atoms in the tissue.
CT and MRI are currently at similar resolutions (≈100×100×100µm) to determine bone
structures such as single trabecles (Link, 2012). CT bears some cancer risk, while MRI
is twice as expensive. Furthermore, MRI enables plenty of working modes due to various
electromagnetic effects as reviewed by Wehrli (2013).
MRI enables functional imaging by visualizing either the non-existence or the accumula-
tion of contrast agents in certain tissues. For example lesions cause notable differences in
the fluid distribution of the brain. The protons of water are visualized by MRI and anatomi-
cal differentiation of tissue types and shape is enabled by their different water content. Last
but not least, MRI can visualize structural parameters, such as the directionality of tissues,
from direction gradients — basically the degrees of movement freedom of the fluids within
a tissue. Rebuzzi et al. (2013) identified fracture prone patients by analysing water, fat and
bone marrow contents of calcanei, relating them with trabecular thinning. Wu et al. (2011)
measured the phosphorus content of cortical bone and created values similar to the bone
mineral density. A novel MRI contrast agent to label bone microdamage was investigated
as part of this thesis.
3.6. Bone For Life Project
The effectiveness of osteoporosis treatments can be quantified in clinical control studies.
However, in order to develop new treatments and to understand the underlying biological
events, certain amounts of tissue samples need to be extracted, prepared and analysed. This
is principally possible in human studies, but always a practical and ethical issue. Further-
more, studies on humans are complicated by varying factors of nutrition, alcohol, smoking,
exercise, medications and onset of menopause (Newton et al., 2004). Therefore, various
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animal models to mimic postmenopausal osteoporosis have been designed. Mature sheep
are similar to humans in size, weight, bone remodelling rates and other factors (Newman
et al., 1995; Swann, 2005; Arens et al., 2007). Ovariectomized ewes develop osteoporosis-
like symptoms due to estrogen withdrawal and are a well accepted model (Newton et al.,
2004; Turner, 2007; Sigrist et al., 2007; Oheim et al., 2012).
The Royal College of Surgeons in Ireland, in collaboration with other major Irish insti-
tutions, set up the multidisciplinary “Bone for Life” (BFL) project to study the effects of
osteoporosis in sheep (Lee et al., 2004).
group
study time
treatment
group
in months size
CON 1 12 control 18 1†
OVX 1 12 ovariectomy 16 3†
CON 2 31 control 16 2†
OVX 2 31 ovariectomy 11 3†
ZOL 2 31 ovariectomy + ZOL 4 1†
all ∑65 ∑10†
Table 1.1.: Animal groups in the Bone for Life project and their numbers of surviving
animals at the end of the study time that were included for further analysis. †: number of
sheep that died prior to the end of the study. ZOL: 25 mg of zoledronic acid in month 21.
Central to the BFL project were a flock of 75 sheep. All sheep were female, skeletally
mature, of mixed breed, aged between 4–9 years with an unknown lambing number and
no previously known muscoskeletal issues. The animals were divided into 5 groups with a
study duration of 12 or 31 months, ovariectomy versus control and a bisphosphonate treated
group (Table 1.1). For an extensive description of the animals’ health and death, weight,
hormone levels and treatments including husbandry, ovariectomy surgery, fluorochrome
labelling and sacrifice see Brennan (2008) and Kennedy (2007). Bone remodelling was
labelled with a series of fluorochrome markers (Lee et al., 2002) as shown in Table 1.2.
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fluorochrome 12 month group 31 month group
name
emission months tissue months tissue
colour after OVX age after OVX age
Oxytetracycline yellow 0 12 0 31
Alizarin complexone red 3 9 12 19
Calcium green green 6 6 16 15
Xylenol orange orange 9 3 20 11
Calcein blue sky blue 11 1 24 7
Table 1.2.: Fluorochrome labels used in the Bone For Life project. Bones were harvested
12 or 31 months after ovariectomy. The specific age of newly grown tissue is therefore
twelve months minus the months of fluorochrome administration. Tissue age in months.
For a historical overview on fluorochromes utilized in bone see tables A.1 & A.2.
Ovariectomy was performed on 38 sheep at the start of the study (OVX 1 and OVX 2
group), to induce early stage osteoporosis with an absence of sex hormones. Animals
in the control groups (CON 1 and CON 2 group) had nothing done with them. A cohort of
five OVX 2 sheep received the anti-resorptive drug zoledronic acid (ZOL group) after 21
months in a superclinical dose of 25 mg in 5 weekly intravenous doses. Zoledronic acid is
a bisphosphonate so potent that a yearly intravenous administration in humans is sufficient
to increase bone mineral density (Reid et al., 2002). In ewes, it suppresses turnover rates
by 95 % within 4 weeks (Portero-Muzy et al., 2012).
The Bone for Life project focussed on bone quality and quantity. The publications related
to the project include the PhD theses of Kennedy (2007), Brennan (2008), Healy (2009),
Holland (2012), Mahony (2013), further MD and MSc theses and numerous peer-reviewed
journal publications.
Mahony (2013) focussed on DEXA scanning, the clinical gold standard method of osteo-
porosis detection, and found trends of lower BMD in the OVX groups and statistically
significant differences in sub-areas of some bones. Kennedy et al. (2008a) found no BMD
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Figure 1.5.: Animal groups and fluorochrome labels in the Bone for Life project5. Arrow
widths in the Sankey diagram represent group sizes. Small †: prematurely departed sheep
(months not in scale). Time line at the bottom: start of the study by ovariectomy of OVX
sheep (scalpel), fluorochrome label administration (colour bars, months into study), zole-
dronic acid administration (syringe) and sacrifice (large †).
differences between CON 1 and OVX 1 vertebral bodies. Clinically, DEXA identifies up to
20% of patients that sustain an age-related fracture — between 80% (Sanders et al., 2006)
and 96% (Kanis et al., 2002) of patients are not classified as osteoporotic and subsequently
do not receive preventive osteoporosis treatment and will break a bone. DEXA indicates
the amount of bone present, but has a limited relation to the quality or strength of bone.
Based on this, a clinically applicable method to measure the strength of bones in vivo was
used with BFL tissue in this work.
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Differences in the trabecular architecture and thinning of trabecular struts were evident
in the knee in the OVX groups (Holland et al., 2011; 2012; 2013). In the L 3 vertebra
there was no difference in the trabecular architecture, but increased remodelling and sub-
sequently lowered strength of OVX 1 vertebrae (Kennedy et al., 2008a). Using SEM and
nanoindentation on single femoral neck trabeculae, Brennan et al. (2009; 2011c) found
decreasing mineralization and modulus in OVX 1 and OVX 2 that was compensated by
ZOL. Although the loss of trabecular bone is the most striking change in osteoporosis
(Burr, 2010), cortical bone bears between 40% and 90% of the loads (Holzer et al., 2009)
and most fractures are attributable to insufficient cortical rather than trabecular bone (Burr,
2010; Zebaze et al., 2010). Cortical turnover in BFL tissue were quantified by Kennedy
et al. (2009a) and Healy et al. (2010) based on the fluorescent labels that were given at
defined time points. Parts of this work combine this fluorescent identification with nanoin-
dentation to measure the mechanical properties of recently remodelled osteons.
Increased cortical remodelling and porosity were found in OVX 1 by Kennedy et al.
(2009a) and in OVX 2 by Healy et al. (2010) and Khan (2010). They cut the entire cortices
to identify and count the BFL fluorescent turnover labels histologically and used µCT to
examine porosity. Histology can be used clinically to assess turnover rates but is limited to
small studies and has very limited repeatability (Cohen et al., 2010). High resolution CT
can be used clinically to measure cortical porosity to a certain degree (Goldenstein et al.,
2010). Non-harmful technologies, such as MRI, to obtain information about microdamage,
turnover and cortical porosity are preferable and were investigated in this work.
The BFL project involved several studies on bone quality and mechanical characteristics.
Trabecular bone cores were tested in compression by Brennan (2008; 2012), tests on single
trabeculae were performed in tension by McGrotty (2006) and with nanoindentation by
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Brennan et al. (2009), entire vertebra bodies were compression tested by Kennedy et al.
(2008a). In cortical bone, Kennedy et al. (2009a) and Healy et al. (2010) found increased
turnover and porosity in OVX 1 and OVX 2 but no corresponding decrease in the com-
pressive strength. Brennan et al. (2011b) found no difference in microdamage between
CON and OVX, but an accumulation of in vivo microdamage in ZOL metacarpals. In con-
trast, Khan (2010) found cracks in non-load bearing ribs with higher crack density in OVX
but lower in ZOL, and he confirmed an elevated amount of resorption cavities in OVX
that went back to CON levels in the ZOL group. Kennedy et al. (2008c) found no dif-
ference in the fatigue strength of CON 1 and OVX 1. Interestingly, distinct differences in
the behaviour of the fatigue induced microdamage were observed. Recently grown osteons
showed an increased likelihood of attracting microcracks as well as a higher probability of
stopping their progression. This crack blunting effect was thought to increase the fatigue
resistance and compensate for inferior properties of OVX bone (Kennedy et al., 2008c).
Interaction patterns of microcracks and osteons — such as surrounding, deflection or stop-
ping of damage — were observed earlier (Schaffler et al., 1995; O’Brien et al., 2005) with
unknown osteonal age. Histological studies of microcrack propagation allow for only one
to four snapshots in time (O’Brien et al., 2002; Zarrinkalam et al., 2005; Voide et al.,
2009). Some studies observed damage progression continuously (Norman et al., 1995;
Nalla et al., 2005a;b; Hazenberg et al., 2006b), however, in sample volumes that were
several magnitudes bigger than the size level of individual osteons and microcracks, which
may cause an unresolvable mix of mechanical effects. Interactions of microdamage and
osteons occur at a micrometer level and should therefore be observed at this level in real
time, which was attempted in this work.
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4. Objectives
This research seeks to deepen the knowledge of bone structure and quality in an ovine
early osteoporosis model and to see how this is affected by bisphosphonate treatment.
Four studies were carried out to investigate individual aspects of tissue structure behaviour,
damage generation and observation.
Specific objectives:
1. To design an experiment capable of real-time observation of microcrack initiation
and propagation in relation to the microstructure of ovariectomized sheep bone.
2. To detect novel, calcium-chelating, bone microdamage-labelling contrast agents with
fluorescence microscopy and magnetic resonance imaging.
3. To determine mechanical differences between ovariectomized and healthy animal
bone tissue on the microstructural level using nanoindentation.
4. To analyse the effects of ovariectomy and treatment with zoledronic acid on the bone
indentation properties with an in vivo applicable submillimeter testing device.
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Bone
1. Introduction
The fracture mechanism of bone on the micrometer scale occurs in the form of microcracks
(Frost, 1960). Microcracks split along a path with high local stresses and low material resis-
tance. This results often in a splitting of lamellar layers rather than a rupturing. Osteons
in bone act like fibres in any fibre reinforced composite. Osteons both attract cracks in
their vicinity as well as blunting cracks once they reach the osteon, thus creating effec-
tive barriers against crack propagation (O’Brien et al., 2003). This phenomenon has been
observed to occur more in osteons of younger age (Kennedy et al., 2008b).
However, there are no mechanical strength data available as to how precisely lamellar
direction and the occurrence of osteons influence crack propagation and direction on the
microscale.
1.1. Bone as a Structural Composite
Bone strength depends on the structural strength of its constituents and their arrangement.
In Osteoporosis the strength of bones decreases as well as toughness of the bone on the
macroscale and in samples down to the millimeter scale. It is well known that the direction
of the lamellar structure plays an important role in the orientation of microdamage (Peterlik
et al., 2006).
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However, strength and toughness data are mainly available for macroscopic samples
(Ritchie et al., 2006a). Microcracks initiate in older interstitial bone as the most brittle
and weak structure (Rho et al., 2001b). Further crack propagation depends both on the
local stress levels and on local strength. The local stresses are influenced by the crack’s
length (O’Brien et al., 2005) and the stiffness of microstructures surrounding it (Currey,
2002; Hazenberg et al., 2006a;b). The local strength has diverse influences e. g. of the col-
lagen fibre and hydroxyapatite content, orientation, interconnection or age. But both local
stiffness, strength and structural orientation are highly altered by remodelling processes
in living bone. Immature osteons are more likely to stop cracks than older ones, presum-
ably due to their incomplete calcification (Kennedy et al., 2008c). Osteoporosis results
in decreased bone strength in later stages of the disease. However, models of early stage
osteoporosis are inconclusive about whether bone strength decreases or stays constant for a
certain time (Kennedy et al., 2008c). This is attributed both to increasing bone turnover in
the onset of osteoporosis and resulting removal of damaged bone as well as to an increased
capability of new osteons to interfere with microcrack propagation (Kennedy et al., 2008c).
1.2. Crack Propagation Measurements
To monitor crack propagation directly, fluorescent contrast agents can be used during
mechanical tests (Lee et al., 2000b). Recently developed sequential labelling techniques
have improved our understanding of crack propagation but allow for only limited snapshots
in time (O’Brien et al., 2002; Zarrinkalam et al., 2005; Voide et al., 2009). On the other
hand, toughness tests performed in the past were done primarily on bulk bone samples
and crack propagation velocities measured on the surface of bone. This provides insights
into the macroscopic fracture mechanics of bone, but it does not show how microdamage
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sample dimension
crack
property width height thickness area volume length
parameter 2w 2h t A V l1
reference unit mm mm mm mm2 mm3 mm
Norman et al. (1995) 17.5 16.8 2-9 35-158 590-2650 6
Nalla et al. (2005a;b) 13-18.3 1.2-3.4 15-61 3.1-5.5
Hazenberg et al. (2006b) 20 20 1 20 400 3
Hazenberg et al. (2006b) 15 35 0.6 9 315 3
this study 1 2-5 6-10 0.1-0.15 0.2-0.7 1.2-7 0.2-0.6
Table 2.1.: Fracture toughness experiments and their sample dimensions.
1 Both the sample volume and the sample strength were reduced by two magnitudes, which required great
handling care during all stages of the experiment. While e. g. the Hazenberg et al. samples allowed
clamping in the rig with M5 screws, the samples in this study could suffer fatal destruction from inaccu-
rate or involuntary forceps movement.
interacts with different structures. Furthermore, microdamage initiation takes place at the
mineralized collagen fibril level within the size range of 1 µm (Vashishth et al., 2000).
Crack propagation imaging in real time on the microscopical level of bone will provide new
insights into failure mechanisms related to microstructures and into the short-term benefits
of increased bone remodelling.
Such a test would require a) a high spatial imaging resolution, b) high time resolution, c)
propagating cracks must be clearly distinguished from their surrounding structures, (d) any
rig used to stress samples must fit into such an imaging modality.
Similar experiments for bone crack propagation observation have been performed before
(Table 2.1). However, all used significantly bigger sample volumes.
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2. Aims
The overall goal of this study was to link the structure of cortical bone on the osteonal and
lamellar levels with the propagation of macrocracks and microcracks.
The specific aims were:
1. To design and manufacture a testing device to create damage at a size similar to in
vivo occurring microcracks of 50–2000µm.
2. To measure the propagation of the main cracks with high resolution in space and
time to derive fracture mechanical properties on the micrometer scale.
3. To observe the initiation of microdamage in the stress fields ahead of the main cracks.
4. To investigate the differences in failure of cortical bone between normal and ovariec-
tomized sheep.
31
CHAPTER 2. MICROCRACK PROPAGATION
3. Materials and Methods
3.1. Miniature Tensile Rig
To monitor crack propagation on a micrometer resolution in real time, a miniature tensile
device was required that met the following criteria:
• To clearly visualize even small crack propagations, the samples need to be kept in a
water soluble Ca2+-chelating fluorescent dye throughout the test. The optical distor-
tion should be kept at a minimum.
• The device must fit into a fluorescence microscope with appropriate optic filter cubes
and a camera system of high resolution in space and time.
• The sample must be close enough to the lens to image the sample surface.
• The sample must be held tightly enough to avoid slipping out of the grips and must
be gentle enough not to induce stress concentrations causing breakage of the delicate
sample of 100 µm thickness.
• The grips must be flat enough to avoid collision with the lens under all circumstances.
• Collision with any ocular must be avoided under all circumstances.
• No solid parts must be directly underneath or above the sample to enable the use of
transmitted polarized light.
• The set-up must allow a quick sample change.
A device accommodating all these restrictions was designed (Fig. 2.1 A) and manufactured
(Fig. 2.1 B). The test rig consists of a closed frame in which a traverse can move linearly.
A bone sample can be placed in metal end caps (Fig. 2.1 C) which are held with pins on
the fixed frame side and the movable traverse.
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Figure 2.1.: Tensile rig design (A) and manufactured (B) and close-up of a loose and an
embedded sample (C). Base (1), guiding rods (2) and a fixed traverse (3) build the rig’s
frame. Holders (5 & 8) were attached to the load cell (4) and to a movable traverse (7).
Bone sample (10) embedded in metal end caps (9) and attached on the holders (5 & 8).
Threaded rod (6) was used for load transduction. Size comparison: 16.25 mm coin1.
3.2. Bone Material
The bone samples used in this study originated from an ovine model of early stage osteo-
porosis (Lee et al., 2004; Kennedy, 2007; Kennedy et al., 2008a;b;c; Brennan, 2008; Bren-
nan et al., 2009; Holland, 2012). Animals were ovariectomized (OVX) and kept for a time
period of 12 month, during which the absence of sex hormones caused early stage osteo-
porosis. Turnover was labelled with a series of fluorochrome markers (Lee et al., 2002).
After sacrifice, the bones were kept frozen at −20◦C.
Transverse sections of cortical bone from the metatarsals were cut to ≈200µm thickness
and then hand-ground to 100 µm thickness with consecutive use of SiC emery paper up to
P 2500 to achieve a scratch-free surface (section shape see Fig. 2.2). The samples were
1Irish 1 cent euro coin of 16.25mm×1.67mm, depicting a cláirseach Ghaelach — the Gaelic harp.
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Figure 2.2.: Cortical section, as depicted by µCT. Section thickness ≈100µm, bar: 1 mm.
kept wet during all stages and were finally cleaned of grinding dust by low power ultra-
sonication for 60 seconds. The height of each sample was measured with a micrometer of
a resolution of 0.005 mm and additionally with a coordinate measuring machine (Global
07 07 07, DEA Browne & Sharpe, Hexagon Metrology Inc., US; measuring tip: PH10MQ,
Renishaw, Germany; probe holder: SP600, Renishaw) in a 1×1mm in-plane grid with a
height resolution of 1 µm (Fig. 2.3).
Figure 2.3.: Thickness profile of a full cortex section. The thickness decreases relatively
constant from the lower right edge to the left edge. Horizontal resolution 1 mm, thickness
resolution 1 µm. Alignment of section as in Fig. 2.2.
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3.3. Embedding Procedure
Figure 2.4 illustrates the embedding process. Whole cortex sections were examined on
a fluorescence microscope for recent, labelled in vivo bone remodelling (Kennedy et al.,
2009a) (Fig. 2.4B), the areas marked and the sections cut into ≈ 3mm×7mm×100µm
samples subsequently (Fig. 2.4C). The samples were air dried for 5 minutes prior to the
embedding procedure.
Figure 2.4.: Embedding of samples. A: Polished section ≈100µm thick. B: Initial fluores-
cence imaging to identify areas of interest (orange area) with some turnover. C: Cutting
sample(s) from cortex. D: Dipping sample end into PMMA, let harden, dip other end.
Avoid too much infiltration. E: Align sample in end caps on an embedding rig with two
parallel dowel pins. F: Fill first end cap with PMMA, let harden. G: Fill second end cap
with PMMA, let harden. H: Sample in end caps, ready to be tested. I: Samples loose and
embedded compared to a 1 euro cent coin. J: Insufficiently bound samples are prone to
slip out of the embedding. K: Avoid infiltration of sample.
All embedding was done with a low temperature curing dental PMMA cement (Kem-
dent Simplex rapid, Associated Dental Products Ltd., Swindon, UK) as used by McGrotty
(2006). The cement consists of pre-polymerized PMMA beads and liquid MMA (Methyl
Methacrylate). The polymerization reaction starts once the liquid MMA comes into con-
tact with the pre-polymerized beads. The material hardens beyond liquid applicability
35
CHAPTER 2. MICROCRACK PROPAGATION
within 10 minutes and hardens thoroughly in 1–4h. As the cement is not made from two
chemically different components, the two ingredients can be blended in a certain range of
ratios to yield more liquid or more viscous mixtures as required by the application. In any
case, the outcome theoretically consists of 100 % polymerized MMA, independent of the
mixture ratio. There may be differences in the absolute strength of the compound. How-
ever, in the first tests, it was realized that the main problem of the sample embedding was
not related to failure of the cement, but slippage of the bone samples out of the cement
(Fig. 2.4J). Thus it is not an issue of cement strength but of insufficient surface bonding
between the cement and the bone. Bonding strength increases with surface infiltration due
to more liquid mixtures. However, mixtures of higher liquidity applied to a bone sample
placed in the end cap’s slot may infiltrate the entire bone sample (Fig. 2.4K) and change
the mechanical properties of the bone. Thus the contradicting aims of embedding were: to
create sufficient PMMA-bone surface strength while avoiding full sample infiltration.
A high bonding strength was achieved by dipping the ends of air-dry samples into a MMA
mixture of intermediate viscosity (around that of liquid honey, Fig. 2.4D). The drop on
each side was left to harden for 5–20min. The end caps were placed on a special embed-
ding rig with two parallel dowel pins (Fig. 2.4E). One pin was fixed in the rig, the second
was housed horizontally movable to account for sample length differences. The samples
were placed into the end cap slots and aligned in the first end cap. A cement of interme-
diate viscosity was freshly prepared and one to two drops added to fill the space between
sample and end cap (Fig. 2.4F). This enabled a full filling of empty space due to capillary
effect suction on the one hand. On the other hand, the intermediately viscous mixture pre-
vented further flow onto the middle section of the sample which was designated for mecha-
nical testing. When the first embedding was reasonably hardened after a few minutes, the
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sample was aligned in the second end cap and the embedding repeated (Fig. 2.4G). Embed-
ding the sample in an aligned position was done to minimize bending stresses, caused by
misalignment from the horizontal angle, during the later testing procedure. Initial stabi-
lization in the end caps was given after 10min and the samples were removed from the rig
(Fig. 2.4H & I). Longer initial hardening times in the embedding rig were avoided, because
PMMA that found its way down between the end cap and the rig was still soft enough at
that time to enable a removal of the end capped sample without brute force and the possi-
bility of breaking the delicate bone sample. The samples were then left to harden for 1 h
and rehydrated over night.
After mechanical testing, the samples were removed from the aluminium end caps by soft-
ening and partially dissolving the PMMA in acetone for 4h–10d. The samples were then
embedded with DPX on histology slides for future histological examination.
3.4. Testing Procedure
To measure the forces during the test, a 50 N load cell was mounted in the line of force
(KD24-S, ME-Systeme, Germany). The load cell was attached to a measuring amplifier
(GSV-2FSD, ME-Systeme), which wrote the force values into an ASCII file at a sampling
rate of 50 Hz.
The rig was fitted on the stage of an inverted epifluorescence microscope (Nikon
Eclipse 90i, Nikon Systems, Japan). For accurate positioning of the bone sample, the
tensile rig was attached to the electromechanical stage positioning system of the micro-
scope with a custom-designed adapter plate. To adjust for sample tilting, the rig was made
rotatable inside the adapter plate by ±5◦.
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Prior to the tensile test the samples were micro-notched with diamond paste and a grinding
movement of a scalpel blade (Kruzic et al., 2005). The notch was placed, with assistance
of fluorescent light, to an area with a high likelihood for a propagating crack to interact
with recently formed osteons.
The sample was kept in an aqueous environment during preparation and all stages of the
tensile tests. The wet environment prevented the material properties from altering (Rauber,
1876). Dry bone decreases in toughness by 31 % (Yan et al., 2008). Drying of the outer
layers of wet bone may be quick (Currey, 2009). Therefore, a set-up within an aqueous
environment was preferred for these micrometer sized tests.
Following the notch grinding, the sample was washed to remove debris and grinding paste.
On the the camera side of the bone sample, a cover slip was attached with a pressure
sensitive adhesive (Blu-Tack, Bostik, France). The cover slip provided an even surface
between air and the aqueous medium. Otherwise, the surface tension of the medium around
the sample and the end caps causes a highly concave surface. This would cause optical
distortion and chromatic aberration in an unpredictable, and uncorrectable, fashion.
To visualize the crack opening in real-time, 0.5 mM of the fluorescent contrast agent
Xylenol Orange (Lee et al., 2000b) was added to the medium. Different Ca2+-binding,
water-soluble fluorochromes may be used for this application (Table A.1 & A.2). However,
in preliminary tests Xylenol Orange showed a number of advantages:
• Fast binding dynamics with no noticeable time lag between crack opening and fluo-
rescent labelling.
• High contrast between labelled crack and the bone background.
• High contrast between crack-bound agent and unbound agent.
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Filter cube Abbreviation
Excitation Dichroic Emission
filter λ mirror λ filter λ
Ultraviolet bandpass UV BP 340–380 400 435–485
Blue bandpass blue BP 465–495 505 515–555
Green bandpass green BP 540 / 25 565 605/55
Ultraviolet longpass UV LP 325–375 400 420 longpass
Narrow blue longpass blue LP 470–490 505 515 longpass
Table 2.2.: Filter cubes used for epifluorescence microscopy. The blue LP and UV LP were
supplied from Chroma filters, all others from Nikon. Wavelengths λ in nm.
The microscope was equipped with various fluorescent filter cubes (Table 2.2), a CCD
colour camera (DS-Ri1, Nikon, 11 Mpx) and imaging software (NIS-Elements BR, Nikon).
To visualize Xylenol Orange, a green fluorescent bandpass filter cube was used (excitation
540/25 nm, dichroic mirror 565 nm, bandpass filter 605/55 nm). During the test, time-lapse
images were acquired with a sampling rate of 0.5 Hz with a 10×, 0.30 NA dry objective.
Figure 2.5.: Representative graph of load relative to the image number. Load increases
manifest as steep steps with a fading force proportion over time. Once the force is relatively
steady, it can be assumed that all cracks are stopped. The time from image to image is
indicated by the distance of the light blue lines. Around image 43 some crack propagation
caused the force to drop. At image 65 the main crack propagated through most of the
sample, destroying it nearly completely. Taken from sample #2_2.
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To apply tensile force, the movable support of the tensile rig was pulled with a threaded
rod and the turning of a nut and a spanner by hand. The displacement was increased on
demand, once the crack propagation stopped and the force remained stable. Figure 2.5
shows and describes a typical force over time diagram.
3.5. Crack Analysis
3.5.1. Crack Identification
Cracks
The primary element of interest in this study were propagating microcracks. They were
identified with modified criteria of Lee et al. (1998) listed in Table 2.3. The most important
information was their recorded timely behaviour. All other information and criteria are
important as tools and indicators used during winding back and forth through the video
footage. The majority of items of uncertain character at a static view revealed their nature
when observed back and forth in time.
Diffuse Damage and Stress Whitening
The second kind of damage occurring in bone is so-called diffuse damage. This damage
is at such a small size that makes it impossible to distinguish single entities with light
microscopy with resolutions of 0.3–3µm. Similar to diffuse damage is stress whitening,
as described for example by Zioupos et al. (1994) and utilized by Thurner et al. (2007).
Stress whitening is a form of sub-micrometer damage that is seen as an opaqueness in a
stressed zone. Newly created crack surfaces in a nanometer range scatter light and cause
the bright appearance (Zhang et al., 2013). Fluorescent dyes can penetrate into and label
diffuse damage.
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Property criteria of Lee et al. (1998) criteria in this study
Size Intermediate size, larger than canaliculi, smaller
than vascular canals, 546 nm (I).
 Pre-existing cracks are of intermediate size, larger than canali-
culi but smaller than vascular canals. Initiating cracks are < 10µm.
Cracks may grow to mm-size.
Location The primary crack should originate from the manufactured notch.
Other cracks should originate within 1000µm from an existing crack.
Orientation Splits with microstructural direction and high stresses.
Shape Sharp borders, 546 nm (II).  Sharp borders, ragged edges.
Staining Halo of Fuchsin around borders, 546 nm (II).  Borders stained with fluorescent agent.
Depth Stained through section depth, UV (III). Edges
stained deeper than intervening space, especially
during focusing, bright field 225× (IV).
 Stained through section depth — in theory. Practically unhandy to
perform and expected anyway for propagating cracks.
Timing Forward video footage to check propagation and brightness.
Table 2.3.: Microcrack identification criteria. Roman numbers in brackets refer to the 4 criteria of Lee et al. (1998) for static histology
slides stained with Basic Fuchsin. : principally agrees with Lee et al., however, some criteria are not necessary in a dynamic test.
Wavelengths of light in nm indicate the fluorescent light used for excitation. During the destructive test, it was unhandy to change light
settings, therefore UV and brightfield can be used, but it would not be advisable. The most important information was the timely behaviour.
The majority of items in doubt will reveal their character when observed back and forth in time. All cracks that propagate were expected
to reach through the entire section thickness of ≈100µm. Additionally proving this with different light was not deemed to be necessary.
Fluorescence filter cube choice depends on the fluorescent agent (here: Xylenol Orange & green bandpass cube, Tab. 2.2).
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The phenomena of diffuse damage and stress whitening overlap somewhat, but are not
exactly the same. Diffuse damage is usually detected by histology or SEM after testing —
stress whitening is observed during a test. Diffuse damage is defined by its sub-micrometer
size — stress whitening is mostly diffuse damage but may contain microcracks as well. The
opaque whitening can even be seen with the bare eye on the millimeter range Thurner et al.
(2007), however, not be distinguished into single entities. Stress whitening is partially
temporary, most of it will disappear with the release of the causing stress. Some stress
whitening may be permanent damage and could be seen with high resolution techniques as
a mixture of diffuse damage and microcracks.
Due to the permanent stress situation in this experiment, opaqueing zones were defined
as stress whitening — independent to which extent they were temporary or permanent.
Diffuse damage may also evolve into microcracked areas at elevated stress levels.
Locations of New Damage
The location of newly initiating damage was one of the main interests in this study and was
measured in respect to existing cracks (rb in Fig. 2.9 and all red labelled locations in this
chapter). The nature of the new damage was recorded (diffuse damage versus small micro-
cracks) as well as the size, direction and type of microstructure in which they initiated.
Propagating and Stopping Damage
The other main interest in this study was in propagating versus stopping damage. Micro-
cracks were defined as propagating at a particular time point, when they increased in length
as seen in forwarding video footage. Cracks were defined as stopping, when they did not
progress further at a given stress level. Most stopped cracks arrested at some microstruc-
ture. Once the stress level was increased, formerly stopped cracks may propagate.
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Figure 2.6.: Structure and damage identification. PS: periosteal surface. N: notch, arrows
point at surface. NC: crack caused by the notch grinding (normally much less than in this
sample). Barrier: anything that causes a crack to stop. O: osteon, normally identifiable by
its centre Haversian canal. Osteons go out of the view here. Only a few are labelled. HC:
Haversian canal (in the middle of osteons, only a few labelled). VC: Volkmann canal (in
view plane). LO: labelled osteon from the BFL turnover markers. 1st Cr: first crack (here:
surrounded one osteon from above, stopped at a labelled osteon LO). 2nd Cr: second crack
(here: surrounded one osteon from below). DD: diffuse damage (identified with forward
video data). Sample #2_1.
Practically, at the start of each experiment the stress levels were increased in several dis-
placement steps. Once the first crack was seen to propagate, the displacement was kept
constant. Due to the ongoing damage, the stiffness of the sample decreased and the force
diminished, which in turn decreased further crack propagation. At some stage all cracks
were stopped. During this stage it was possible to adjust the focus without missing any
crack data. The displacement was then increased again. This stepwise technique was
repeated until the sample ruptured completely. These force and displacement characteris-
tics are shown in Figure 2.5. Figure 2.6 illustrates structures identifiable during a test.
3.5.2. Identification of Microstructures that Interact with Damage
Figure 2.7 illustrates locations and measurements of microstructures. Microstructures were
recorded for every crack tip and every location of initiating damage.
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Figure 2.7.: Measuring of microstructures that interact with damage. DD: diffuse damage.
LO: labelled osteon from the BFL turnover markers. MS: microstructure that interacts with
a main crack tip (here 3×) or damage initiation site (here DD). Two cracks were labelled
with small arrows, locations of microstructure-crack interaction with MS (big arrows).
Measurements of all structures in an image (here 4) were recorded with their associated
damage — only one set was shown to limit confusion. Recorded were the structure type,
size, the absolute angle to the horizon and the angle relative to the involved crack. Sample
#2_1, identical image to Fig. 2.6.
3.5.3. Crack Length Measurements
Crack lengths were measured with Fiji (Schindelin, 2008) (Fig. 2.9 & Fig. 2.8). Identifi-
cation of cracks and the exact locations of crack tips was done primarily by back and forth
winding through the time-lapse images. When brightness alone did not suffice to measure
the crack outlines, a numerical derivative with respect to the time was computed of the
pixel brightness in the blue channel similar to Wu et al. (2012). Locations of microdamage
initiation (arrow in Fig. 2.9) were measured relative to the tip of the main crack in polar
coordinates θ0 & r0 and additionally with θb & rb in the case of two main cracks.
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Figure 2.8.: Measured crack dimensions in the case of one (A) or two (B) main cracks.
Figure 2.9.: Representative crack from the study with some of the measured dimensions.
l1: main crack including notch. 2l2: crack ahead of the main crack. ra: undamaged distance
between the cracks. rb: distance to initiating damage (arrow). Green excitation, grey-scale
image of the red RGB channel. Sample #2_1, identical image to Fig. 2.6.
3.5.4. Stress Intensity Factors and Stress Fields
Stress Intensity Factor of a General Crack
The stress intensity factor K is generally:
K =∏Y ·σ
√
pi · l (2.1)
With Y being a set of factors dependent on the specific loading case, the sample geometry,
crack geometry and interactions with boundaries and other cracks. Factors are either named
Y or f hereafter. Individual contributing factors Y can be multiplied to ∏Y . As the test
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was performed under tensile stress σ , only tensile opening of cracks (fracture mode I) was
considered — indicated by the index I in KI). The unit of K is N/mm3/2.
Stress Intensity Factor in an Infinite Plate
Figure 2.10.: Stress intensity factor KI(∞) of a through crack in an infinite plate (index ∞).
Cracks that do not touch a sample edge are labelled with l2 hereafter, with a length of 2 · l2.
The general case of a through crack under tensile stress in an infinite plate (index ∞), as
shown in Fig. 2.10, has the unity factor (eq. 2.2):
Y∞ = 1 (2.2a)
KI(∞) =∏Y ·σ
√
pi · l2 = Y∞ ·σ
√
pi · l2 = σ
√
pi · l2 (2.2b)
Near Field Stresses
The stress intensity factor K is calculated by the stress field at the tip of a crack. Vice versa,
a stress intensity factor K can be used to calculate the local so-called Cauchy stresses
(Fig. 2.11) for a given location in a sample (Paris et al., 1961). This can be utilized for
the calculation of stresses that cause material failure and the initiation of microdamage
(eq. 2.3). The direction-dependent general stress function fi j(θ) in eq. 2.3b is defined for
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Figure 2.11.: The local stresses σx, σy and τxy at a certain location (red filled rectangle)
depend on the distance r and the angle θ relative to the original crack, the stress intensity
factor KI and the length 2 · l2 of the existing crack.
the specific direction in equations 2.3c–2.3f as given by Irwin (1957) and Paris et al. (1961).
The near field function fnf(l,r)(eq. 2.3a) computes the local stresses in relation to the dis-
tance from the crack tip. The stress densification towards the crack tip is accommodated
by the distance from the crack r in the denominator of fnf(l,r) and is visible in Fig. 2.12 for
r→ 0. The near field is defined by a small distance to the crack tip in relation to the crack
length r l. Practically, r / 10%· l can be used.
σθ=0 =
K√
2pir
=
∏Y ·σ ·
√
pil2√
2pir
=∏Y ·σ ·
√
l2
2r
=∏Y ·σ · fnf(l,r) (2.3a)
σij =∏Y ·σ · fnf(l,r) · fij(θ)+higher order terms (2.3b)
σy =∏Y ·σ · fnf(l,r) · fy(θ) =∏Y ·σ · fnf(l,r) · cosθ/2 · [1+ sinθ/2 · sin 3θ/2] (2.3c)
σx =∏Y ·σ · fnf(l,r) · fx(θ) =∏Y ·σ · fnf(l,r) · cosθ/2 · [1− sinθ/2 · sin 3θ/2] (2.3d)
τxy =∏Y ·σ · fnf(l,r) · fxy(θ) =∏Y ·σ · fnf(l,r) · cosθ/2 · sinθ/2 · cos 3θ/2 (2.3e)
σz = 0 (for plane stress) (2.3f)
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Far Field Stresses
In the near field around a crack tip with r l, the higher order terms of the Cauchy stress
equation 2.3b can be ignored (Roylance, 2001), leading to equation 2.4a. However, with
exceeding distance r towards a considerable proportion of the half crack length l, the exact
higher order terms in Westergaard (1939) lead to the far field factor ffar(l,r)(eq. 2.4b). For
small r the far field factor ffar(l,r) is equivalent to the near field factor fnf(l,r)(see eq. 2.4c).
σ(rl) =
K√
2pir
≡∏Y ·σ ·
√
l
2r
=∏Y ·σ · fnf(l,r) (2.4a)
σ(r>10% · l) =∏Y ·σ · ffar(l,r) =∏Y ·σ · 1√
1− ( ll+r)2 (2.4b)
lim
r→0
ffar(l,r) = lim
r→0
1√
1−
(
l1
l1+r
)2 = limr→0
√
(l+ r)2
(l+ r)2− l2 =
√
l
2r
= fnf(l,r) (2.4c)
Figure 2.12 shows the difference between the simplified formula for near field (eq. 2.4a)
and the exact far field solution (eq. 2.4b). The exact solution converges to σr→∞ = 1×
σ far from the crack, as stresses far from the influence of a crack are expected to in a
homogeneous stress field. The near field solution converges inaccurately to σr→∞ = 0.
The wrong convergence value of the near field solution for far field values is inevitably
connected to its forbidden application to the far field. For small distances, the stresses
of both equations become infinite: σij,r→0 = ∞, which causes plastic deformation at the
crack tip. To avoid dealing with plasticity, all cracks that were measured were at least at a
distance of rmin = 20µm from any KI creating major crack. Furthermore, inaccuracies of
the measuring technique cause proportional bigger errors at small distances r.
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Figure 2.12.: Stress field factors relative to the distance to a crack tip. The exact far field
factor ffar(l,r)(magenta) converges to 1 in the far field. The near field estimator fnf(l,r)(blue)
is similar to the far field factor in the near field r < 10%· l. However, the near field solution
is invalid in the far field as it increasingly underestimates the stresses (dashed blue line).
Both axes are dimensionless.
Principal Stresses
The direction dependent plane stresses σy, σx and τxy in the x-y-coordinate system
(Fig. 2.13 A) can be transformed with equations 2.5a–2.5d into the principal stresses σ1
and σ2 in the directions ϕ1 and ϕ2 so that the shear term τxy vanishes (Fig. 2.13 B).
Figure 2.13.: Stress transformation to principal stresses. A: Stresses in a plane in the x-y-
coordinate system. B: Principal stresses σ1,2 in a ϕ1-ϕ2-coordinate system. A and B are
equivalent. σ1 is the major stress.
σ1,2 =
σx+σy
2
±
√(
σx−σy
2
)2
+ τ2xy (2.5a)
|σ1|> |σ2| (2.5b)
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σ3 =
ν ·(σ1+σ2) plane strain0 plane stress (2.5c)
ϕ1,2 =
1
2
· arctan
(
2τxy
σx−σy
)
(2.5d)
For the special case of the near field of a single crack in a plate under tension (Fig. 2.14 A),
the principal stresses are given by Roylance (2001) in eq. 2.6a–2.6d. The angle ϕ1,2 relation
to the stress field location angle θ is given in Fig. 2.14 B.
σ1 =
K√
2pir
· cosθ/2 · (1+ sinθ/2) (2.6a)
σ2 =
K√
2pir
· cosθ/2 · (1− sinθ/2) (2.6b)
σ3 = 0 (plane stress) (2.6c)
ϕ1,2 =
1
2
· arctan(2· tan 3θ/2) (2.6d)
Figure 2.14.: Principal stresses (red) caused by a single crack (black). A: Principal stresses
at a location in reference to the location of a single crack. B: Angle of principal stresses
ϕ1,2 in relation to the location angle θ from a single crack.
Equivalent Stresses after von Mises
The von Mises yield criterion (von Mises, 1913) suggests that failure starts, when a single
equivalent stress value (Fig. 2.15) increases above the strength of the material. The equi-
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Figure 2.15.: Stress representations. A: Stresses in an x-y-coordinate system. B: Principal
stresses σ1,2 in a ϕ1-ϕ2-coordinate system. C: Equivalent von Mises stress σe. A, B and
C are equivalent. The von Mises equivalent stress σe can be computed from the principal
stresses σ1,2 via eq. 2.7a or directly from the x-y-based stresses σx,y and τxy(eq. 2.7b).
valent stress σe can be computed from the principal stresses (of eqs. 2.6a–2.6c) with equa-
tion 2.7a or, in the case of x-y-coordinate stresses in a plate, with equation 2.7b.
σe =
√
1
2 [(σ1−σ2)2+(σ2−σ3)2+(σ3−σ1)2] (2.7a)
σe =
√
σ2x +σ2y −σxσy+3τ2xy (2.7b)
In the special case of the near field of a single main crack, the von Mises stresses can be
determined in relation to the polar coordinates r and θ with equation 2.8.
σe =
K√
2pir
· fMises(θ) =
K√
2pir
· cosθ/2 ·
√
1+3sin2(θ/2) (2.8)
SIF of an Edge Crack in a Finite Plate
The stress intensity solution of the infinite plate (eq. 2.2b) can be modified for different
sample geometries and crack cases. In this study, tensile samples of finite width 2w under
uniform uniaxial stress σ with an edge crack of length l1 were employed (Fig. 2.16). The
most common YI,edge solution for this case is the polynomial estimation of by Brown &
Strawley (1966) (eq. 2.9a). The later analytical solution by Isida (1973) (eq. 2.9b) requires
a more complicated computation but offers a higher flexibility and adaptability and was
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Figure 2.16.: Uniformly loaded plate with edge crack of length l1. Cracks that originate at
the edge of the sample are labelled with the length index 1 hereafter.
therefore used hereafter 2 (Fig. 2.17). The formulae are valid in a crack length range of
l1/2w≤ 0.6 and based on sample lengths of h/2w≥ 1 (not in scale in Fig. 2.16). The Isida
solution contains the secβ -term of Feddersen (1967) for samples shorter than h/2w ≥ 1
(Tada et al., 2000; Liu, 2005).
YBrown = 1.122−0.231
(
l1
2w
)
+10.55
(
l1
2w
)
2−21.72
(
l1
2w
)
3+30.39
(
l1
2w
)
4 (2.9a)
YIsida = secβ ×
√
tanβ/β × [0.752+2.02(l1/w)+0.37(1− sinβ )3] (2.9b)
with: β = pil1/2w; secβ = 1/cosβ (2.9c)
2The polynomial (2.9a) is an earlier approximation for the later Isida form (2.9b), within ±1% for KI in
the range l1/w > 0.6. The single edge crack is treated similarly to a centrally located single crack of double
the length 2× l2 in a finite plate (see Fig. 2.10). Whereas the infinite plate has a geometry factor of Y(∞) = 1,
the single edge crack solutions of a short crack result in YI,edge,l1/w≈0 = YBrown = YIsida = 1.122.
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Figure 2.17.: Stress intensity factor in a finite plate with an edge crack. Yedge can be com-
puted either as YIsida or YBrown. Both axes are dimensionless.
SIF of an Infinite Edge Crack and a Collinear Crack
Figure 2.18.: Uniformly loaded plate with infinitely long edge crack (l1 =∞) and collinear
crack. The microcrack has a length of 2 · l2 with a distance of a to the main edge crack.
The tips of the microcrack are defined as a and b, the tip of the edge crack as 0.
The stress intensity form factors for a collinear microcrack ahead of a macrocrack
(Fig. 2.18) can be calculated with equation 2.10a–2.10d (Rubinstein, 1985; 1999; Rose,
1986a). Variations in the analytical solutions presented by Rose (1986a;b), Rubinstein
(1985; 1999) and Gommerstadt (2009) are discussed in appendix B.1. The equations yield
multiplicative, extensions factors to a basic external, primary acting stress case KI(∞). In
our case this primary case is the single edge crack as described by Isida (1973) (eq. 2.9b),
therefore KI(∞) ≡ KI,Isida is used hereafter. KI(0) is the stress intensity factor at the main
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crack tip, KI(a) at the microcrack’s rear tip, KI(b) at the microcrack’s front tip. E(m′) and
K(m′) are the complete elliptic integrals of the first and second kind (Fig. 2.19) in depen-
dency of the so-called complimentary elliptic parameter m′ 3. Figure 2.19 shows the rela-
tion of KI(0), KI(a), KI(b) and KI(∞).
KI(0)
KI(∞)
= Y0,∞ =
√
b
a
· e(m′∞) (2.10a)
KI(a)
KI(∞)
= Ya,∞ =
√
b
a
·
e(m′∞)− a/b√
1− a/b (2.10b)
KI(b)
KI(∞)
= Yb,∞ =
1− e(m′∞)√
1− a/b (2.10c)
with: e(m′∞) =
E(m′∞)
K(m′∞)
, and: m′∞ = 1− a/b (2.10d)
KI(∞) = KI,edge = KI,Isida (from sample geometry) (2.10e)
Figure 2.19.: Stress intensity relations for edge crack and collinear microcrack. E(m)/K(m)
notation with x = a/b; KI(∞) = KI,Isida . Computed with Wolfram Alpha LCC (2009) 4.
Both axes are dimensionless.
The solutions given by Rose (1986a) and Rubinstein (1985) were developed for a small
microcrack ahead of a much bigger crack of length l2. Therefore, they work under the
3The complimentary elliptic parameter is defined to the elliptic parameter m with m′ = 1−m.
4Fig. 2.19 from: plot sqrt(1/x)*EllipticE(1-x)/EllipticK(1-x) and sqrt(1/x)/sqrt(1-x)*(EllipticE(1-x)/
EllipticK(1-x) -x) and (1-EllipticE(1-x)/EllipticK(1-x))/sqrt(1-x) from x=0 to 1 at www.wolframalpha.com.
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assumption that the dimension of the microcrack l2 is much smaller than the length of
the edge crack l1  l1 respectively a l1 and b l1. Both the lingual and the mathe-
matical formulation of “an infinite edge crack with a collinear crack” and “an edge crack
with a collinear microcrack” are identical. Similarly, the depiction of the microcrack in
Figure 2.18 is the same as Figure 2.20, but extended to infinity 5.
SIF of a Finite Edge Crack and a Collinear Crack
The solutions of Rubinstein (1985) and Rose (1986a) are restricted to microcracks, respec-
tively to the near field around a main crack. Gommerstadt (2009) extended this to finite
sizes of the main crack and the collinear crack (eqs. 2.11a–2.11g). Figure 2.20 indicates
the dimensions of relevance, d is the distance between the middle of both cracks.
Figure 2.20.: Uniformly loaded plate with finite edge crack and collinear crack. The micro-
crack has a length of 2 · l2 with a distance of a to the main edge crack of length l1. The tips
of the microcrack are named a and b, the tip of the edge crack 0. The distance between the
centres of the cracks is d. An edge crack is half a normal crack, so its “centre” is actually
at the edge of the sample.
5The infinite case is “extended” only in a dimensional sense. In reality the case of the infinite boundaries
in Fig. 2.18 is actually a mathematical restriction to the special case of short cracks and makes it less easy to
handle than the more general case of Fig. 2.20.
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The Gommerstadt (2009) solution requires the parameter m′ that can be derived as follows:
m′ =
λ 2−λ 2
1−λ 2
(2.11a)
with: λ = λ1+λ2 (2.11b)
λ = λ1−λ2 (2.11c)
λ1 =
l1
d
(2.11d)
λ2 =
l2
d
(2.11e)
d = l1+a+ l2 (2.11f)
l2 =
b−a
2
(2.11g)
Successive insertion of 2.11b–2.11g into 2.11a 6 yields m′ in a form that is solely dependent
on a, b and l1 (eq. 2.12a).
m′ =
b−a
b+ ab/2l1
(2.12a)
k′ =
√
m′ =
√
b−a
b+ ab/2l1
(2.12b)
k =
√
m =
√
1−m′ =
√
1− b−a
b+ ab/2l1
(2.12c)
When the original formulae of Rose (1986a) are combined with the elliptic moduli of the
far field from Gommerstadt (2009), they yield the far field factors 2.13a–2.13c.
Y0,ff =
e(m′)
k
=
e( b−a
b+ab/2l1
)√
1− b−ab+ab/l1
(2.13a)
Ya,ff =
e(m′)− k2
kk′
=
e( b−a
b+ab/2l1
)+ b−ab+ab/2l1 −1√
1− b−ab+ab/2l1 ·
√
b−a
b+ab/2l1
(2.13b)
6The aesthetics of m′ in eq. 2.12a, as well as the striking simplicity of eq. 2.11a–2.11g, do not reflect
the intricacy and the error potential that lies within this rearrangement. Special thanks to Daniela Müller for
reminding me of the correct denominator sign.
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Yb,ff =
1− e(m′)
k′
=
1− e( b−a
b+ab/2l1
)√
b−a
b+ab/2l1
(2.13c)
For the special case of a microcrack of short length compared to the main crack
( liml2/l1→0 ) and the microcrack being placed in the vicinity of the main crack ( lima/l1→0 ),
the elliptic integral parameter m becomes the m∞ of Rubinstein (1985) and Rose (1986a)
(subsequently: m′→ m′∞: eq. 2.14a vs. 2.10d, k′→ k′∞: eq. 2.14b, k→ k∞: eq. 2.14c). The
factors Y0,ff, Ya,ff and Yb,ff become the special, limiting case of the near field with Y0,∞, Ya,∞
and Yb,∞ as given by Rubinstein (1985) and Rose (1986a) (eqs. 2.14d–2.14f).
lim
l2/l1→0
a/l1→0
m′ = lim
l1→∞
m′ = lim
l1→∞
b−a
b+ ab/2l1
=
b−a
b
= 1− a/b = m′∞ (2.14a)
lim
l2/l1→0
a/l1→0
k′ = lim
l1→∞
k′ = lim
l1→∞
√
b−a
b+ ab/2l1
=
√
1− a/b = k′∞ (2.14b)
lim
l2/l1→0
a/l1→0
k = lim
l1→∞
k = lim
l1→∞
√
1− b−a
b+ ab/2l1
=
√
a/b = k∞ (2.14c)
lim
l2/l1→0
a/l1→0
Y0,ff = lim
l1→∞
e(m′)/k = e(m′∞)/k∞ =
√
b/a ·e(1−a/b) = Y0,∞ (2.14d)
lim
l2/l1→0
a/l1→0
Ya,ff = lim
l1→∞
e(m′)− k2
kk′
=
e(m′∞)− k2∞
k∞k′∞
=
√
b
a
·
e(m′∞)− a/b√
1− a/b = Ya,∞ (2.14e)
lim
l2/l1→0
a/l1→0
Yb,ff = lim
l1→∞
1− e(m′)
k′
=
1− e(m′∞)
k′∞
=
1− e(m∞)√
1− a/b = Yb,∞ (2.14f)
All calculations of stress intensity factors were done with a custom-made Excel sheet.
MS Excel does not excel in offering the computation of complete elliptic integrals, thus
values of e(m′) were computed with Wolfram Alpha LCC (2009) 7.
7The ratio of the complete elliptic integrals of the first to the second kind e(m′) = E(m′)/K(m′) can easiest
be solved with inputs similar to: EllipticE(m)/EllipticK(m) where m=0.5 at www.wolframalpha.com .
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Collinearisation of a Non-collinear Crack
Figure 2.21.: Non-collinear microcrack. A: Edge crack with non-collinear second crack.
B: Equivalent distance ae based on von Mises stresses.
The formulae for collinear microcracks (eq. 2.10) work under the condition — as indi-
cated by the name — that both cracks are in-line. However, this condition is not satis-
fied for most real world cases. The issue could be solved by the analytical attempt of
Rose (1986b), with the disadvantage of causing complex mathematics due to the approach
through complex numbers. However, an equivalent distance ae can be generated as well
from the von Mises stress distribution function of equation 2.8. Interestingly, the angle
function fMises(θ) = cosθ/2 ·
√
1+3sin2(θ/2) is nearly independent of the angle θ and
close to unity ∆ fMises(θ) = [1,1.155] in the angle range ∆θ = [−90◦,90◦], with its maxi-
mum at θmax =±70.5◦ (Fig. 2.22) 8. The near independence of the von Mises stress field
from the angle θ enables the simplification in equation 2.15a.
ae = ra ·
√
fMises(θ) = ra ·
√
cosθ/2 ·
√
1+3sin2(θ/2) (2.15a)
be = 2· l2+ae (2.15b)
8The equivalent distance ae approach is not totally exact. However, as the range of resulting factor
∆ fMises(θ) is very close to 1, the inaccuracy is in the negligible low percent range.
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Figure 2.22.: Angle θ dependency of the von Mises stress function at the tip of a single
crack. The stress field is symmetrically to the horizontal axis with θ = 0◦. Graph in polar
coordinates with θ circumferentially and fMises(θ) (dimensionless) radially.
With the von Mises angle function fMises(θ), the equivalent collinear distance ae in depen-
dency of the polar coordinates ra and θ can be defined as in equation 2.15a. b is succeeded
by be from equation 2.15b. The square root in ae originates from the decreasing stress
field with the square root of the distance ra. As fMises(θ) is quite close to 1, square rooting
fMises(θ) might not make a big difference. Including non-collinearity of second cracks, the
far field formulae (eqs. 2.13a–2.13c) result in the factors Yff,nc for the f ar f ield of non-
collinear cracks in equations 2.16a–2.16c.
Y0,ff,nc =
e(m′)
k
=
e( be−ae
be+aebe/2l1
)√
1− be−aebe+aebe/2l1
(2.16a)
Ya,ff,nc =
e(m′)− k2
kk′
=
e( be−ae
be+aebe/2l1
)+ be−aebe+aebe/2l1 −1√
1− be−aebe+aebe/2l1 ·
√
be−ae
be+aebe/2l1
(2.16b)
Yb,ff,nc =
1− e(m′)
k′
=
1− e( be−ae
be+aebe/2l1
)√
be−ae
be+aebe/2l1
(2.16c)
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Far Field Stresses of an Edge Crack and a Microcrack
Concluding: building from the general stress field equation of the near field (eq. 2.1),
extending it to the far field (eq. 2.4b), the geometry factors of the single edge crack in a
plate of finite dimensions (eq. 2.9b), the extension with a collinear crack of infinite size
(eqs. 2.10a–2.10c) and its extension to a collinear crack of finite size (eqs. 2.13a–2.13c),
the modification to non-collinearity of cracks (eqs. 2.16a–2.16c), the stresses σx, σy and
τxy can be computed (eqs. 2.3c–2.3e). From σx, σy and τxy the principal stresses σ1,2 can
be derived (eq. 2.5a) and the von Mises equivalent stress σe (eqs. 2.7a & 2.7b). Table 2.4
shows all crack cases used in this study, with their associated stress intensity factors Kedge,
K0, Ka and Kb and the resulting stresses σy, σx, τxy and σe. With these formulae the equi-
valent stress level at any location ahead of the major cracks in this study were calculated.
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Single edge crack Edge crack and non-collinear crack
Kedge = σ ·YI,Isida(l1) ·
√
pil1 K0 = σ ·YI,Isida(l1) ·Y0,ff,nc ·
√
pil1
Ka = σ ·YI,Isida(l1) ·Ya,ff,nc ·
√
pil1
Kb = σ ·YI,Isida(l1) ·Yb,ff,nc ·
√
pil1
σy = σ ·YI,Isida(l1) · ffar(l1,r0) · fy(θ0) σy = σ ·YI,Isida(l1) ·
[
Y0,ff,nc ffar(l1,r0) fy(θ0)+Yb,ff,nc ffar(l2,rb) fy(θb)
]
σx = σ ·YI,Isida(l1) · ffar(l1,r0) · fx(θ0) σx = σ ·YI,Isida(l1) ·
[
Y0,ff,nc ffar(l1,r0) fx(θ0)+Yb,ff,nc ffar(l2,rb) fx(θb)
]
τxy = σ ·YI,Isida(l1) · ffar(l1,r0) · fxy(θ0) τxy = σ ·YI,Isida(l1) ·
[
Y0,ff,nc ffar(l1,r0) fxy(θ0)+Yb,ff,nc ffar(l2,rb) fxy(θb)
]
with: fy(θb)(2.3c), fx(θb)(2.3d), fxy(θb)(2.3e), ffar(l2,rb)(2.4b)
Y0,ff,nc(2.16a), Ya,ff,nc(2.16b), Yb,ff,nc(2.16c), ae(2.15a)
common factors: σz(2.3f), YI,Isida(l1)(2.9b), ffar(l1,r0)(2.4b), fy(θ0)(2.3c), fx(θ0)(2.3d), fxy(θ0)(2.3e)
σe =
√
σ2x +σ2y −σxσy+3τ2xy (2.7b)
Table 2.4.: The two crack cases in this study with their stress intensity factors K0, Ka and Kb and the resultant stresses σx, σy, τxy and σe.
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4. Results
4.1. Number of Samples and Measurements
Figure 2.23.: Section and sample numbers in the microcrack experiments.
Figure 2.23 illustrates the sample numbers in this study. From the 12 month group
(nCON = 18, nCON = 16) of animals, 42 cortical bone sections were cut and ground. The
sections were examined under fluorescent light for recent turnover and sections which
exhibited little or no osteonal turnover were excluded. Of the remaining 12 different cor-
tical sections from 9 animals (nCON = 5, nCON = 4) a total of 18 tensile samples were cut
from cortical areas where osteonal turnover was evident. All 18 samples were prepared
for tensile testing, embedded in end caps and pre-notched. Of the 17 samples tested, 12
samples (from 9 different animals) failed in the desired manner of slow failure, with the
main crack initiating from the pre-machined notch (except in one case). The rest of the
samples failed out of the imaging area, close to the end cap embedding or ruptured in
an instant. During tensile testing, only 3 samples slipped out of the embedding and were
re-embedded and re-tested subsequently (e. g. sample 10_2b). Samples that showed insuffi-
cient embedding strength during or at the end of the embedding process were re-embedded
until sufficient strength was achieved.
Of the 12 samples with satisfying failure behaviour, all images (n = 4354) were analysed.
There were 230 valid measurements of the main cracks taken, of which n = 121 after the
crack began propagating, 109 second cracks were measured (sketch 2.24).
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name1 group position thickness images
1st crack 2nd crack stress
in µm bp p s fp fs np ns w c
2_1 CON anterior 101−106 323 2 0 4 1 2 1 2 11 4
2_2 CON side 90−96 442 4 2 5 5 6 4 7 11 4
5A1 CON posterior 83−94 497 13 4 4 4 11 4 11 12 6
10_2b OVX post., 1/2 side 95−108 287 3 11 14 12 9 11 10 9 11
20_1 CON posterior 104 315 5 1 2 1 5 1 5 4 3
22B1 CON ant., 1/2 side 94−102 279 4 15 4 10 8 12 6 17 5
23B1 OVX anterior 109−123 158 7 0 0 0 0 0 0 2 0
23B2 OVX posterior 102−113 339 3 4 4 0 2 1 1 9 11
26_1 OVX post. edge 87−94 409 3 2 7 5 4 0 9 4 2
31_1 CON post. edge 80−90 311 3 7 12 0 9 1 8 10 12
32A1 OVX post. edge 86−95 601 3 0 6 2 7 0 9 1 2
32A2 OVX post. edge 80−90 393 3 2 11 1 5 1 5 15 2
∑= 12 6×CON ∑= 4354 52 48 73 41 68 36 73 103 62
6×OVX ∑= 121 109 109 165
Table 2.5.: Successfully tested microcrack samples. Sample thickness measured with a coordinate measuring machine (Sec. 3.2). Images
is the number of images taken in the experiment. 1st and 2nd crack refers to the primary edge crack originating from the notch and
a secondary crack ahead of the first one. The numbers indicate the number of crack measurements in each experiment. bp: before
propagation of the main crack, p: propagating crack, s: stopped crack, f: f ar tip of 2nd crack, n: near tip of 2nd crack, w: stress whitening
of material, c: cracking of material.
1 Leading number: BFL animal number. Capital letter: if more than one ground section. Second number: sample cut from section. Small letter: second test if
sample slipped out in first attempt without being damaged.
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Figure 2.24.: Illustration of the measurements of main cracks and damage areas. Left: the
one or two main cracks were measured every time they changed length. Right: newly
appearing microcracks and diffuse damage were measured at various stages of the main
crack(s).
165 areas of newly initiated microcracks and stress whitening were located ahead of the
cracks (nwhitening = 103, ncracking = 62, Fig. 2.24 right). Table 2.5 lists all successfully
tested samples, main and secondary cracks and the microdamage regions.
To investigate the interaction of damage and microstructure, the microstructure was
measured. This included the microstructures that interfered with all main crack tips
(n = 121) and at the far and near tip of second cracks (2×: n = 109). Furthermore, the
microstructure of the areas in which damage initiated were measured (n = 165).
4.2. Main Crack Properties
Figure 2.25 shows the lengths of the cracks and their stress intensity factors KI. The graph
includes all main cracks after they began propagating (l1 = 878±533µm, n1st = 121) and
the second cracks’ leading crack tips (2l2 = 319± 426µm, n2nd = 109). Stopped cracks
did not propagate actively during the time of observation and at least up to the next load
increase. Propagating cracks were measured at some stage during active propagation —
meaning in the next image, without further load increase, they were longer.
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Figure 2.25.: Stress intensity factors KI in dependency of the length of the crack. Triangles:
KI,0 relative to l1 of the first crack. Rhombi and ellipses: KI,a and KI,b relative to 2 · l2 of
the second crack.
4.2.1. Stress Intensity Factor Properties
The stress intensity is defined generally by KI =∏Y ·σ
√
pi · l (eq. 2.1). A linear regression
was built to determine the effects and to determine how the influence of crack stopping and
propagation could best be expressed.
In an additive regression model, taking account for the stress and the root of the first crack’s
length, KI,1 was increased by 0.462N/mm3/2 in propagating cracks compared with stopped
cracks (p < 0.001, with the significant by-factors for the calculation: σnom: p < 0.001,
√
pi · l1 : p < 0.001, adj. R2 = 0.824).
In order to acknowledge the multiplicative character of KI = ∏Y ·σ
√
pi · l in the linear
regression, the factors σnom and
√
pi · l1 were logarithmized. Y was assumed to increase
additively and not multiplicatively between the propagating versus stopping of the first
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crack. The multiplicative linear regression yielded similar results with an increase in KI,1
by 0.430N/mm3/2 (p < 0.001, with by-factors of log(σnom): p < 0.001, log(
√
pi · l1 ):
p < 0.001, adj. R2 = 0.813).
When the relation of KI to the stress σnom and crack length l1 were ignored (Fig. 2.26), the
average stress intensity of propagating first cracks KI,0,prop = 2.09± 1.85N/mm3/2 was
0.71N/mm3/2 higher (p = 0.008) than the stress intensity of stopped first cracks with
KI,0,stop = 1.38± 1.06N/mm3/2. Furthermore, the first crack KI,0,prop was significantly
higher than any KI of crack tip a and b (p < 0.001 vs. KI,a,prop = 0.94± 1.04N/mm3/2,
KI,a,stop = 0.54± 0.68N/mm3/2, KI,b,prop = 0.67± 0.70N/mm3/2 and KI,b,stop = 0.44±
0.49N/mm3/2). The values of the stopped first crack were higher than any other stopped
crack tips (KI,0,stop vs. KI,a,stop, p < 0.001; KI,0,stop vs. KI,b,stop, p < 0.001) and still higher
than values of propagating far tips (KI,0,stop vs. KI,b,prop, p = 0.004).
When the cracks were sub-grouped, the first crack values were significantly higher than any
of the second crack values (KI,0 = 1.67± 1.46N/mm3/2 vs. KI,a = 0.66± 0.83N/mm3/2,
p< 0.001; KI,a vs. KI,b = 0.52±0.58N/mm3/2, p< 0.001) (Fig. 2.26 top). There was a sta-
tistically significant increase between all propagating crack tips KI,prop versus the stopped
crack tips KI,stop (p < 0.001, the average of the multiplicative increase from the stopped to
respective propagating tips of the same location in Fig. 2.26).
With a maximum number of 9 parameters in the regression of the stress intensity factor
KI, the results of less extensive analyses were confirmed. The input parameters were the
nominal stress σnom (p < 0.001), the root of the crack length
√
pi · l (p < 0.001), and the
logarithm of the root of the crack length log(
√
pi · l ) (p < 0.001), Furthermore, the cracks
were differentiated with 6 binary variables, of which 4 gained significance: stopped cracks
had lower KIs by −0.465± 0.141N/mm3/2 than propagating cracks (p = 0.001), OVX
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Figure 2.26.: Stress intensity factors KI in relation to the crack tip and propagation status.
Error bars: 1 SD.
animals showed lower KIs by −0.600±0.088N/mm3/2 than CON (p < 0.001), the second
crack far crack tips had −0.607± 0.142N/mm3/2 lower KI,bs than the main crack tips
(p < 0.001) and the second crack near crack tips had −0.498±0.139N/mm3/2 lower KI,as
than the main crack tips (p < 0.001).
4.3. Initiation of Microdamage
The second data part of this study was to determine the circumstances under which micro-
damage in the micro tensile experiment occurs. Microdamage initiations were observed,
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and their location noted in relation to the main crack(s) (see sketch 2.24). A total of 165
valid microdamage initiations were observed in the 10 samples (Tab. 2.5). Of these, 129
appeared when there were two main cracks, requiring a more complex analytical compu-
tation approach (Table 2.4 right column). The microdamage was classified 62 times as
microcracking and 103 times as stress whitening.
4.3.1. Microdamage Initiation Locations
Newly initiated microdamage was homogeneously distributed ahead of the first and second
cracks (Fig. 2.27). The microdamage location distribution was symmetrically around the
main crack propagation direction, the horizontal θ0,b = 0◦ line. From the von Mises equi-
valent stress function (eq. 2.8), a higher damage incidence would be expected with high
location angles θ , i. e. parallel cracks above or below the main crack, rather than pre-
dominantly in front of the crack within narrow θ angles. The average distance from the
main crack was r0 = 438± 313µm (n0 = 165), from the second crack rb = 316± 348µm
(nb = 129). The average angles relative to the first crack tip 0 were θ0 = 5.41◦± 27.38◦
and the average of the absolute angles was |θ0|= 21.61◦±17.59◦.
OVX appeared to include cases of failure which exhibited a high y-component of the
distance rb (see e. g. red diamonds between y = −250 . . .− 500µm in Fig. 2.27 A & B).
The absolute values of the y-component of the location of damage was highly signifi-
cantly increased in OVX in general by ∆yOVX = 64.4± 17.6µm (p < 0.001, n = 165,
adj. R2 = 0.074) respectively by ∆yOVX,2 = 79.6± 20.4µm in cases of 2 main cracks
(p < 0.001, n = 129, adj. R2 = 0.108). The coordinates were independent of stress
whitening and microcracking (p > 0.1).
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Figure 2.27.: Microdamage initiation locations in relation to the main crack tip 0 (A) and
the far crack tip b of the 2nd crack (B). The polar coordinate systems of θ0, r0 respectively
θb, rb are indicated from the horizontals θ0,b = 0◦.
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4.3.2. Microdamage Initiation Stresses
With the previously determined stress intensity factors KI of the main crack(s) (p. 65), the
local Cauchy stresses at the microdamage location were calculated (see Table 2.4). The
local stresses are composed of a primary part from the major crack with KI,0, and, if a
second main crack existed, of a stress portion from the far tip of the 2nd crack with KI,b.
The Cauchy stresses σx, σy and τxy were then condensed into a single von Mises equivalent
stress value σe (eq. 2.7b).
The nominal stresses on the tensile samples at the time of microdamage initiation were
on average σnom = 0.620± 0.428N/mm2, the von Mises stresses at the locations were
σe = 1.77± 1.27N/mm2. Damage occurred around cracks of an average stress intensity
of KI = 1.58± 1.32N/mm3/2. Fig. 2.28 shows the local von Mises stresses in relation to
their distance to the main crack tip in the main crack direction. The upper limits of the
microdamage stress plot is hyperbolic, similar to the stress function σ = K√
2pir
(eq. 2.4a
respectively eq. 2.4b as seen in Fig. 2.12), with a reciprocal decrease with the distance r0
respectively rb.
It appeared in Fig. 2.28, that samples from the CON group had the initiation of micro-
damage in a wide range of stresses, while samples in OVX did not just locally fail on
average at lower stresses (∆σe = 0.852± 0.215N/mm2, p < 0.001, n = 169), they also
did not exhibit lower stresses than the lowest CON samples. This was true both for the
locations in relation to the first crack tip 0 and in relation to the far crack tip of the second
crack b (∆σe,2 = 0.858±0.213N/mm2, p < 0.001, n = 129).
Interestingly, there was no significant difference between locations that showed micro-
cracking and the ones with stress whitening. The only influence to differentiate the two
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Figure 2.28.: Stress at the microdamage initiation site relative to the x-component of the
distance r0 to the main crack tip 0 (A) respectively of the distance rb to the far crack tip b
of the 2nd crack (B).
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Figure 2.29.: Stress intensity factors and von Mises stresses at microdamage initiation.
Areas indicate the distribution of OVX and CON group.
damage cases was a trend (p = 0.054) that a higher primary stress intensity factor KI,Isida
resp. KI,0 would preferentially cause stress whitening (Fig. 2.29).
Fig. 2.30 shows the ratio of the microdamage initiating local stresses θe to the nominal
tensile stress θ . The local stresses are expectantly higher by a factor of 1–15.
In general, using the von Mises stresses (eq. 2.7b) to express and compare the local stresses
might make not a big difference compared with the stresses in the tensile direction y: (σy =
1.81±1.20 MPa, n = 165 vs. σe = 1.71±1.22 MPa, n = 129). The von Mises equivalent
stress was still considered to be a more accurate depiction of the stress state at failure.
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Figure 2.30.: Microcrack initiation stresses σe in relation to their ratio with the nominal
stresses σ .
4.3.3. Interaction of Damage with Microstructure
Microstructures that interacted with damage had an average size of 121.5µm± 65.3µm.
The amount of structures observed are given in Tab. 2.6. The data describing the micro-
structures are similar for all cases. However, the microstructural information is linked
either to data of crack tips or of initiating damage locations, which differ totally in their
content. Thus, there are two very distinct subsets of the microstructure data.
Table 2.6 includes both microstructures that interacted with the main cracks and micro-
structures in which new damage ahead of the main cracks initiated. The counts refer
to individual crack measurements and their associated microstructures (see Tab. 2.5) and
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old osteons new osteons lamellar bone
group area normal penetrated 12 m 6 m 3 m interstitial surface
CON
CT 75 17 10 36 3 40 26
∑=306ID 56 10 2 7 6 14 4
OVX
CT 54 69 0 0 13 20 19
∑=241ID 27 17 0 0 2 19 1
∑= 212 113 12 43 24 93 50 ∑=547
Table 2.6.: Microstructures that interacted with damage. New osteons: tissue age in
months. Area: microstructures at crack tips (CT) or at newly initiating damage (ID).
not to measurements of individual cracks. The difference is that most individual cracks
were measured multiple times at various propagation stages, so most structures counted in
table 2.6 are not individual structures but sometimes the same structures measured as often
as a crack measurement would require.
The surface lamellar bone (periosteal and endosteal) was excluded from some statisti-
cal computations. This was done because these structures were very resistant against
crack propagation and interfered with computation of normal inner-cortical bone struc-
tures which were both the main focus of this study and the majority of crack cases. Of the
5 theoretically available fluorescent turnover labels, only structures from 3 of them (3, 6
and 12 months old) were observed in this study and also just in low numbers.
There were only two different types of interactions distinguished how damage inter-
acted with osteons: most osteons were not destroyed (nosteons = 291), other osteons were
destroyed severely (nstraight through = 113) and usually straight through the osteon. There
was no further distinction of damage-osteon-interaction done, such as: “crack stopped at
the cement line” or “propagated around osteon” or “deflected by osteon”. The category
“not destroyed” included all these cases and the timely information of the crack includes if
or at what propagation stage a crack was stopped.
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Of the 113 fractured osteons, a significantly higher number occurred in the OVX group
(OVX: 86 of 241 locations =̂35.7%, CON: 27 of 306 locations =̂8.8%, p < 0.001, Pear-
son’s chi-squared test). From the 79 observed interactions of recently grown osteons with
damage, 81% were observed in CON bones (n = 64), only 19% in OVX bones (n = 15).
4.3.4. Influences of Microstructure to Tissue Damage
The microstructures were determined at the main crack tips as well as at locations of newly
initiating damage ahead of the main crack tips. Due to the stress intensity computations
earlier, it was possible to compute the stresses σe at any location in a sample ahead of
the main cracks (sec. 3.5.4). Newly initiating damage that was observed at any location
ahead of the main cracks (n = 165, sec. 4.3.2) therefore offered a full data set at multiple
time points of interest of their damage initiating stress σe, their failure characteristics and
their surrounding microstructure. A regression analysis was performed to find parameters
influencing the von Mises stress σe at the damage initiation time point (adj. R2 = 0.191,
p < 0.001, n = 165). The size of microstructure was significantly correlated with the
stress (p < 0.001). The bigger the microstructures were, the lower the stresses were to
induce damage in these structures. The other microstructure dimensions did not show any
significant effects (angle of microstructure absolute and relative to the cracking direction,
both p > 0.1). OVX tissue was significantly weaker that CON tissue (p < 0.001, also
seen in sec. 4.3.2). Some microstructural characteristics did not show any influence on the
damage inducing stress, such as osteons vs. recently formed osteons (of any age or pooled
together) vs. interstitial bone.
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Figure 2.31.: Microcrack initiation stress σe relative to microstructure size. Lines indi-
cate the maximum stress level that microstructures withstand. Bigger microstructures are
weaker. The maximum stresses level in OVX tissue is lower than in CON tissue. New
osteons (filled symbols) do not appear to have any influence. Structure cracking occurs
at lower stress levels than stress whitening. Size describes the linear distance that a crack
would travel through the structure.
Figure 2.31 illustrates the differences between OVX and CON, the structural size depen-
dency and the tissue age independence. There were two microstructure trends apparent:
osteons that fractured straight through (as observed in forwarding image footage) had lower
stresses to initiate failure (p = 0.065). Furthermore, outer lamellar bone required higher
stresses to initiate damage (p = 0.094). Outer lamellar bone missed statistical significance
due to the low number of only 5 cases.
76
CHAPTER 2. MICROCRACK PROPAGATION
The correlations altered slightly with changed input parameters: when the CON / OVX
information was left out (adj. R2 = 0.091, p = 0.001, n = 165), osteons that failed straight
through were then highly significantly related with lower stresses (p = 0.004 from p =
0.065 before). This was related to the fact that most osteons that ruptured fully were in the
OVX group (nOVX,rupture = 86 vs. nCON,rupture = 27).
Local stress σe and the stress intensity factor KI were shown to correlate strongly
(Fig. 2.29). Therefore, the factors affected by one should affect the other as well. This
was tested in an additional regression similar to the last one with KI as the dependent
variable (adj. R2 = 0.182, p < 0.001, n = 165). As before the size of microstructure was
significantly correlated with KI (p < 0.001), OVX tissue was significantly less resistant
than CON (p < 0.001), outer lamellar bone showed no difference versus normal osteons
(p > 0.1), neither did interstitial lamellar bone (p > 0.1). The difference between nor-
mal osteons and osteons that fractured straight through was more pronounced (p = 0.043).
There was also a significant difference between normal osteons and recently grown osteons
now (p = 0.040). Cracking versus whitening, which was not significantly related with
stress before (p > 0.1), was significantly related with the stress intensity (p = 0.050).
4.4. Stress Whitening versus Cracking
The character of newly initiated damage was distinguished into stress whitening and micro-
cracking. The occurrence of stress whitening versus microcracking was used as an outcome
parameter in a regression analysis (adj. R2 = 0.052, p = 0.014, n = 165). It showed that
microstructure size was positively correlated with cracking (p = 0.049), so bigger micro-
structures were more likely to develop cracks rather than the less severe stress whitening.
CON and OVX tissue did not show influences on new damage initiation (p = 0.709).
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Surprisingly, stress whitening was positively correlated with the main crack stress intensity
KI (p = 0.009, visible in Fig. 2.29 at cases of higher KI). This might indicate that shorter
cracks with lower KI are surrounded by relatively homogeneous stress fields that promote
damage both in the form of stress whitening and more severe cracking, whereas longer
cracks with higher KI may be powerful enough at their tips to enforce mainly their own
crack propagation, but do not initiate severe damage in their surrounding.
Short cracks create stresses that may initiate other damage in their environment — long
cracks create stresses in their environment that make themselves even longer9.
Another unexpected relation was a negative trend of the von Mises stress levels σe with
cracking (p = 0.057). When microstructures cracked they had lower stresses than struc-
tures that showed stress whitening.
9This effect is known in daily life as “money begets money” (Wilson, 1572), “nothing succeeds like
success” (Janin, 1830s) or as the “Matthew effect” (Merton, 1968).
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5. Discussion
This study looked at crack propagation in osteonal bone on the micrometer level in real-
time. Additionally, the initiation of microdamage in the stress field around main cracks was
studied. The failure was designed from tensile loads in transverse sections of metatarsals
from control and 12 months ovariectomized sheep.
5.1. Ovariectomized Sheep Bone is Less Tough
The bones from the ovariectomized sheep (OVX) showed lower stress intensity factors
during the tests (p. 65). With the average K values of KI,0 = 1.67± 1.46N/mm3/2, OVX
animals showed significantly lower KIs by −0.590± 0.086N/mm3/2 than CON. A stress
intensity factor KI in principle describes a crack. Observing how cracks, with a certain KI,
react, for example if they stop at a structure of if they propagate, can be taken as a failure
criterion. Therefore, even if KI is itself not a measure of material toughness, together with
material failure information, it can be used to describe the material’s resistance to crack
propagation. The crack propagation resistance of OVX bones was strongly diminished, the
material was more brittle.
In earlier experiments on material of the same origin, other mechanical properties of OVX
were shown to change such as: stiffness decrease of trabeculae by ≈ 10–15% (Bren-
nan et al., 2009), decrease in stiffness of trabeculae by 16.4% (Brennan et al., 2011c),
decrease in mineral content of trabeculae 11.8% (Brennan et al., 2011c), tissue hetero-
geneity increase of 12.6% (Brennan et al., 2011a), reduction in ultimate strength of ver-
tebra bodies of 8.25% (Kennedy et al., 2008a), increased stiffness reduction of vertebra
bodies of 17.5% (Kennedy et al., 2008a), reduced bending modulus of cortical bone of
13.4% (Kennedy et al., 2008c), increased surface crack density of cortical bone of ≈15%
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(Kennedy et al., 2008c), reduced yield strength of whole bone sections (Kennedy et al.,
2009a), reduced stiffness of whole bone sections (Kennedy et al., 2009a), differences in
microindentation parameters on cortical bone (Sec. 4.1.6 & 4.2.6) and reduced nanoinden-
tation modulus of young tissue (Sec. 3.2). While on the other hand, there were also several
factors that did not change such as: no change in strength of whole bone sections (Healy
et al., 2010), no change in compressive strength of whole bone sections (Kennedy et al.,
2009a), no change in work to fracture of whole bone sections (Kennedy et al., 2009a), no
change in trabecular hardness (Brennan et al., 2009), no change in bending fatigue life
(Kennedy et al., 2008c), no change in crack density (Kennedy et al., 2008c), as well as no
difference in tissue hardness (Sec. 3.1).
This study found a decrease in stress intensity factor resistance by 35.3% in the OVX sam-
ples. The higher percentage change in this mechanical value may be explained by a bigger
influence of estrogen deficiency on dynamic crack propagation than it had on the more
static tests that were performed previously.
Decreasing bone resistance is associated with age in general and with several specific fac-
tors (Wang & Puram, 2004). Aged interstitial bone is higher mineralized (Grabner et al.,
2001) and contains more microcracks (Schaffler et al., 1995), as well as vice versa in areas
close to microcracks the stiffness is elevated (Zioupos, 2005). Collagen properties and
cross-linking change (Zioupos, 2001; Wang et al., 2006). On the other hand, bone turnover
increases (Kennedy et al., 2009a), newly build osteons have a lower stiffness (Guo et al.,
1998; Zimmermann et al., 2011) that can increase the toughness (Malik et al., 2003).
These results are supported by the findings of Ritchie et al. (2006b), who reported a 40%
toughness decrease over 65 years of human aging. Zimmermann et al. (2011) showed R-
curves with KI,C with crack lengths l1 similar to this study. Nalla et al. (2004) reported
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similar stress intensity factors of KI,C = 2.06N/mm3/2 for cortical bone of young humans,
decreasing to KI,C = 1.26N/mm3/2 for old humans. The smallest damage used for stress
intensity factor measurements were done by Mullins et al. (2007; 2008) via nanoindenta-
tion techniques with cracks sized 7–56µm and KI,C = 0.4–2.3N/mm3/2.
5.2. Ovariectomized Sheep Bone is Less Strong
It was observed, that newly forming microdamage in the stress fields ahead of the main
damage is different between OVX and CON bone. Microdamage initiated in OVX bones
at significantly lower local stresses (Fig. 2.28). Interestingly, the calculated local von Mises
stress of failure was around 1–5N/mm2, which is a factor of 10–20× below the organ level
applied stress for failure of bones (Zioupos & Currey, 1998).
5.3. Distribution of Stress
The distribution of microdamage was significantly different between OVX and CON bone.
Microdamage in OVX samples initiated significantly further away from the main cracks
parallel to the main cracks (Sec. 4.3.1).
The patterns of damage in front of the main cracks, as well as their low stress levels can be
explained as follows: In tensile tests, a self-selection takes place, driven by 3 influences, a)
the stress distribution in general, b) locally high stresses due to unfavourable microstructure
orientation and stiffness, c) the actual strength of the weakest material. Microdamage
occurs wherever these three factors combine sufficiently and the real stress surpasses the
real strength. During the test, the weakest areas in the stress field fail first. The main crack
may then propagate through pre-damaged areas, being subject to crack propagation arrest
at further microstructures.
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The failure of the weakest and / or most structurally disadvantaged area of bone causes a
relaxation of the inhomogeneous stress state in the material, which releases other highly
stressed areas. The zone of microdamage in front of the main cracks seems to be limited
to around 1000µm, although the theoretical stresses beyond that distance are still within
the range of the failure stresses closer to the main crack. The distance of several osteon
diameters appears to sufficiently distribute and relax the inhomogeneous peak stresses in
the stress field around the main crack tip.
5.3.1. Interaction of Damage and Microstructure
In this study, 74% of the microstructures associated with damage were osteons (404 of
547), only 17% were interstitial bone. This does not conflict with seemingly opposing
numbers by other researchers, who found that 9 out of 10 microcracks initiate in interstitial
bone (Schaffler et al., 1995: 87%, Kennedy et al., 2008b: 91%). This was caused by the
main interest of this study: the focus was on the structures that interacted and interfered
with damage — not where cracks initiated. Much damage may initiate in interstitial bone,
but it propagates immediately through these weak structures to rest at stronger structures
— e. g. at an osteon, consequently the structure identified in this study to interact with the
damage in this case would have been an osteon. Naturally, the used technique results in
low interstitial bone counts and high osteon counts.
Old versus New Osteons
Of all events where recently remodelled, fluorescently labelled, new osteons interacted
with cracks (n = 79), 81% were observed in CON bones, only 19% in OVX bones. It
was expected, that these would be more equally distributed over the two treatment groups.
Especially, as early stage osteoporotic bone is known for elevated levels of recent bone
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turnover. On the other hand, a higher number of interactions of cracks with new osteons in
CON was also observed by Kennedy et al. (2008b).
There was little difference seen in the interaction of damage with old osteons compared to
new osteons (older respectively younger than the first fluorescent turnover label 12 months
before tissue harvesting). The only significant difference in this study was that new osteons
as damage initiation locations were associated with main cracks with slightly lower stress
intensity factors KI than old osteons.
Based on Kennedy et al. (2008b) it was initially expected that newer osteons would some-
how “attract” cracks, due to their lower stiffness, and then stop these cracks, due to pre-
sumably higher toughness. It was one of the original aims of this study to observe this
presumed behaviour in real time. However, with the available data from the experiment it
was not possible to either support this neither to rule it out. This may either be because
the differences were not as big as expected, or due to low numbers of new osteon-damage
interactions in this study. Crack-microstructure interactions cannot be directed towards par-
ticular structures of interest in this experimental set-up. The cracks just defined their own
random way through the material — they either serendipitously hit some new osteon or
they just did not. There only way for the experimenter to somehow influence the path of a
crack was in defining a sample region that contained a slightly higher count of new osteons
and grind the crack starting notch into this region. Furthermore, the primary loading direc-
tion determined the rough crack direction. Other than that, crack interactions with new
osteons were subject to pure chance.
To gain further insights into the interactions of new osteons with damage, the sample num-
bers would need to be increased by a factor of 2–5. For the current study there were
17 sections tested, 12 of them successfully, 4354 images analysed, 230 main crack and
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165 initiation site measurements performed and 547 damage-microstructure interactions
recorded. An expansion of sample numbers would require several weeks for the experi-
ments and several months for their analysis — this was beyond the scope of this work.
Ovariectomized Bone has Inferior Old Osteons
There were significant differences between microstructures in OVX bones and control
bones. The OVX structures withstood less local stress (Fig. 2.31). However, there were no
indications that this was in relation to recently grown tissue. The effects appeared in struc-
tures that grew before the ovariectomy in this study. This raises the question of how much
involvement recently grown tissue actually has in the issues associated with osteoporosis.
Changes in the old tissue appear to be the issue — it gets brittle. Undeniably, there is a
huge increase of bone remodelling with the onset of osteoporosis. However, alterations in
this small percentage of the entire bone volume may be of smaller importance at the organ
level than it is commonly believed.
Osteons may become more brittle in osteoporosis through increased calcification. Osteo-
cyte death and subsequent area calcification is associated with osteoporosis, however, in
early stage osteoporosis this effect should be low. Furthermore, increased calcification may
come from insufficient control of osteocytic osteolysis. Following this, one important job
of a healthy osteocyte in a non-osteoporotic individual would be to create and retain a
subtle state of demineralization.
The issues of osteoporosis may be attributable to old osteons — not to new osteons.
Size of Microstructures
In this study it was shown that the size of microstructures reflected directly in their resis-
tance against damage. This directly supports an hypothesis of Taylor (2000), which related
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bone strength to sample size: due to probabilistic effects of the flaw distribution, big-
ger bones have lower strength. Taylor (2000) estimated from this, that the optimal size
of microstructures in bone is around the volume of individual osteons. Taylor’s graph
(Fig. 2.32) of strength versus structure size ends in a plateau of maximum strength at a cer-
tain structure size — interestingly, figure 2.31 shows similar characteristics. The plateau
in this study is at a structure diameter of 110–140nm, which, at a normal osteons length of
1–4mm, equals to a volume of 0.1–0.6mm3, which fits favourably to the 0.1mm3 magni-
tude of Taylor (2000).
Figure 2.32.: Relation of stressed volume size and fatigue strength. The stressed volume
is the proportion of a sample that is stressed significantly (i. e. over 80% of the maximum
experimental stress). This enables comparison between different testing methods, such as
bending versus compression. From Taylor (2000).
The sharp decrease in structural strength with increased size in this study shows dramati-
cally how important the maximum size limitation of osteons in bone is.
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Outer Lamellar Bone is Protective
The findings in this study regarding primary lamellar bone are in agreement with what
other researchers found. Primary lamellar bone had a higher stress tolerance than cortical
osteonal bone. The outer lamellar bone may therefore act to protect the entire bone. Most
animals grow fast enough to gain primary lamellar bone — to their own benefit. Humans,
on the other hand, have evolved medicine so far that they outlive the best times of their
bones — and may subsequently suffer osteoporotic issues, an unfortunate drawback of the
medical / scientific developments over the past 200 years10.
When Fail, Fail Fast, Fail Loudly
Microstructures with initiating damage in the more severe form of cracking failed under
lower stress than the ones that developed stress whitening (sec. 4.4). This is counter-
intuitive at first glance — because higher stresses should cause more severe damage.
Furthermore, individual osteons that failed straight through were associated with lower
stress levels (sec. 4.3.4). This is counter-intuitive as well, as a full destruction of round
lamellar structures should require higher stress levels than delamination.
On a second thought this is a principle known from software engineering: “when fail, fail
fast”, occasionally followed by “fail loudly”. This means that when a system realizes that
it will fail, it should fail as soon as possible and it should fail loud enough to be recognized.
Systems like that are called fail-fast systems. They enable and encourage the failure at the
level of small components, which will give alarm to enable some higher level structure to
cope with the failure somehow and survive without a catastrophic crash.
10The Western World traded in tuberculosis, diarrhoea and meningitis (Lozano et al., 2012) for the lesser
of two evils: adiposis, cardiovascular disease, depression, Alzheimer and osteoporosis (Lopez et al., 2006).
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This is exactly the case in bone between the microstructural level and the organ level:
• Individual structures may fail: osteons or size magnitude equivalent tissue portions.
• Some structures are prone for failure: for example unusually weak old osteons that
will fail inevitably at some stage.
• Structures will fail fast: under low stress and in the more severe way of cracking.
• Structures will fail loudly: osteocytes sense cracks in bone.
• Some feedback mechanism of the higher level structure fixes everything: osteocytes
send a signal, a BMU remodels the area in time.
• The higher level structure survives: the mechanical integrity of the bone is ensured.
There are theories, that with elevated turnover in osteoporosis, there will be an increased
heterogeneity and a higher number of potential sites of microcrack initiation, which in turn
will lead to an elevated burden of microcracks over prolonged time. The data in this study
do not support this view11. The initiation of damage seems to be exactly the other way
round: individual structures fail, because they are suddenly more prone to, and the higher
level structure deals with it by remodelling the increasing sites of damage. In the long run,
this still results in the same increased microdamage burden. But we have to understand the
underlying principles in order to treat the disease. For the past three decades, osteoporosis
has been treated by lowering the remodelling activity. This does not tackle the real problem.
The problem is connected to fast failure of individual structures. These structures seem to
be too brittle, so they fail under lower loads. If we do not treat brittleness at a tissue level
any medication is a drop in the bucket — without even knowing if the bucket holds water.
11In fact, the data here indicate that these theories are somewhere close to utter non-sense or at least are
purely observational rather than causal.
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Other studies have shown that in osteoporosis the osteocytes are dying. In our animal
model, Brennan et al. (2011b) showed that after 12 months of OVX, there was a 10%
proportion of osteocytes associated with apoptotic remnants. After 31 months, 15% of
the cells showed apoptosis signs. Normal apoptosis is done within a few days. However,
if this would be the speed of the “apoptosis” observed here, there would not be a single
cell left by 12 months. We observe a remarkably slow apoptotic process here. It more
resembles a slow and dragging starvation death than a well structured fail-fast process12.
These cells are fighting for their lives as long as they can — because it might just be a
temporary lack of nutrients13. Under no circumstance are individual osteocytes allowed
to die a silent and lonely death — because they are the vitally important messengers of
the failure of bone microstructures. If a majority of the messengers at the lower level
vanish over time — without failing loudly — the higher level structure will not be alarmed
and one day fail catastrophically. Osteocytes have a remarkable capacity to survive their
own starvation and they fight for years as the numbers tell us. However, the currently
treatments of osteoporosis are not aimed at starving osteocytes. Because osteocytes do not
fail loudly when they fail in solitary starvation14 — and medics and scientists do not pay the
12Judging from these facts, individual osteocytes under low estrogen cannot under any circumstances be
allowed to fail-fast.
13Other cells, like muscle or fat cells can reduce their numbers in case of starvation, however, bone cells
cannot because they cannot be replaced with new cells easily after a starvation period.
14Medics are familiar that starvation is a silent death. In fact, most failures due to starvation are. For
example it is one of the recommended ways of humanely killing laboratory animals by oxygen starvation
— their brain cells just die a (supposedly) peaceful and silent death. There may be a short period of panic
during this procedure when performed at a rat or mouse, however, once the cells are in a state of advanced
nutrient starvation the animals stop their loud failure, get remarkably calm at death’s door and finally all
systems shut down silently. As a second example, malnourished humans do not die loudly or dramatically,
they undramatically get unconscious one day and do not wake up again. One interesting, practical indicator
of how not-loud this is, can be seen in the generally loudness-driven media coverage: 5 million children die
world-wide per annum from malnutrition, that is 14 000 per day, however, media constantly prefer to draw
their attention to single events in which one dozen people die in one loud explosion.
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appropriate attention to the fact that osteocytes fight a desperate and enduring fight against
the odds against starvation and that this is the start of the higher structure catastrophic
failure that we know under the name of osteoporotic fracture. Future medical treatment
for osteoporotic patients and potential osteoporotic patients must honour and care for the
osteocytes.
Conclusion: bone at the mechanical microstructural level is a fail-fast system. I hereby
hypothesize that the elevated number of remodelling sites observed in early stage osteo-
porosis can be sufficiently explained by the rules of fail-fast systems. Medical treatment
must acknowledge this. As long as the principles of this fail-fast system at the mechanical
microstructural level are guaranteed, the entire organ as the higher level structure will be
fail-safe. Once individual osteocytes die a slow and unfortunately silent death, the system
comes out of balance and will fail one day catastrophically.
We should not interfere with remodelling as much as we have for decades to “treat” osteo-
porosis — this may be neat to treat some symptoms of the disease — but it does not
change anything down at the level of the suspects involved. Future research and medical
care must a) take proper care of starving osteocytes, and b) decrease the brittleness and
maybe increase the failure stresses of individual microstructures.
“If a problem is not completely understood, it is probably best to provide no solution at
all” Scheifler & Gettys (1996).
We hereby (may) understand the problem.
Provided that this theory is at least partly true, we may then finally try to develop and
provide proper solutions.
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5.4. Limitations
5.4.1. Bone Embedding Medium
The PMMA cement used for sample embedding is two-phased: a powder, consisting of
small beads of pre-polymerized PMMA and a liquid pre-phase of PMMA, that binds the
beads together by polymerization. In a previous study on single trabeculae (McGrotty,
2006), the mixed cement sometimes leaked into the testing area of the trabecle. The resi-
duals on the surface were then washed off with the liquid component of the cement. How-
ever, this technique led to an infiltration of the whole sample with the liquid pre-phase of
the polymer with a potential to polymerize in the voids and change the mechanical proper-
ties. This might not have had much of an effect in McGrotty’s test, as the trabeculae were
tested in tension in their predominant microstructural direction, yielding ultimate tensile
stresses of σu = 27N/mm2. But for this study, where splitting of microstructures domi-
nates and the stress levels of microdamage were in the region of σe = 0.5 . . .5N/mm2,
even a slight PMMA infiltration may cause a significant increase in the splitting strength
and had to be avoided by increasing the cement viscosity. In contrast, the viscosity must
be low enough for the mixture to be sucked into the end cap’s hole by capillary action.
For proper wetting of the sample’s surface and to penetrate the voids to build a sufficiently
strong embedding for the tensile test it has to be also quite liquid. Furthermore, polymeri-
zation begins as soon as the powder and the liquid phase are mixed and viscosity then
increases continuously. Additional liquid phase can be added on demand to decrease the
viscosity again, but the strength of the cement suffers with lower bead content (Belkoff
et al., 2002). It was not impossible to get sufficient embedding but the technique was still
not satisfying. The challenge was to get the small range of viscosity in which all negative
effects are avoided. When the viscosity of the mixture is too low, the liquid parts may
infiltrate the sample and ruin it, when it was too viscous, the sample did not bind and trans-
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fer enough load into the sample, instead the sample would slip out of the end cap and the
embedding had to be repeated. Even if the grain of the powder was not known exactly, finer
grinding might help from a rheological perspective of non-Newtonian fluids. This should
allow lowering the liquid fraction in the mixture and improve the flowability into small
capillaries and interstices between bone and end cap with a decreased potential of infiltra-
tion of the testing region by excess liquid phase present between the big beads. Mixing the
two phases for longer time > 2min with a higher liquid content than normal, did result in
a mixture that was less likely to infiltrate the entire sample accidentally, but had sufficient
adhesivity to yield the pull-out from the end caps.
MMA is a hydrophobic solvent, therefore, embedding had to be done on air-dried bone.
The samples were exposed to air-drying before and during the embedding for 30–60min
and were rehydrated as soon as possible afterwards. Currey (1988) concluded that the
mechanical effects of drying and re-wetting of cortical bone “can probably be ignored”.
5.4.2. Limitations of Stress Intensity Factor Calculation
Stress Situation
Stress intensity factors are mostly calculated for plane strain situations, which are given for
sample thicknesses of t ≈ 1 . . .10mm in cortical bone (Currey, 1998). In this experiment,
with t ≈ 0.1mm, there is a plane stress situation15. No thickness dependence was seen
between t = 0.5 . . .2mm by Behiri & Bonfield (1984), while on the other hand, Norman
et al. (1995) reported that the mode I toughness varied significantly with t = 2 . . .6mm and
15So-called plane strain occurs in thick sample geometries in which the sample cannot divert straining
energy into the third dimension (the thickness). Therefore, there is no strain into the thickness of the sample,
it stays exactly the same thickness. The strains occur purely in the two dimensional plane. While in thin
samples, external load energy can be distributed to change the thickness dimensions as well. A thin sample
in tension will get thinner. However, no external loads act against this thinning. The stresses are purely in
the two dimensional plane, hence its name plane stress.
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become constant at t > 6mm. The influences of the plane strain situation are not known.
As the sample thickness was kept within a narrow range (see Table 2.5), the results are
consistent and comparable within the study.
Stress Calculation behind Second Crack Tip
The local stresses σy, σx, τxy (or merged into one equivalent stress σe) for each individual
microdamage location (n = 173) consisted of a part σe,0 from the first crack tip 0 with
KI,0 (n1 = 173), and, if a second main crack existed (n2 = 132), of a part σe,b from the far
tip b of the 2nd crack with KI,b. For some microdamage locations in the stress field, the
second crack portion σe,b could not be calculated, because the microdamage location was
in front of the first crack, but behind the far tip of the second crack (nneg rb = 41). The
formulae for computing the Cauchy stress field values (eq. 2.3) did not permit computation
behind the crack tip with negative x-components of the distance rb. In these cases, the total
equivalent von Mises stress σe was computed as the σe,0 from the first crack. Of the total
173 microdamage locations, 64 had only 1 crack, 68 had 2 cracks and a valid rb, 41 had 2
cracks but a negative x-components of rb and gained no σe,b. From the 68 locations with
both σe,0 and σe,b, the average loss was calculated to σe,b = 29.1%± 11.7%·σe,0 (range:
∆σe,b = [9.8%,62.3%] ·σe,0).
Fracture Mode I
The stress intensity factors KI were only calculated for fracture mode I (tensile opening),
but not for mode II (in-plane shear) and mode III (out-of-plane shear) (see Fig. 5.17).
The computed stresses are therefore only exact for cracks perpendicular to the external
stresses. For cracks with a wide deviation from this direction the calculations suffer some
inaccuracy. On cracks within a small angle range the inaccuracy is small.
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5.5. Future Work
When looking at the principle of Five Ws and one H in relation to this study, one would be
able to answer each of the six questions already.
“What is it about?” Microdamage in ovine cortical bone.
“What happened?” Material failed, leading to the initiation and propagation of cracks.
“When did it take place?” In a tensile test with images and forces recorded.
“Where did it take place?” Damage took place at the tip of main cracks and as initiating
damage in remote locations.
“Why did it happen?” The material failed whenever the local stresses were higher than
the local strength. Strength and stress states were highly dependent on the structure of the
material and on the already existing damage.
“How did it happen?” Main cracks propagated further and were occasionally stopped
by structures which were able to withstand the damage. Microdamage occurred as novel
failure sites, presumably at the weakest locations through delamination.
There are several research directions leading from the results of this work, to deepen the
analysis of the data with different approaches, to connect it with further material data and
to improve both the experimental and the computational techniques. Each idea would help
to deepen our knowledge of the answers to one or several of the W-questions regarding
microdamage initiation and propagation in bone. For decades, bone researchers have been
interested in the how and why bone fails, as well as the when and where, respectively, under
which loading and structural conditions and where the material is prone to fail in the future
and if and how this can be prevented.
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5.5.1. Magnification of Motion and Colour
Wu et al. (2012) introduced a method for real-time motion and colour intensity magnifica-
tion. Applied to the time dependent image data of this study, this enables a more accurate
determination of time, size and shape of initiating microdamage. It could help in the detec-
tion of yet overlooked locations with less severe microdamage that did not necessarily lead
to fluorescent dye uptake and signal. Furthermore, it would help to define the crack tips
more accurately, as well as strain changes in the close vicinity around the crack tip.
5.5.2. Local Strain Visualization via Strain Maps from Digital Image Correlation
Figure 2.33.: Digital Image Correlation in cortical bone under tensile load. Colours repre-
sent the tissue strain in percent in the tensile direction. From Hoc et al. (2006).
So-called Digital Image Correlation (DIC) can be applied to the existing image series to
calculate strain maps (Fig. 2.33) of the samples for any time point (Winwood et al., 2006;
Hoc et al., 2006; Sun et al., 2010). DIC works by identifying reference points and com-
paring these patterns to subsequent images and computing the local strain of the material.
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Strain maps provide timely information of the microdamage initiation as well as the local
strain resistance. Most DIC programs are proprietary, but free tools are available16.
5.5.3. Electronic Displacement Control
Figure 2.34.: Loading and partial unloading during a tensile test provides the sample stiff-
ness at various stages of damage progression. From Nalla et al. (2005b).
In the rig design used, the load was applied as displacement via a screw thread by hand and
was inhomogeneous over time. This could be improved to yield a constant strain over time
by building in an electromechanical motion device, such as a motor with a worm gear. The
motor device could be controlled electronically, which would enable advanced loading
patterns, such as the continuous loading and unloading of Fig. 2.34. This enables crack
growth rates to be measured over time and also the behaviour of stiffness and compliance
of the sample in respect to the test progression and failure state (Nalla et al., 2005b).
16Free DIC can be performed based on the open source DIC and Tracking Package for MATLAB available
from www.mathworks.com.au/matlabcentral/fileexchange/12413 or with the MOIRE software available from
www.opticist.org/node/73.
95
CHAPTER 2. MICROCRACK PROPAGATION
5.5.4. Calcification Mapping
Figure 2.35.: Mineralization map of a trabecle from qB-SEM. From Brennan et al. (2011c).
Zioupos (2005) pointed out the co-occurrence of high local mineralization and micro-
damage in fatigue samples, especially in interstitial bone. The heterogeneity of cortical
bone influenced the initiation of microdamage and presumably the propagation and coa-
lescing of cracks (Zioupos et al., 2008). Mineralization maps of bone can be obtained by
quantitative backscattered scanning electron microscopy (qB-SEM), as used by Brennan
et al. (2011c) for trabecular bone from the BFL project (Fig. 2.35). Connecting minerali-
zation maps of the tested samples from this study and the life imaging would increase our
knowledge of the initiation of microdamage and the progression of macrocracks in bone.
5.5.5. Microstructural Direction Implication
The most extensive broadening and continuation of this research would be the implications
of the microstructure of bone.
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Differentiation of Tissue Types
The age of osteons in the BFL bones (see Table 1.2) can be related to the crack characteris-
tics. Furthermore, this study did not focus on a differentiation between full osteons, part
of osteons and interstitial bone. Up to 87% of all microdamage initiates in interstitial bone
(Schaffler et al., 1995; O’Brien et al., 2003; Zioupos, 2005). However, this behaviour was
not investigated in this study due to time constraints.
Testing of Periosteal Lamellar Bone
There was one sample tested, with a relatively wide periosteal lamellar rim, in which the
notch for crack initiation was of insufficient depth, so the notch ended in periosteal lamellar
bone rather than in the main osteonal cortex. Although there was only a layer of around
100µm between the notch tip and the osteonal bone, this material did not fail at the start of
the test. Instead the osteonal bone behind the lamellar bone began to rupture. Only after the
main crack in the osteonal cortex was already at a length of around half of the entire cortical
thickness did the small periosteal lamellar bridge fail. The KI values from this sample were
around 2× higher than for other cracks. The reason for this elevation was clearly due to
the microstructural environment of the notch tip. Correct treatment of all values from this
sample would have been a) to include it in the study data, the introduction of an extra
binary variable in the analysis of variance and to either compute a compensatory value
for any analysis with less variables or to exclude it there or b) to exclude this one sample
entirely. Option b) was chosen due to practicality issues.
Nevertheless, it would be very interesting to broaden this study towards periosteal bone
with additional samples. As periosteal bone appeared much stronger than osteonal bone,
this further rises the question of how much the mechanical properties of cortical bone
samples get skewed with the inclusion of even small amounts of the outermost bone layers.
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Calculation of Fibre Directions
The directionality of the microstructure is of huge importance in bone failure. Numerous
studies related the occurrence of damage with the character of the osteonal bone (e. g.
interstitial, old & new osteons) (Schaffler et al., 1995; O’Brien et al., 2003). However,
relation of local stresses with an accurate microstructural direction and the direction of
the failure was not performed. Partly this was due to the difficulties in determining the
microstructural direction and in the difficulties performing experiments that are able to
visualize damage accurately in space as well as the load relative to the crack behaviour.
Figure 2.36.: Circular polarized light image of a section of cortical bone in transverse
direction. The average background direction can be estimated to be 20° from the horizontal
with two osteons embedded in it. Image width: 320µm, resolution: 3.2 µm/px.
The direction of lamellae can be visualized with collagen fluorescence (Ascenzi & Lomovt-
sev, 2006), which is technically demanding and limited to small volumes. Lamellar orien-
tation can also be assessed from birefringence patterns in polarized light17, as used by
17Circular polarized light images can be obtained from bone sections that are thin enough to allow bright
light to pass through (≈100µm). The set-up was with white, randomly orientated light from a mercury bulb,
passed through a monochromatic filter of λ = 546±5nm (Bromage et al., 2003), a linear polarization filter, a
+λ/4-plate, the birefringent sample, a −λ/4-plate, a linear analyzation filter and into the microscope camera.
The wavelength λ for the λ/4-plates should be close to the monochromatic filter λ ≈ 560nm.
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Mauer et al. (2009) for orientation mapping for cortical bone sections18. The method was
based on the principle, that bone lamellae exhibit different brightness intensities in pola-
rized images (Fig. 2.36). Therefore, the direction of peaks and valleys in the brightness of
such images is equivalent to the direction of the lamellae (Fig. 2.37 B). Peaks and valleys
of intensity can be detected with edge detection methods. The in-plane directions α of
the peaks and valleys can be derived from edge detection algorithms19, implemented as
macros in MATLAB R2007B (The MathWorks Inc., Natick, USA).
Figure 2.37.: Angular information contained in polarized light images (e. g. Fig. 2.36). A:
The out-of-plane angle β is related to the intensity of individual pixels in circular polarized
light images of bone. B: The in-plane angle α of a central pixel can be calculated from the
neighbour pixels by determining the directionality of peaks and valleys.
18The technique is not constrained to cortical bone, but is applicable generally to any images that suffi-
ciently represent the structural directions of a material.
19The core operations were so-called image convolutions G = S∗A, which are a special type of multipli-
cation in which pixel values of an original image A are multiplied individually with corresponding values of
a small filter matrix S, also called kernel. The sum of this set of multiplications over S is the resulting value
for the central pixel. The procedure is repeated for every pixel in the image, resulting in G.
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The calculation of the microstructure directionality required five steps:
1. Image sharpening20 with a Laplace filter21 SLaplace,d22 (Fig. 2.38 A).
2. Highest and lowest values were cut with a Cutting Edge Filter23 (Fig. 2.38 B).
3. Scharr edge detection filters24 convolution of Gx and Gy (Fig. 2.39A & B).
4. The in-plane direction angle is α = arctan(Gy/Gx)25 (Fig. 2.39C).
5. In low contrast areas26 αs were approximated with Alfalfa27 (Fig. 2.40, red lines).
20Laplace filters create the second partial derivative (Spivak & Pig, 1995), which, in the human perception,
looks quite different to the original (Fig. 2.36 vs. 2.38), however, for edge detection it is just a sharpened
input.
21Discrete, Laplace kernels can be computed as SLaplace,d = 4d+1 ·
 d/4 1−d/4 d/41−d/4 −1 1−d/4
d/4 1−d/4 d/4
.
22The design parameter d in SLaplace,d defines the weighting of the diagonals within the limits of
∆d = [0,1]. Most common are d = 0 (underemphasizes diagonals), d = 1/3 and d = 0.5 (overemphasizes
diagonals), MATLAB recommends d= 0.2. The Anglo-Saxon Futhark letter d, pronounced dæg, meaning
“day”, was used in honour of the Viking history of Ireland. Furthermore, its shape fits better for a diagonals
pronouncing parameter than any ancient Greek letter.
23Edge detection kernels do not work well with deviating data. As Laplacian sharpening “roughens”,
values outside the edges of±2.5standard deviations σ from the mean G were cut to G±2.5σ , hence Cutting
Edge Filter. Somehow similar is Winsorising (Hastings et al., 1947) in cutting to± percentiles, however, not
in equal distance from G, so which may make it more vulnerable for single direction outliers.
24The common edge detection filter from Sobel & Feldman (1968) was optimized by Scharr (2000),
resulting in Sx,Scharr =
 3 0 −310 0 −10
3 0 −3
 and Sy,Scharr =
 3 10 30 0 0
−3 −10 −3
 (Scharr & Weickert, 2000).
25Mathematically correctly α = arctan(Gy/Gx) should be “αi j = arctan(Gy,i j/Gx,i j) for i ∈ [1, image width]
and j ∈ [1, image height] with i being the counter of the vertical image column and j the counter of the hori-
zontal image row”. The notation α = arctan(Gy/Gx) is normally used for the division of one matrix through
another. MATLAB, as a fourth generation programming language, offers individual number calculations
when operators are preceded by a dot, thus resulting in Alpha = arctan(Gy./Gx).
26Low contrast is exhibited by 2%–15% of regions, resulting in random α (see Fig. 2.39 C vs. 2.40).
27Lamellae are relative parallel in the micrometer range, so α can be approximated from neighbour αs
with a novel algorithm called Alfalfa (Approximation logic from alphas located far away).
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Figure 2.38.: A: Sharpening of circular polarized structural image (Fig. 2.36) with a
Laplace kernel. B: Detection and shifting of exceptionally high (red, >+2.5σ ) and low
(blue, <−2.5σ ) values with the Cutting Edge Filter. Image widths: 320µm.
Figure 2.39.: A & B: Horizontal image Gx and vertical image Gy respecitively from Scharr
(2000) edge detection kernels Sx and Sy applied to Fig. 2.38 B. C: Visualization of the
in-plane angles α = arctan(Gy ./Gx). All image widths: 320µm.
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Figure 2.40.: In-plane angles α computation of the structural directions in bone. Green:
αs from Scharr in regions of sufficient contrast (Fig. 2.39 C). Blue: αs from Alfalfa in
regions of low contrast. The original polarized image (Fig. 2.36) is used as a background
for comparison with the structural directions. Image width: 320µm.
The methods mentioned above to calculate full maps of in-plane angles α were developed
for this study and tested in general, but not applied in the end. Further details and opti-
mization will not be mentioned here.
The out-of-plane angle β is related to the intensity I of each individual pixel in circular
polarized images (Bromage et al., 2003). Bright pixel are related to horizontal fibres, dark
pixels to vertical fibres (Fig. 2.37 A). The out-of-plane angles β were determined from the
relation of the individual pixels’ intensity to the image’s extreme intensities with β = 0◦
for Imax and with β = 90◦ for Imin.
Loading Curve Characteristics
The loading curves from the experiments contain information that has not been investi-
gated. Figure 2.5 shows a representative loading curve from the test. The fading force
after a force increase is not constant. Instead it depends on the structures that interact with
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the main cracks at a certain time point. Structures that allow crack propagation easily will
cause a more rapid force decrease. Therefore, the first derivative of the loading curve in
relation to the corresponding images would be of interest. The higher the first derivative
after a force increase, the more material is destroyed. As the force decreases show a loga-
rithmic character, the half-life would be of interest too. Scientifically interesting would be
a connection of these purely load derived values with the damage seen in the images, as
well as with the microstructure type and direction at the tip of the main cracks.
Development of a Microstructure Dependent Failure Model
The ultimate aim for the progression of this study would be to develop a novel model
for failure of cortical bone that is based primarily on the microstructure at the level of
single lamellae. Bone fails either due to delamination of individual lamellae, or through
the initiation of damage at material inhomogeneities, such as cement layers. However, the
latter might not be primarily due to the material characteristics of cement layers, but to the
insertion of stiffness and strength inhomogeneities. If the microstructural directions were
known to a micrometer level, much better predictions of damage initiation and progression
could be made.
Microstructural Finite Element Modelling
Bone exhibits a highly complex microstructure, which leads to complex failure situations.
If the failure of a structural material is modelled, it should accommodate the structure.
Most numerical simulations and analytical approaches of the crack behaviour in cortical
bone use fairly simple material models with a small number of stiffnesses, simple geometry
and isotropic material behaviour (Deng et al., 2008; Najafi et al., 2007; 2009). However,
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bone does not fail in simple ways at a macrostructural level, nor will it on a microstructural
level (Reilly & Burstein, 1974; Taylor, 2003; Currey, 2005).
A solution for this would be to include the microstructural directions, as described above,
into FE models. Furthermore, stiffness maps should be included28.
Although, the microstructural directions from the techniques above are not claimed to be
the real orientation of the fibres in cortical bone, they at least represent a reasonable esti-
mation of the directions. Any directional data on the microscale is supposed to be better
than the usual assumptions of isotropic material behaviour of bone — which is only the
assumed material model for many simulations, simply because there are no better data
available (Dong & Guo, 2004; 2006). The ratios of the isotropic elastic moduli in simula-
tions like Dong & Guo (2004) are fine-tuned to provide more realistic crack propagation,
however, they still effectively assume the highly structured composite material bone to be
splitting equally in all directions.
Using a material failure model in an FEM simulation has the additional benefit that the
model itself can be validated. Strain levels, as well as microdamage can be compared
between the real failure images and the simulation results.
Last but not least, FEM can be used to build hypothetical tissues on the basis of real tissues.
For example elevated bone turnover can be modelled with FEM and give insight into the
tipping point of the benefits and disadvantages of turnover.
28Stiffness mapping can be done with various techniques, such as Nanoindentation or SAM (Currey,
2002; Raum, 2008). Osteons are the largest continuous structures in osteonal bone, each has a constant age
and an undisturbed concentric cylindrical shape. Stiffness data resolution should be at least a fraction of an
osteonal diameter and in the range of 5 . . .25µm. The sections of this study were scanned with SAM at a
resolution of 15µm.
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6. Conclusions
In conclusion, in this study, on thin compact bone specimens from the metatarsals of sheep
one year post-ovariectomy versus controls, the crack propagation on a tissue level as well
as microdamage initiation behaved as follows:
1. A test was successfully created to investigate crack propagation and microdamage
initiation in transverse bone sections on a micrometer level in real-time.
2. OVX bones had a lower resistance against crack propagation than CON bones.
3. OVX bones showed lower strength against new damage initiation.
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3. The Application of Calcium-chelating
Lanthanide-based Contrast Agents
for Labelling Damage and Vascular
Structures in Cortical Bone
1. Introduction
In Osteoporosis, there is a clinical need for more precise estimations of an individual’s
fracture risk to ensure better targeted drug therapy and better monitoring of disease pro-
gression. In 2000, the European Society of Biomechanics identified the development of
a clinical method to quantify bone microdamage as a research priority (Prendergast &
McCormack, 2002).
1.1. Microdamage Detection with Fluorescent Contrast Agents
Histology is the most common technique to detect microdamage in bone (Chapurlat & Del-
mas, 2009). Basic Fuchsin was the first contrast agent to detect microcracks (Frost, 1960)
and it is still the gold standard in science. However, Basic Fuchsin is non-specific to micro-
cracks per se, only poorly water soluble and has to be applied in ethanol solution. Water
soluble, chelating agents are also available (Tables A.1 & A.2), but only the tetracycline
family is approved for human use (Arlot et al., 2005; Land et al., 2007). Furthermore,
the nature of any fluorescent contrast agent — water soluble or not — requires a method to
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excite and measure fluorescing light very close to the microdamage site. This is due to pho-
tons in the visible light spectrum having a relative high absorption rate in tissue, resulting in
maximal usable depths of vision of 50–500µm. As vertebrates possess endoskeletons, this
excitation and collection of visible light information as close as a few hundred micrometers
from the microdamage of interest is extremely challenging. Therefore, fluorescence-based,
histological techniques for microdamage research are mainly used in scientific research and
are not readily applicable in the clinic.
1.2. Magnetic Resonance Imaging of Bone
Bone can also be visualized using Magnet Resonance Imaging (MRI) (Wehrli et al., 2006).
MRI is based on measuring the nuclear magnetic resonance of the nuclei of atoms inside
tissue. High magnetic fields align the spin of protons. Further application of high frequency
magnetic fields in the resonance frequency of the protons flip the spin of protons when
photons are absorbed. When these excited protons flip back they emit photons which can
be detected by their electromagnetic signal. Bone contains only minor amounts of water
and therefore has a very low magnetic signal close to the background level.
MRI works without any potentially harmful x-ray radiation, which renders it much safer in
application than CT or PET. Furthermore, MRI scanners are already in clinical use and the
field of clinical MRI use is evolving rapidly (Griffith et al., 2010).
Since the end of the 1990s, MRI has been used to diagnose and monitor osteoporosis in
research and small clinical trials (Link et al., 1998). MRI-derived trabecular bone micro-
structure parameter analysis has superseded DEXA scanning in determining fracture risk
and monitoring disease progression and drug effects (Ladinsky et al., 2008; Bauer & Link,
2009). Other studies focused on the gross anatomical geometry of cortical bone (Gomberg
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et al., 2005; Sievänen et al., 2007), cortical porosity (Gnudi et al., 2004) as well as the
actual content of cortical pores (Goldenstein et al., 2010).
However, wider use of MRI for osteoporosis monitoring is still limited by the higher costs
of the scans compared to DEXA, as well as the lack of standardization of methods (Bauer
& Link, 2009).
1.3. Contrast Agents for MR Imaging of Bone
Recently, gadolinium-based contrast agents for MR imaging of bone have been developed.
Gadolinium-based contrast agents work through shortening the T1 relaxation time of pro-
tons located nearby. They are commonly used in concentrations around 0.1 mmol/kgbodyweight .
Gadolinium in itself is toxic (Penfield & Reilly, 2007), however, chelated in stable contrast
agents it is considered to be non-toxic and safer than iodine-based contrast agents for CT
work (Murphy et al., 1996). Cases where people suffered from gadolinium-based MRI
contrast agents are very rare (Canavese et al., 2008). Furthermore, the vast majority of
complications occurred in patients with severe renal dysfunction.
Figure 3.1.: DOTA (left) and the potential DOTA-based bone contrast agent BPAMD (right)
introduced by Kubícˇek et al. (2005).
New approaches involving MRI contrast agents for bone imaging use known chemical
mechanisms to bind to exposed calcium in microcracks and other calcium covered sur-
faces. Calcium ions make up for ≈25% of bone weight (Roschger et al., 1998). Chemical
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synthesis of potential new Gd-based contrast agents are based on the core structure of
DOTA (Fig. 3.1) for securely binding the Gd3−-ion 1.
Currently, there are two different Ca2+-binding mechanisms for potential new contrast
agents: Kubícˇek et al. (2005; 2010) and Vitha et al. (2008; 2009) modified DOTA with
one bisphosphonic acid group −C(PO3)2 to bind to calcium (Fig. 3.1). This is the same
chemical binding as in bisphosphonates, which are well known to bind to bone surfaces.
McMahon et al. (2009; 2011) developed agents based on DOTA with one to four iminodi-
acetate moieties −N(CO2Na)2 to bind to calcium. It is expected that the iminodiacetate
binding is less strong than the bisphosphonate binding and as such that the contrast agents
of McMahon et al. (2011) may not be permanently bound to the bone tissue. Radioactive
derivates of some MRI contrast agents have been shown to attach to bones in vivo (Vitha
et al., 2008).
However, direct visualization of bone-seeking or even microdamage-seeking MRI contrast
agents in MR images has not yet been undertaken.
1.4. MRI Contrast Agents used in this Study
This study applies the recently developed contrast agents from McMahon et al. (2009) to
image microdamage in bone. The MRI contrast in these compounds is achieved by a central
gadolinium ion which changes the magnetic relaxation time of the H2O molecules around
it. However, designing and testing an MRI contrast agent is difficult as the imaging tech-
niques are time-consuming and financially expensive. Thus fluorescent derivatives of the
contrast agents were synthesized to prove binding to bone damage using epifluorescence
1DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) is one of the strongest known com-
plexing agents for lanthanides, including Gd.
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microscopy. Gadolinium is in the chemical group known as lanthanides, which all exhibit
similar chemical properties due to their similar configuration of valence electrons. Thus,
other lanthanides can be used instead of Gd. While gadolinium’s paramagnetic properties
render it useful as an MRI contrast agent, the lanthanides europium and terbium fluoresce
in the visible range and can be detected using epifluorescence microscopy.
The compounds were named with the researcher’s initials BMM (Brian McMahon) and
consecutive compound numbers. Table 3.1 lists the properties of all the compounds tested
so far, while Figure 3.2 shows the principal chemical structures of some of those used.
Compound Lanthanide Ligands H2O on Gd
BMM 65 Tb 1x
BMM 63 Tb 1x (Ester)
BMM 76 Tb 3x
BMM 61 Tb 3x (Ester)
BMM 66 Eu 3x
BMM 59 Eu 3x (Ester)
BMM 108 Gd 1x 1x
BMM 114 Gd 3x 1x
BMM 125 Gd 3x 2x
BMM 91 Gd 4x 1x
Table 3.1.: Compounds tested. The lanthanides Eu (europium) and Tb (terbium) are used
for epifluorescence work, Gd (gadolinium) for MRI work. Ligands refers to the number of
calcium binding moieties, the ester forms of the ligands should not bind to calcium. H2O
on Gd refers to the number of water molecules which are directly affected by the Gd.
The iminodiacetate groups in the compounds show Ca2+ binding ability and were expected
to bind to exposed Ca2+ on bone surfaces. The ester analogues −N(CO2Et)2 should not
bind to Ca2+ and hence served as a negative control to confirm that the core structure of
the compound does not non-specifically bind to bone. The naphthalene rings (top right of
the structures in Figure 3.2) are used as optical excitation centres — the exciting photons
are captured there and the energy then transfers to the lanthanide ion where it emits in the
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Figure 3.2.: BMM 66 (left), three binding moieties for calcium (double arms of CO2Na)
combined with a fluorescing europium atom; BMM 59 (middle), the ester analogue to
BMM 66, does not bind to calcium and acts as an internal control; BMM 114 (right), the
gadolinium analogue to BMM 66 used as an MR imaging contrast agent.
ion’s characteristic colour which can be seen using epifluorescence microscopy. The MRI
compounds would not require the naphthalene because their physical visualization is based
on the direct magnetic influence of the Gd3−-ion on the surrounding H2O molecules. The
presence of Gd changes the magnetic spin relaxivity of the surrounding water which can
then be measured with a MRI scanner. The lanthanides are added as one of the last steps
of the chemical synthesis, and can be easily adjusted for the application: Eu and Tb for
epifluorescence, Gd for MRI.
All BMM compounds are similar in structure, the main variations are the lanthanide and the
number of calcium-chelating ligands. BMM 65 with only one Ca2+-ligand showed inferior
binding in preliminary tests than BMM 66 and BMM 76 with three ligands. Therefore,
further synthesis was directed towards three ligand compounds.
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2. Aims
1. To demonstrate the potential of novel fluorescent contrast agents to label exposed
Ca2+-ions in scratches and microdamage in bone and to determine an optimal appli-
cation and imaging protocol.
2. To demonstrate the potential of novel magnetic resonance active contrast agents in
MR imaging and optimize application and visualization.
3. To apply MRI contrast agents to fatigued samples of compact bone to visualize
structural features such as macrocracks, microcracks, vascular canals and resorption
spaces.
4. To use the MRI contrast agent to image voids and differentiate bone samples of
osteopenia from control ewes.
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3. Materials and Methods
3.1. Potential of Fluorescent Contrast Agents
To test the binding potential of the novel fluorescent contrast agents, scratch tests were
carried out similar to O’Brien et al. (2002). Fresh bovine tibiae were obtained from a
slaughterhouse and stored at −20◦C until required. Cortical bone from the mid-diaphyses
was cut into ≈ 5 cm long sections using a band saw. Bone sheets of ≈ 600 µm thickness
were cut with a diamond cut off wheel (127mm×400µm, #330CA, Struers) on a slow
speed saw (Minitom, Struers, Denmark), the cutting grooves removed with 1200 grit SiC
emery paper on a grinding wheel (DP10, Struers) under running water and cut further into
≈7×3×0.4mm sheets aligned with the bone grain.
Figure 3.3.: Scratch test performed with an incision cut with the backside of a #22 blade.
Upper left: scratched, fluorescent labelled and embedded sample.
Lines were scratched on the surface of the beams, perpendicular to the longitudinal grain
direction, using the backside of a #22 scalpel blade in an incision cut at an angle of ≈ 60◦
between the bone and the blade (Fig. 3.3). The contact force was determined for two
experimenters (P. M. &B. MM) with a weighing balance and was in the range of 15±5 N.
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Samples were kept covered with water during all scratching to avoid potential chemical
alteration such as oxidation.
The specimens were then immersed in 1.5 ml Eppendorf vials containing freshly made
aqueous solution of the contrast agents and placed in a vacuum desiccator. Vacuum was
applied2 until the water based solutions began to seethe3, the desiccator was then sealed and
left for a defined time. This procedure ensured the formation of a constant pressure equi-
librium at the vapour pressure of water at room temperature of 2–3 kPa (abs). Specimens
were then washed in distilled water and subsequent scratches were applied if required.
The specimens were then air-dried, dipped in xylene and mounted on glass slides with
mounting media (DPX, Fluka, Switzerland). Further scratched specimens were prepared
with Alizarin Complexone, Xylenol Orange and Calcein Green as a comparison with the
works of O’Brien et al. (2002) on these common contrast agents for the detection of bone
microdamage with fluorescence microscopy.
The mounted samples were then analysed using an inverted microscope (Nikon Eclipse
90i, Nikon Systems, Japan) for their fluorescence intensity. A 10×, 0.30 NA and a 4×,
0.13 NA, dry objective were used with the filter sets described earlier (Tab. 2.2). Images
were captured using a CCD colour camera (DS-Ri1, Nikon, 11 Mpx) and imaging software
(NIS-Elements BR, Nikon).
Image post-processing was done in ImageJ version 1.45i (Abramoff et al., 2004; Ras-
band, 2011). Rectangular regions of interest (ROI) of at least 100 pixels were defined on
2The application of vacuum for staining was initially adapted from previous experiments in the literature.
However, during the experiments, it was realized that the underlying physical principles were not clear and
may even be highly controversial as discussed later.
3The millimolar-concentrated BMM agents in water seethed under vacuum with similar characteristics
than distilled water — judged by optical, subjective observation of bubbling in the desiccator.
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the scratch as well as on bone surface on both sides. The average fluorescence intensi-
ties of these ROIs were then determined with the measure function of ImageJ. The two
background intensities were averaged and the ratio of scratch intensity versus background
intensity calculated in Excel.
Parameters of the contrast agent application were (a) the compound type, (b) the compound
concentration and (c) the penetration time in vacuum.
3.2. Optimal Application and MR Imaging Parameters
Mid-diaphyseal bovine cortical bone was used to cut ≈ 5×5×5mm cubes with a slow
speed diamond saw (see section 3.1). The cube surfaces were smoothed with 1200 grit SiC
emery paper and washed in distilled water. Surface scratches were applied with a scalpel
blade as on the fluorescence samples on two of the sample’s sides and then immersed into
freshly made aqueous solutions of the MRI contrast agent (BMM 114 or BMM 125) and
placed in a vacuum desiccator at 2–3 kPa when required. The samples were then washed
5× in distilled water under vacuum to wash out any residual contrast agent from vascular
canals. Control scratches were made after the immersion. Specimens were kept wet during
all stages of cutting, grinding and scratching.
Samples were either dabbed off on one side and then up to 5 samples were glued with
cyanoacrylate glue into 40 ml polystyrene tubes (VWR, USA), or single samples were
placed into 1.5 ml polypropylene micro tubes (Sarstedt) and these tubes tied together with
Parafilm, which allowed 4 separate samples to be scanned in one set-up. Non-glued sam-
ples in 1.5 ml-tubes were fixed with small strips of the same material.
MRI scans were performed on a 7 Tesla small animal scanning unit (BioSpec 70/30,
Bruker, Germany) based in the Institute of Neuroscience, Trinity College Dublin. A
115
CHAPTER 3. CONTRAST AGENTS
400 mT/m gradient and a 7 cm diameter volume coil were used for transmission. Signal
detection was performed using a surface coil. Spin-lattice relaxation time T1 appeared to
be the best indicator for the contrast agents. The inversion time of the water was set to
1100 ms to suppresses the signal from unaffected water.
The in-plane resolution was set to 2562 px for the field of view of 26.6 mm, resulting in
a spatial resolution of 104 µm/px. Out-of-plane 30–50 slices of 100 µm/px were recorded.
Averaging of 30–70 scans was used to decrease noise. A maximum resolution of 52 µm/px
was achieved in one scan of prolonged time (see Fig. 3.12).
All image analysis was carried out with ImageJ (Rasband, 2011). The coil used for the
imaging did not provide a homogeneous magnetic field and the field intensity decreased
with the distance from the coil. Thus, to normalize the non-homogeneous intensity, the
ImageJ plug-in Nonuniform Background Removal was applied to the surrounding water
intensity (Fig. 3.4).
An important parameter for the quality of MR images is the Signal to Noise Ratio (SNR).
It is defined by the average signal intensity divided through the standard deviation of the
signal: SNR = intensitysignalstandard deviationsignal . For the MR images the signal of the sample surround-
ing water was used (green dimension in Fig. 3.4 D) compared to the standard deviation of
this water signal (brown dimension in Fig. 3.4 D). Signal to noise ratios higher than 12 are
considered as being sufficiently good for MR imaging of bone structures (Li et al., 2008).
The main parameter for the efficiency of a contrast agent in imaging is its contrast against
the background. The contrast intensity of the BMM contrast agents (blue dimension in
Fig. 3.4 D) was normalized against the water intensity (green dimension in Fig. 3.4 D)
and thus calculated as contrast = intensitycontrast agentintensitysurroundingwater . The contrast should be as high as
possible to enable easier identification of structures.
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Figure 3.4.: Post-processing and measuring of an MR image. A: Section of an image
of a raw and uncorrected MR image stack, showing 2 cubical samples. B: Line profile
of intensities (along red arrow in A). The background intensity decreases over the image
position in the detecting coil (red dashed line). C: Normalized MR image. D: Line plot
normalized to the water intensity. Outer bone surfaces are labelled O, Haversian canals
H. Green dimension: normalized water intensity. Blue dimension: contrast of contrast
agent on the outer surface of a bone sample. Brown dotted dimension: Noise level of the
background water. Bar: 5 mm.
Regions of interest (ROI) were defined around the outer surface of the specimen and in the
background water. The average grey value intensities of these ROIs were then determined
and their ratios calculated.
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3.3. MRI of Fatigued Samples
This part of the study aimed to apply the MRI contrast agents to detect microdamage in
fatigued bone specimens.
3.3.1. Power Analysis
The results of the fluorescence part of this chapter were known, when the fatigue part of the
study was in planning. Therefore, based on these timely earlier results (mentioned later
in section 4.2), a power analysis was performed to determine the sample size to detect
microdamage in bone with MRI contrast agents and the imaging modalities available. The
null hypothesis is that no differences can be seen between bone and labelled structures in
bone. The minimum Type I error level to reject the null hypothesis was taken as α = 0.05
— so the statistical chance to detect a false positive effect, which only comes from random
errors, is 5%, or p < 0.05.
The minimum Type II error level to accept the null hypothesis was set to β = 0.2, that is
the chance of getting false negatives, where there is no difference that one would conclude
that there is a difference, arising from random error. Cohen’s d can be used to estimate the
sample size and is calculated as d = x1−x2s , where x1 and x2 are the two effective means
and s being the standard deviation of x1 and x2 (Cohen, 1988). The initial cube sample
measurements give some indication for these values. The MRI images were normalized
to the water intensity, so the effect value x2 = xwater = 1. This applies to both the MRI
intensity of water surrounding the sample as well as to water in bone voids. The Signal
to Noise Ratio (SNR) of the water background in our initial images is SNR = 4 . . .30.
The standard deviation for the water is the inverse of the worst case SNR, being s2 =
1
SNRworst case
= 14 = 0.25.
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Our x1 is any structural unit which is (a) filled with water and (b) labelled with contrast
agent on its structural surfaces. From the cube samples it is known that the contrast agent
is able to increase the contrast of any labelled surfaces by a factor of ≈ 8±2-times higher
than the water intensity, which gives us x1 = 8 and s1 = 2.
In Cohen’s definition s is the standard deviation of both x1 and x2, as they are expected to
be the same. However, if s1 6= s2 then Hartung et al. (2008) suggests to calculate a pooled
standard deviation s=
√
(n1−1)s21+(n2−1)s22
n1+n2
, which results in s=
√
(5−1)22+(5−1)0.252
5+5 =0.40
for our case. This results in a Cohen’s d of 17.5 .
If the same samples were scanned twice and compared between each other, a paired t-
test would be used. This would result in a necessary n-number of n = 2 per group to
detect differences between labelled and unlabelled surfaces calculated with G*Power 3
(Düsseldorf, Germany).
3.3.2. Fatigue Testing
Fresh bovine femora, obtained from a slaughterhouse (Kepak Clonee, Ireland) were stored
at −20◦C until required. Cortical bone from the mid-diaphyses was cut transversely into
≈ 5cm long cortical tubes using a band saw. These cortical tubes were ground on their
abutting cut faces with 1200 grit emery paper. Then areas of osteonal and plexiform bone
were identified under a stereo-microscope (SD30, Olympus, Japan) at 30× and labelled
with marker. The osteonal dominated cortical bone was then used for further testing. This
step was included as relatively young bovine bone only exhibits small areas of osteonal
remodelled cortex. In order to gain clinically relevant (i. e. human-like) microdamage
behaviour, only osteonal dominated cortical bone was used.
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Figure 3.5.: Fatigue sample preparation. A: Core drilled blank. B: Ends turned flat, centred
and waisted. C: Fatigued and broken. D: Sliced, ground and embedded for histology.
The preparation of waisted cylindrical specimens for the compression fatigue test were
based on the method of O’Brien (2000) and Taylor et al. (1999) with modifications. Cor-
tical sections with sufficient amounts of osteonal remodelling were cut with a band-saw
into nearly rectangular rods of ≈1cm×1cm×5cm aligned with the long axis of the bone.
These rods were aligned in 120 ml flat bottom tubes (Sarstedt, Germany), fixed with dental
cement (Suprastone, Kerr, Italy) and hardened over night. Samples were then rehydrated
for 24 h. Cylindrical cores were core-drilled using a high-speed-steel core-milling cut-
ter of internal diameter 6.7 mm and 40 mm internal length at a rotation speed of 350 rpm
(Fig. 3.5A). On a manual lathe the cylinder ends were turned flat and a centre hole was
drilled into one end with a center drill (Fig. 3.5B). The samples were clamped in a CNC
lathe with a three-jaw chuck and a live lathe center. The samples were then waisted to a
gauge diameter of 5.25 mm over a 7 mm gauge length, using a spindle speed of 900 rpm, a
feed rate of 0.07 mm/rev and a cutting depth of 0.25 mm (Fig. 3.5C). The samples were then
rehydrated for 24 h.
An INSTRON 8501 servo-hydraulic testing machine was used in load control mode to
apply axial compressive force to the specimens. The test rig contained two brass end caps
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Figure 3.6.: Fatigue sample in fatigue rig. A water bath made of flexible tube around the
sample was designed to hold ≈1ml of contrast agent.
fitting the exact diameter of the cylindrical samples to avoid contact damage. The brass
end caps were fixed in parallel aluminium plates to prevent off-centre loading (Fig. 3.6).
The samples were kept in a water bath during the fatigue tests to keep the mechanical
properties close to in vivo conditions. The water bath consisted of a single piece of a
transparent flexible tube with inner diameter 10 mm and a length fitted to the sample’s
clear height of 8–15mm. The tube was glued and sealed with transparent silicone onto the
lower end cap. As there was a very limited amount of these novel synthesized contrast
agents available, it was important to work economically and use a water bath of minimal
volume. The tube was compressed with the sample, however, the forces to compress the
tube were in the range of Newtons, while the forces on the bone specimens were around
1500 N. Thus the tube might have affected the force measurement during the test, but with
less than one percent. The specimens were placed in the lower end cap and the bath filled
to the brim with the contrast agent before mounting the upper end cap.
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Specimens were tested at a frequency of 3 Hz, with a stress ratio σmin/σmax = 0.1 and
a stress range ∆σ = 110MPa. The number of cycles was recorded along with the dis-
placement of the sample by a customized LabView (National Instruments, USA) program.
From sample length and machine displacement the deflection of the sample in each cycle
was calculated. The LabView program was looped back to the testing machine and enabled
to interrupt the testing procedure. An interruption was triggered by increased machine dis-
placement caused by high sample deflection due to advanced fatigue damage. Failure was
defined at a 10% increase in the cyclic deflection range indicating a 10% stiffness loss, or
by physical failure of the sample. Fatiguing to 10% deflection range increase coincided
with the presence of at least one large crack and most samples split into two parts. A total
of 15 samples were used to establish a protocol with the best contrast agent combination
and concentration for staining both for fluorescence work and for MRI (Table C.3).
3.3.3. MRI Scanning of Fatigue Samples
MRI scanning of the fatigue samples was carried out as described in section 3.2. Up
to 9 cylindrical samples were stacked into a 40 ml PP tube. Due to the decreasing field
strength and SNR over the depth of the used receiver coil, only the upper half of the samples
contained valuable information. MRI scans were taken before and after the fatigue testing.
3.3.4. µCT Scanning
To confirm any spatial information, µCT scans were performed (Scanco, mCT-40, Bassers-
dorf, Switzerland). The scans were performed over the full height of the waisted part of
the fatigue specimens and were taken with a homogeneous resolution of 15 µm.
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3.3.5. Histology
To confirm the MRI findings, a number of samples was prepared for histology. Specimens
were stained en bloc in a 0.0005 M aqueous solution of Calcein Green in a desiccator at
50 mm Hg vacuum for 16 h (O’Brien et al., 2003). The specimens were then cut into 200–
250 µm thick transverse sections and ground with Frost’s “rapid manual method” (1958) to
100±10 µm thickness with 1200 grit SiC emery paper. Frost’s gripping device4 was used
to grind the sections with an emery sheet placed on a table. Grinding was done with some
ml of added tap water. From time to time excessive grinding debris was removed, dirty
water replaced and the sample flipped to the other side. In regular intervals the sample was
rinsed and the thickness checked with a micrometer. Upon reaching the desired thickness,
the samples were placed in a beaker with≈1% detergent5 in water6 and cleaned gently with
a soft brush for 20s–3min, poured in a porcelain Buchner funnel and rinsed ≈1min with
tap water under continued gentle brushing. The samples were then dried slightly with tissue
and left to air-dry on clean glass slides for 5–20min. The dry samples were placed on glass
slides, soaked with xylene, covered with DPX and cover-glassed (Fig. 3.5D). Histology
4The so-called “Frost’s gripping device” consists of an approximately 2cm wide strip of emery paper
that is wrapped transversely around a histology glass slide with its abrasive side outward. The emery paper
strip is held on the back side. The front side is moved in flat, non-linear movements with light to medium
pressure over bone sections (Frost, 1958; Beauchesne & Saunders, 2006).
5Some references suggest 1% detergent. However, to the best of my knowledge, there is no indication
why this should be the correct or even a sensible amount, neither is the kind of detergent specified in most
publications. Ordinary detergent is usually stored in soap dispensers — which makes it unhandy to measure
any volume of it with decent accuracy. An honest description of the technique would be: take any amount of
any soap that the nearest soap dispenser offers into a 50–200ml beaker, fill up with any workable amount of
tap water, add bone, clean. “1% detergent” for cleaning bones is — in my opinion — an over-precise term
used in publications rather than in labs.
6Some people refer to distilled water being used for this task. Considering the initial amount of grinding
dirt as well as the samples being used only for light microscopy, this seems overshot. If the available tap
water is free from obvious dirt it can be used for this purpose. Dirty histology slides of bone are caused by
insufficient brushing or by insufficient drying — but not by washing with tap water.
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was carried out on an inverse epifluorescence microscope (section 3.1) and microdamage
was identified with the criteria of Lee et al. (1998) (sec. 2.3). Images were taken with a
10×, 0.30 NA objective at a resolution of 2.01 µm/px.
3.3.6. Cross-Technique Comparison of Bone Morphology
Structures, such as Haversian canals, resorption spaces, outer surfaces, micro- and macro-
cracks, were compared over the different imaging modalities with Fiji. The individual his-
tological images were aligned with the three-dimensional µCT stack by finding matching
patterns of large features such as macrocracks and resorption spaces. The µCT slice best
fitted to a histological image was then matched to a slice of the three-dimensional MRI
scan. Sizes of observed damage in the MRI scans were measured and compared to the
sizes obtained from µCT and histology.
3.4. MR Imaging for the Determination of Cortical Porosity
The aim of this part of the study was to determine if cortical bone of ewes one year after
ovariectomy could be distinguished from control animals by means of MR imaging with
contrast agents. The MRI with contrast agent was expected to highlight changes better than
ordinary MR imaging. The cortical porosity for metatarsals of the same animals, measured
by µCT, was shown to increase by a factor of 2 (Kennedy et al., 2009a). The contrast agent
BMM 114 was used in 1 mM concentration with a 4h incubation time. ImageJ was used
to determine the measured volume in mm3, the total number of holes, the total volume of
holes in mm3, the average size of holes in voxels of 1043 µm3, the normalized number of
holes in #/mm3, the normalized volume of holes in vol-%. Repeated measures ANOVA in
SPSS was used to determine differences between contrast agent treatments (no BMM vs.
BMM) and animal groups (OVX vs. CON).
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3.4.1. Power Analysis
The null hypothesis for this part of the study is that one cannot see any differences between
ovine cortical bone in control and 12 months after ovariectomy. The minimum Type I error
level to rejecting the null hypothesis was taken as α = 0.05, while the minimum Type
II error level to accept the null hypothesis was set to β = 0.2. Comparing animals from
control and ovariectomized group would be done with an independent t-test.
Study Method animal, Cohen’s d units sampleduration size*
Kennedy et al. (2009a) µCT sheep, 12 m 2.07−1.04(0.29+1.28)/2 = 1.31 %-vol 22
Kennedy et al. (2009a) histology sheep, 12 m 0.046−0.016(0.026+0.009)/2 = 1.71 #/mm2 14
Chavassieux et al. (2001) histology sheep, 6 m 2.77−0.97(0.32+0.78)/2 = 3.27 %-vol 6
Burr et al. (2001) histology macaque, 18 m 0.21−0.12(0.04+0.03)/2 = 2.58 #/mm2 8
Table 3.2.: Cortical porosity in ovariectomized animal studies. Star: derived total sample
size in two groups for this study from the data of the individual references.
Values for the power analysis can be derived from previous works. Studies which measured
cortical porosity in ovariectomized animals are listed in Table 3.2 with their Cohen’s d and
an estimated n-numbers for this study, calculated by G*Power. A subset of animals from
Kennedy et al. (2009a) were used with more pronounced turnover rates, thus the sample
numbers were chosen to be 12.
3.4.2. Bones for MRI Comparison
The bones used for this part of the study were from an ovine ovariectomy model, which
focussed both on trabecular (Brennan et al., 2011b; Holland et al., 2011; Kennedy et al.,
2008a; 2009b) as well as cortical bone (Kennedy et al., 2009a; 2008c;b; Brennan et al.,
2011b). The most appropriate bones for the MRI investigation into cortical porosity were
the left distal metatarsals. The porosity of the left mid-diaphyseal metatarsals has already
been determined by means of µCT and histology (Kennedy et al., 2009a).
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4. Results
4.1. Scratch Tests for Fluorescence Intensity
Figure 3.7.: Scratch test with 0.5 mM of Alizarin Complexone, Xylenol Orange and Cal-
cein Green under vacuum as in O’Brien et al. (2002), visualized with different fluorescence
filter cubes. At longer staining times, the contrast agents underwent red-shift and their
intensity in certain channels decreased (labelled with a star). Bar: 200 µm.
To establish our modified protocol of the O’Brien et al. (2002) method, scratch tests were
performed with established fluorescent contrast agents (Fig. 3.7). In contrast to previous
studies, the fluorescent contrast agents experienced a red-shift (star in Fig. 3.7) of their
colour spectrum when they were applied for the recommended 4h of Lee et al. (2000b)
and O’Brien et al. (2002) and even for the 30mins of O’Brien et al. (2000). The red-shift
is most pronounced in the UV longpass cube, where the colours changed towards red for
all three contrast agents tested. With a green excitation and a red bandpass emission filter,
the red-shifts can be seen to push the emission spectrum even further into the infrared. The
red-shift into infrared decreases the intensity in all channels. However, in the UV longpass
this actually increased contrast to the bright blue background emission of the bone. In the
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green bandpass, the infrared-shift decreased the contrast of the scratches against the dark
red bone background. In the blue longpass filter cube, the contrast was decreased when
the colour of Xylenol Orange and Calcein Green changed from a mixture of bright green
and orange to dark red with green rims. The bone background emission was negligible
compared to the bright fluorescence signal of these commercially available contrast agents.
Figure 3.8.: Scratch test with the novel fluorescent contrast agent BMM 66 in 4 mM con-
centration for 24 h under vacuum on an ≈ 1000–1500µm thick sample. Filter cubes for
image acquisition from left to right: green bandpass, blue longpass, UV longpass, UV
bandpass. Bar: 500 µm.
With the modified protocol, scratch tests were carried out using a variety of contrast agents
with parameter variations. Figure 3.8 shows a representative scratch labelled with 4 mM
of BMM 66 for 24 h in vacuum on a 240 µm thick sample. The beginning of over-staining
can be seen as decreasing signal intensity of the scratch in the UV bandpass (Fig. 3.8).
However, red-shifting together with decreasing intensity of the contrast agents was only
noticeable in a few cases of both long staining time and highest concentrations (4 mM) in
the UV bandpass filter.
For a quantification of the contrast agents’ potencies and optimization of application pro-
tocols, the ratios of the scratch intensity versus the bone background intensities were
measured and a linear regression analysis performed. The linear regression model in itself
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Figure 3.9.: Contrast ratio of BMM 66 labelling in relation to incubation time, concen-
tration and sample thickness. Samples were all incubated in vacuum and images taken
with a green bandpass cube (excitation 540/25 nm, DM 565 nm, bandpass 605/55 nm) and
measured in the red RGB channel. The lowest plane marks a contrast ratio of 1, meaning
no contrast between labelled scratch and the bone background fluorescence. The middle
plane represents all samples with a thickness t > 600µm and red circles. The upper plane
represents all samples with thickness t < 400µm and blue circles.
was highly significant (p < 0.001). There were significance positive correlations with the
contrast ratio of the log of incubation time (p < 0.001), the log of incubation concentration
(p < 0.001), the scratch force (p < 0.05) and a negative correlation with the sample thick-
ness (p < 0.001). Compared to BMM 66 there was a significant decrease in the contrast
ratios of BMM 59 (p = 0.016), BMM 61 (p = 0.02) and BMM 63 (p = 0.001). This was
expected as these were the ester derivatives, which should not bind to bone. BMM 65 and
BMM 76 showed a lower but not significant (p = 0.222, p = 0.190) contrast ratio than
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BMM 66. BMM 66 with the highest contrast ratio appeared to be the most promising con-
trast agent and was taken for further experiments. Figure 3.9 represents the most important
factors — concentration, time and sample thickness — for BMM 66. The longer the incu-
bation time and the higher the concentration, the higher was the contrast ratio, as well as
for thinner samples the contrast increased significantly against the autofluorescence of the
bone material. The scratch tests were done in collaboration with Brian McMahon, fur-
ther details about binding and the fluorescence of specific compounds in laser scanning
confocal microscopy can be found in McMahon et al. (2009; 2011) and McMahon (2011).
4.2. Application of MR active Contrast Agent for MRI
Three-dimensional images of the novel contrast agents were obtained with an MRI scanner.
Table 3.3 lists a selection of scans performed. In general, samples showed higher T1 signal
intensity on the ground outer sample surfaces as well as in the vascular canals compared
to the normal water signal. Both water and contrast enhanced surfaces had much higher
signal intensities than bone (Fig. 3.11).
Scan # Figure Objective
1_13 - MRI set-up; visualization of BMM 114
1_54 & 8_09 3.4 & 3.12 Different application regimes
1_30 & 1_36 3.11 BMM 114 vs. BMM 125; bleeding of excessive con-
trast agent
1_41 3.10 BMM 114, BMM 108, BMM 91; surface occupation
with fluorescent contrast agents
4_03 & 5_03 3.17 Fatigue induced macrocracks; surface occupation with
fluorescent contrast agents
6_03 & 7_03 - Non-fatigued samples
7_04 3.18 Fatigued samples
8_11 & 9_06 - OVX vs. CON without contrast agent
10_05 & 11_07 - OVX vs. CON with contrast agent
Table 3.3.: MRI scans and their objectives.
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A series of scans were performed to compare the variety of MRI contrast agents available
as well as their optimal application regime. Despite the low quality of the scan, it indicated
no superior contrast of BMM 108 or BMM 91 over BMM 114 (Fig. 3.10). Samples D
and E were labelled with fluorescent agent to chelate exposed Ca in the samples prior to
occupation by MRI agents. This was done by dip dyeing the samples’ ends for 1 min and
did not show any binding inhibition of the MRI contrast agents compared to their unstained
central areas.
Figure 3.10.: Different MRI contrast agents. (A) BMM 114, (B) BMM 108, (C) BMM 91,
(D) BMM 114 pre-labelled with Alizarin Complexone and Xylenol Orange, (E) BMM 125
pre-labelled with Alizarin Complexone and Xylenol Orange. All contrast agents 4 mM,
24 h under vacuum. Bar: 5 mm.
Contrast agent leaked from samples and bound to other samples over a three day period
(Fig. 3.11). The samples were rinsed 5 times in distilled water before the sample tube
preparation. However, that does not seem to be sufficient to wash out excessive unbound
contrast agent from the vascular system. For further experiments where different contrast
agent regimes were used, the samples were kept in separated 3.5 ml or 1.5 ml polypropy-
lene tubes (Sarstedt), which allowed up to 4 samples to be scanned in one set-up. While
both BMM 114 and BMM 125 successfully bound to exposed calcium surfaces, BMM 114
showed superior contrast compared to BMM 125 (Fig. 3.11).
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Figure 3.11.: Bleeding of contrast agents over time. The upper image was taken on the day
of the preparation, the lower image three days later. The negative control sample in the
middle shows more contrast agent on the outer surface while the other two samples show
decreasing contrast of vascular canals. Left sample was treated with 4 mM BMM 114 for
24 h in vacuum, right sample with 4 mM BMM 125 for 24 h in vacuum. Bar: 5 mm.
A series of scans were performed to find out which staining scheme would be most effi-
cient. A linear regression analysis (p < 0.001, adj. R2 = 0.717) showed, that the logarithm
of the concentration is the most important predictor (p < 0.001) of the signal intensity of
the contrast agent against the water. Incubation time did not show any significant difference
(p > 0.1) between 10 min and 24 h. No subgrouping of time (e. g. > 1h) reached signifi-
cance. The standard treatment was done under ultra sonication at room pressure, as well as
the rinsing out of excessive contrast agent with distilled water in multiple steps of > 5min.
There was no significant difference on the outer surface intensity of the contrast agent if
the contrast agents were applied with no ultra sonication but under vacuum (p = 0.336) or
with neither sonication nor vacuum (p > 0.1). Washing under sonication was not different
from washing under vacuum (p > 0.1). It was not possible to compare the contrast in the
vascular system of these samples.
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The linear regression did show a trend for BMM 91 (p= 0.071) and BMM 108 (p= 0.097)
to produce a lower contrast ratio than BMM 114. BMM 125 was slightly, but non-
significantly, lower than BMM 114 (p > 0.1). There was a significant difference between
the first scans, a group of following scans (1_54 – 7_04) and later scans (p < 0.001 and
p = 0.003 respectively). Within these 3 subgroups of scanning sessions there was no sig-
nificant difference between the individual scans (all p > 0.1). Figure pi shows the SNR and
the contrast for a selection of scans performed. SNR as well as intensity ratio were not
constant over time.
An optimal application window for the concentration and incubation time as well as
severity of treatment for BMM contrast agents appears to be relative wide.
Figure 3.12.: Different application regimes with 4 mM of BMM 114, background corrected
high resolution scan (52 µm/vx). (A) Negative control without contrast agent. (B) 24 h under
vacuum. (C) 24 h under vacuum. (D) 4 h no vacuum. Same scan (1_54) as Fig. 3.4.
132
CHAPTER 3. CONTRAST AGENTS
Figure 3.13.: Contrast of different application regimes of scan 1_54 (Fig. 3.12).
Figure 3.14.: Contrast agent intensities (bars) and Signal to Noise Ratios (SNR, black line)
of individual MRI scans.
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4.3. Fluorescent and MR Contrast Agents on Fatigued Samples
In the fatigue tests, the bones failed at an average of 8540± 5780 cycles. The number of
cycles to failure fit a Weibull distribution (R2 = 0.98, Fig. 3.15). A list of samples can be
found in the appendices (Table C.3 on p. 298).
Figure 3.15.: Fatigue life of individual samples, corrected for 110 MPa, in relation to the
probability to failure with Weibull best-fit line.
BMM 66 was seen in previous tests as being the fluorescent contrast agent with the highest
fluorescence intensity. Consequently, BMM 66 was tested as fluorescent contrast agent
for microdamage in fatigue samples as a proof of concept in three samples (#5, 9 and
25). Figure 3.16 shows an ultimate failure causing macrocrack and a smaller microcrack
branching off from it. Both were clearly labelled with BMM 66. A 1 mM solution (sample
#5) labelled bigger, open cracks, while thinner cracks appeared to be less labelled. While
4 mM (sample #25) showed clear labelling even of thin microcracks.
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Figure 3.16.: Fatigue microcracks labelled with BMM 66 under green epifluorescence
(excitation 540/25 nm, DM 565 nm, emission 605/55 nm). A: Sample #5 with 1 mM and
a labelled wide open crack (big arrows). B: Sample #25 with 4 mM had a clearly labelled
macrocrack (big arrows) and a microcrack extending with a length of ≈ 250 µm (small
arrows). Bars: 100 µm.
Based on the scratch tests and the first MRI scans, a set of MRI samples was prepared
to evaluate the best protocol for labelling of fatigue samples (Fig. 3.17). Samples stained
with Alizarin Complexone and Xylenol Orange before fatigue testing and with BMM 114
during fatigue testing showed no difference in their MRI signal. Samples stained with
4 mM of both the fluorescent BMM 66 and the MR agent BMM 114 showed equal bright-
ness compared to pure BMM 114 in MRI. Plexiform bone samples showed no vascular
canals throughout the whole depth, other samples showed a high variation of vascular
canals. Macrocracks appear less bright the thinner the crack appears. Figure 3.18 demon-
strates a large crack over the three imaging modalities of MRI, µCT and standard histology.
Macroscopic cracks as well as bigger vascular canals can be seen with all three techniques.
However, more detailed structural information can only be derived from the histology. The
135
CHAPTER 3. CONTRAST AGENTS
Figure 3.17.: Fatigue samples with different labelling regimens. Bar: 5 mm.
Figure 3.18.: Comparison of MRI, µCT and histology. Blue arrows: vascular canals. Red
arrows: cracks. Green arrows: cracks from histological preparation. Bar: 1 mm.
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MRI image is around the state of the art in high resolution in human pre-clinical applica-
tion. The µCT scan has a resolution around around 5–10 times higher than state of the art
high resolution CT in clinics. Resolving with this amount of detail would expose patients
to a hundredfold higher X-ray doses. The ex vivo histology resolves all microscopical
morphological details.
Figure 3.19.: Void count by size difference of before and after fatigue MRI detected voids
in the bones. Count in 1043 µm3 voxels measured in a 5 voxel thick layer. Big differences
in size indicate major cracks (purple area).
Fig. 3.19 shows the difference in sizes of individual voids before and after fatigue testing in
the same samples. A number of voids were detectable in both scans. These are Haversian
canals and resorption spaces that do not change their size due to fatigue (blue). Numerous
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small to medium sized voids were detected in only one of the two scans. These are around
the detection limit of the technique and are randomly picked up by one of the scans. They
can be considered as random imaging noise. The most interesting group are the bins 11–30
and 31–600 voxels in size (purple label). Such high differences in size only appear in the
after fatigue group but not vice versa. All these voids are cracks that originated during
the fatiguing. While 31–600 voxels are clearly macrocracks which can be seen also by
eye, the 11–30 voxels sized cracks are in the region of big microcracks. 11 voxels of
1043 µm3 correspond to a crack which is visible with one voxel width and an areal size of
150µm×750µm, 30 voxels to 250µm×1250µm.
These tests showed that microcracks can be located in bulk specimens of cortical bone
non-destructively by the size difference of voids in before and after fatigue scans. The
difference in size, which was clearly distinguishable from imaging noise, corresponds to
damaged areas of 150µm×750µm and bigger.
4.4. Contrast Enhanced MR Imaging for Comparing Bone Porosity of
Estrogen Deficient and Control Sheep
A set of bones were MRI scanned to find out whether contrast enhancement with the novel
BMM contrast agents would enable a better identification of estrogen deficient ovine bone
from control bone. The same bones were scanned twice — once before and once after
the contrast agent application. Repeated measurement ANOVA was used to determine
differences between the treatments and groups.
The amount of canals per volume in #/mm3 in both animal groups changed significantly
(p = 0.012) from 1.31±0.41 before to 2.39±0.75 after BMM application. There was no
difference between the control group and the estrogen deficient group (p > 0.1); without
138
CHAPTER 3. CONTRAST AGENTS
Figure 3.20.: Volumetric measurements derived from MR images with and without BMM
contrast agent in the two animal groups.
BMM: CON 1.27± 0.37 vs. OVX 1.36± 0.49; with BMM: CON 2.39± 0.77 vs. OVX
2.38± 0.83 (Fig. 3.20 A). However, previous reported porosities for these animals tripled
in histology (p < 0.01) and doubled in µCT (p < 0.01) (Kennedy et al., 2009a).
The volume of holes in vol-% of the whole bone over both animal groups did change
significantly (p < 0.001) from 1.58± 0.57 before to 6.13± 1.71 after BMM application.
There was no difference between the control group and the estrogen deficient group (p >
0.1); without BMM: CON 1.68±0.60 % vs. OVX 1.46±0.57 %; with BMM: CON 5.79±
1.72 % vs. OVX 6.55±1.80 % (Fig. 3.20 B).
The average hole size in voxels of 104 µm3 in both animal groups changed significantly
(p = 0.005) from 3.66±1.59 before to 8.23±3.66 after BMM application. There was no
difference between the control group and the estrogen deficient group (p > 0.1); without
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BMM: CON 4.11± 2.09 vs. OVX 3.12± 0.48; with BMM: CON 7.68± 3.31 vs. OVX
8.89±4.33 (Fig. 3.20 C).
This test indicated that additional contrast agent increases measures of detectable voids
in both groups of bones. Differences between the two groups were expected based on
Kennedy et al. (2009a), but were not found.
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5. Discussion
The overall aims of this study were to demonstrate the potential of novel contrast agents
for fluorescence work and for MRI on bone, to optimize their application and to evaluate
their potential for the detection of microdamage and vascular canals in cortical bone.
5.1. Fluorescence Scratch Tests
Scratch tests, based on O’Brien et al. (2002) with an extended parameter set, were used to
evaluate the potential of novel calcium binding fluorochrome contrast agents (McMahon
et al., 2009) to label microdamage in bone.
A labelling protocol was developed and optimized for fluorescence intensity. There was
no significant difference between the three potent fluorescent agents BMM 66, BMM 65
and BMM 76, although there is a trend for BMM 66 to be more intense. The highest
fluorescence intensity was obtained at 3 kPa vacuum for 24 h in a 4 mM aqueous solu-
tion and early signs of over-staining and optical quenching were seen for this amount of
agent exposure. Significant quenching in scratch tests was shown with established fluo-
rescent contrast agents. Signs of quenching occurred with 0.5 mM solutions after 30 min
with Alizarin Complexone and Calcein Green and after 4 h with Xylenol Orange. At 4
hours, scratches were severely over-stained (Fig. 3.7) and at 24 hours even vascular canals
were heavily stained (not shown). The quenching red-shifted the emission spectrum of the
contrast agents and decreased the fluorescence intensity. Patel et al. (2009) showed that
static quenching of Calcein Green occurs at concentrations below 30mM. Therefore, the
concentration of Calcein Green on the scratch surface is suspected to be < 30mM.
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In general the BMM contrast agents were slower in binding than the established and com-
mercially available fluorescent contrast agents. This was expected as the lower binding
activity of the novel contrast agents was designed to be more biocompatible than existing
compounds and to offer the potential of in vivo usage. The binding mechanism of the novel
BMM contrast agents is a chelation of the imminoacetate ligand groups onto free calcium
ions on the surface of hydroxyapatite crystals exposed on surfaces. The ester analogues
BMM 63, 61 and 59 with a dysfunctional ligand group did not show significant binding,
thus non-specific binding of the contrast agents’ structure can be ruled out.
The sample thickness was surprisingly an essential contributor to the intensity contrast of
the fluorescent contrast agents versus the bone background brightness. This is due to the
influence of autofluorescence of bone, which increases with sample thickness in epifluo-
rescence microscopy, while the absolute intensity of the contrast agent stays constant, thus
with thicker samples the contrast ratio was reduced. The sample thickness was therefore
reduced from 600 . . .1200µm to 200 . . .400µm. This phenomenon did not appear in pre-
vious works of Lee et al. (2000b) & O’Brien et al. (2002) because of the much brighter
fluorescing compounds used there and their much higher signal to background ratio.
Further factors were identified as varying the fluorescence intensity: the time when a con-
trast agent was mixed before usage, different compound batches and the force of scratching.
Scratches in all experiments were carried out with a scratching force of 15±5N. However,
when this force was decreased close to 0 N in a small sub-study, the fluorescence contrast
decreased to nearly zero as well. Therefore, the scratching forces should be monitored
and kept constant as far as possible during scratch tests. No experiment was specifically
carried out to determine the effect of blunting of the tool used to scratch the bone. How-
ever, as bone consists of hydroxyapatite crystals, which are ceramics, steel tools such as
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scalpel blades are expected to blunt gradually, which is a common problem in surgery as
well. Therefore, the scalpel blades were replaced regularly every 10–20 samples to keep
scratch geometry and induced damage morphology and severity consistent. When aqueous
solutions were mixed over a month prior to use there was nearly no fluorescence signal
detectable from the scratches. However, this is based on personal experience and there
was no specific experiment performed to validate this. Further differences were seen from
sample to sample in the background intensities, which are presumably related to the sample
thickness and perhaps to sample mineralization as well as differences in surface grinding
before the scratching. For future experiments of fluorescent contrast agents all the above
mentioned factors should be considered and monitored.
BMM 66 proved to be successful in labelling fatigue induced microdamage at 1 mM and
4 mM inside of bones. Staining microdamage in bulk specimens from fatigue tests, how-
ever, requires longer times than labelling in scratch tests, which was also experienced by
O’Brien (2000). This is attributed to two factors: firstly, it is more difficult for the agent
to access exposed calcium as it has to penetrate through the vascular system of bulk bone.
Secondly, the amount of exposed calcium is lower on microcrack surfaces because micro-
cracks are surface-like with little damage in the surrounding matrix, while scratches have
a zone of forcefully destroyed material, which exposes calcium also in the depth direction.
5.2. Application of MR Active Contrast Agents
5.2.1. Interactions of Noise, Resolution and Scanning time
In MR imaging three main factors contribute to the resulting image content and quality —
image resolution, signal noise and required scanning time. One cannot be changed without
affecting at least one of the others.
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Resolution is an issue in detection techniques in general. It must be high enough to detect
the features of interest. Resolution is not a major issue in lab bench science, as one can
choose techniques with higher resolution, however, clinical imaging is limited by biocom-
patibility as well as time. Microcracks are about 100− 300µm wide, 300− 1500µm in
the longitudinal bone direction and 1− 10µm opening thickness. Thus the gold standard
of detection is fluorescence microscopy with resolutions of 0.5− 4 µm/px. Fluorescence
microscopy is invasive and destructive and therefore clinically difficult to apply. MRI
offers non-invasive detection, but the resolution is significantly lower than in microscopy
and features of interest are in the same size range as the resolution. Current whole body
MRI scanners can obtain resolutions up to 250×250×400 µm3/vx, while peripheral MRI
scanners are able to obtain resolutions up to 823 µm3/vx within the patient’s comfort level
(< 30min) (Boutroy et al., 2005). In this work, 1043 µm3/vx were obtained normally and
523 µm3/vx maximally.
Imaging noise should be low compared to the signal of interest. The Signal to Noise Ratio
(SNR) is used to quantify the relative noise level and thus the quality of images. In MRI of
137×137×410 µm3/vx resolution, SNR > 12 are recommended by Li et al. (2008). To lower
the noise, data can be averaged from single imaging scans. However, the scanning time
is related to the square of SNR improvements: doubling the SNR quadruples the scanning
time. With the open receiver coil used here, the noise increased with the distance from the
coil, complicating clear feature identification.
Increasing the SNR would be possible by (a) decreasing the resolution in the xy scanning
plane, (b) decreasing the resolution against the scanning plane, (c) increasing the scanning
time, (d) using smaller sample tubes and fewer samples, (e) scanning sample tubes multiple
times in different orientations, (f) using more sophisticated hard- and software. Option (a)
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is a disimprovement in terms of crack identification, while (c–e) decrease the number of
samples in each scan and / or increase the scanning time and (f) was not available. Option
(b), was chosen for the experiments in section 3.4. Obtaining data at 1043 µm3/vx required
≈ 8–16h with the equipment available. While resolutions of 823 µm3/vx are also possible in
less than 30min (Boutroy et al., 2005).
5.2.2. Optimization of Labelling Protocol for MRI
The gadolinium derivates of the contrast agents were observable in an MRI scanner with
the T1 relaxation time. A usable surface labelling protocol of the MRI contrast agents
has been established and optimized within the limited number of MRI scans available.
When imaging fluorescence contrast agents, the measured intensity comes from the com-
pound itself. Therefore, higher concentrations will be seen gradually as brighter contrast.
With higher concentrations, but still below the saturation of all ligands, many compounds
(including Alizarin Complexone, Xylenol Orange, Calcein Green and BMM 66) start to
quench, resulting in red shifts and decreased visibility. Therefore, the optimal contrast
agent exposure is in specific ranges for most fluorescence contrast agents.
MRI contrast agents on the contrary are not directly detected but their effect on surrounding
protons (mainly in water molecules) is visualized. This effect might get saturated and
further Gd concentration increase will have no additional effect, neither a higher contrast
nor quenching and deteriorating contrast. This limits the likelihood of overstaining, but
an accurate determination of a lowest detection limit is difficult. There were only minor
differences in contrast agent intensity between 4 mM and 1 mM, 24 h and 4 h and with or
without vacuum, and even the small amount, leaking from the vascular systems of two
samples, was sufficient to clearly label a third sample in 3 days (Fig. 3.11). So the lower
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limit of detection for BMM 114 on exposed outer surfaces of bone might be lower than
expected. However, there is no evidence for a minimal concentration of BMM 114 to label
microdamage in bulk bone. Thus, a relatively strong treatment, 4 mM for 24 hours in
vacuum, was chosen for bulk bone imaging.
5.2.3. Estimation of the Contrast Agent’s Occupation Ratio Against Potential
Calcium Binding Sites
An estimation of how many exposed Ca2+-sites were occupied by the contrast agent is diffi-
cult. Optical quenching of established fluorescent contrast agents was seen from 30 min on.
However, the amount of contrast agent increased further with time. Concluding, even the
established fluorescent agents did not occupy all available Ca2+-sites or came to a chemical
equilibrium of binding. In fluorescence tests on BMM 66 there was a significant difference
in the intensity of 4 h vs. 24 h incubation, while there was no difference on MRI sam-
ples with similar treatment. Even low exposure without vacuum was effective for showing
nearly unchanged MR contrast. Thus it is believed, that only a small amount of the avail-
able Ca2+-sites in bone are occupied by any agent. The occupation rate is expected to be
lower than 10% of all potential Ca2+-sites. However, no experiment was conducted to find
an exact value.
Scanning Electron Microscopy based Energy-dispersive X-ray spectroscopy (SEM-EDX)
images were taken (data not shown) of a sample which was clearly labelled with the fluo-
rescent BMM 66. The limit of detection of SEM-EDX is around 0.1− 0.2%-mass, the
sample surface is measured to a depth of around 2 µm. The EDX profiling showed no
lanthanides within the detectable limits.
A recent study by Landrigan et al. (2011) used BaSO4 precipitation for the detection of
microdamage with µCT. They found the Barium to be just about detectable in an SEM-
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EDX. However, this method involves large quantities of contrast agent precipitation, while
BMM contrast agents are detectable in MRI with much lower concentrations. The required
occupation ratio of contrast agents to the available Ca2+-sites seems to be low for BMM
compounds as well as for the established fluorescent agents. This explains also the failure
of prelabelling of exposed calcium with fluorescent agents to prevent MRI contrast agent
to bind at surfaces to visualize only newly formed damage (see Fig. 3.10).
Yet, this occurred in O’Brien (2000) and O’Brien et al. (2002), but was not interpreted
as such: Xylenol Orange labelled scratches changed during the subsequent addition of
Calcein Green towards the green spectrum (see O’Brien, 2000, Fig. 3.8). This might have
been due to binding of Calcein Green on yet unoccupied Ca2+-ions in the Xylenol Orange
labelled scratch. Oxytetracycline was also seen as replacing any other fluorescent agent
in these tests (Lee et al., 2000b). This may have been caused by binding to non-occupied
Ca2+-ions as well, rather than to chemical replacement of other agents.
Both fluorescent BMM contrast agents as well as established fluorescent contrast agents
for bone occupy only a fraction of the available Ca2+-sites. In order to obtain satisfying
MRI contrast, the amount of required contrast agent seems to be at least one magnitude
lower than for the fluorescent BMM analogues.
5.2.4. Washing effects
Sufficient washing is necessary to remove all unbound leftovers of the contrast agent from
the vascular system of the bone samples. Single sample tubes can be used to separate the
samples and prevent cross-over labelling. Thorough cleaning of excessive contrast agent is
not so essential when only histology is used (Lee et al., 2000b; O’Brien et al., 2003), as the
processing of the samples removes excessive dye. In the non-destructive MRI, excessive
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contrast agent affects the contrast inside the vascular system. Furthermore, excessive Gd
contrast agent leaks into the surrounding water over time and decreases its normal T1 time.
Relative specific T1 exist for different tissue types and are used to distinguish tissues in
MRI by suppression or enhancement of the signal (Lu et al., 2004). Leaking Gd agents
reduce the T1 time of surrounding water.
In the scans 1_54 to 7_04 a better washing regime was introduced, which reduced the
leakage of excessive contrast agent into the water and therefore increased the background
water T1. This increasing background signal lead to a decrease in the contrast of the labelled
surfaces — which was normalized against the water signal (Fig. 3.14).
Correct suppression of background water leads to low signal of the water. Incorrect sup-
pression leads to an increased water signal, however, the absolute noise stays nearly con-
stant. A high Signal to Noise Ratio (SNR) can be taken as a measure of the quality of MRI
scans due to low noise levels. However, high SNRs also occur due to incorrect background
T1 time and insufficient background signal suppression. Thus it remains questionable as
to how the theoretically derived recommended SNR > 12 of Li et al. (2008) has its prac-
tical limitation and justification. High SNRs are only desirable if the signal of interest
is, by choosing adequate T1 times, enhanced rather than suppressed. Thus in this study a
maximization of the SNR can be misleading.
Still, higher contrast and consistent contrast would be preferred. Future work should be
aware of monitoring the effective contrast more rigorously and re-adjusting T1 times as
soon as deviations are noticeable.
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5.2.5. Application of Vacuum for Bulk Bone Staining
The role of vacuum in the application process of contrast agents is debatable. Contrast
agent labelling depends on three effects: the distribution through the vascular system, dis-
tribution through the canalicular system and binding to exposed Ca2+-surfaces.
In vivo, vascular circulation will facilitate the distribution of contrast agents throughout
the blood system. Further distribution through the canalicular network, however, is not
influenced by the blood pressure (Li et al., 2010), but more so by mechanical loading (Price
et al., 2011). On both scales Brownian motion is an important factor for distribution of
particles. Brownian motion, however, is not much changed with pressure but with the size
of particles and the absolute temperature. Particles, furthermore, spread out and distribute
in relation to the square of the time (Einstein, 1905). The binding of contrast agents to
exposed Ca2+-surfaces occurs chemically.
In experimental set-ups the in vivo vascular circulation can be substituted partly. This can
be attempted by vacuum application. However, vacuum is not applicable clinically and
not comparable to in vivo effects of distribution. Vacuum does not play an important role
in mixing liquids by Brownian motion — but it is effective by producing bubbles at the
vapour pressure, leading to mixture in vessels wider than the bubbles, i. e. in the millimeter
range. In narrow vessels, vacuum might be effective if it is continuously alternated around
the vapour pressure and thus provides large volume differences and liquid exchange. How-
ever, under constant vacuum pressure inside a micrometer-size canal system, appearing
bubbles either do not move but displace fluid or they move unidirectionally outwards, thus
hindering a bidirectional fluid flow and mixture. If vacuum sucks contrast agent onto inner
surfaces is questionable. Chelating contrast agent bind chemically up to a chemical equi-
librium — any vacuum forced increase of contrast agent binding might be Ca2+-unspecific.
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Concluding, vacuum application the facilitate distribution and binding of contrast agent in
bulk staining of bone might be inadvertently counter-productive.
Ultrasound supports particle distribution through increased fluid motion. It does not pro-
duce counter-productive effects in micrometer sized canaliculi, nor does the increased
molecular motion interfere with chemical binding and increase the risk of unspecific
binding. Therefore, ultrasound should be preferred in bulk bone staining.
However, this reasoning appeared at a late stage throughout the studies and was only
included to some extent in later experiments.
5.2.6. Evaluating Efficiency with ImageJ
The bone surface contrast of negative control samples was higher than the theoretically
expected 1.0 (Fig. 3.13). This can derive from edge effects in the MRI due to the sudden
density and intensity change or be an artefact of the measuring technique, overestimating
slightly due to thresholding on the edges. The measuring technique uses a threshold so
high that no water background will be included in the bone surface. Based on this, regions
of interest (ROI) were drawn and their average intensity measured. The ROIs in BMM
labelled samples were much bigger than the thin line of the control sample, whereas this
cannot emerge from a plot of average intensities (Fig. 3.13). The negative control sample
in a separated vial (Fig. 3.12) clearly shows that the bright intensity around BMM samples
are not just edge effects of the MR imaging itself but that the contrast agents are responsible
for the highly labelled surfaces seen in all MRI images.
Concluding, Gd-based BMM contrast agents were successful for the labelling of bone
surfaces and vasculature in MR imaging, based on changes in the T1 signal. Sufficient
MR signal is tolerant against changes in concentration, incubation time and severity of
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treatment but is dependent on good scanner settings. Contrast enhanced MR imaging of
bone has a high potential to provide additional information for animal experiments on bone
growth and diseases as well as clinical applications such as resorption space evaluation or
stress fracture detection.
5.3. Using Fluorescent and MR Contrast Agents to Identify Macro-
and Microdamage
A fatigue test was set up to evaluate the potential of MR contrast agents to detect macro-
and microcracks in cortical bone.
The plexiform bones used had few vascular canals or other distinct features, while most
osteonal samples had a variety of labelled features. This would facilitate the identification
of microdamage in plexiform bone. On the other hand, human bone is not plexiform and
there is a need to identify and clearly distinguish microdamage from the artefacts seen
in human bone rather than bovine bone. Therefore it was decided to use osteonal bone
samples for future work.
Microdamage occurs in a range of around 100µm×300µm (O’Brien et al., 2003). The
majority of scans were performed at a resolution of 1043 µm3/vx. This would show average
microcracks around 1–10 voxels in size. There were numerous voids in this size range
detected in fatigued samples compared to unfatigued samples. However, it as the samples
were fatigued close to fracture and most samples did experience at least one macrosco-
pically visible crack, it is not clear whether any observed smaller cracks originated from
the macrocrack or were influenced otherwise by the macroscopic damage. For example,
smaller cracks can open wider when the bulk bone fractures than they can inside the vol-
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ume of a bone. The macrocracks with a length of 1–5mm were clearly labelled with the
applied MRI contrast agents. Clear identification of microdamage still remains elusive.
However, the MRI scans clearly show Haversian canals as well as resorption spaces. Cli-
nically, information about resorption spaces in bone and changes over time therein can be
used to predict bone strength and fracture risk data more accurately. MRI derived porosity
can be combined with DEXA results, which might on their own be insufficient to detect
early changes in OP / osteopenia (Kennedy, 2007), to derive better estimations of bone
quality and quantity.
It was possible to backtrack single MRI slices to corresponding µCT slices and µCT slices
to histological slices. MR images of 1043 µm3 were comparable with µCT images of
153 µm3. This is attributed to the low specificity of µCT for voids. This is because µCT
detects only density differences and these are not very high in bone compared to bone with
small voids filled with water. MRI appeared equal or better in detecting voids in bone at
a resolution 7-times coarser in every direction in space. This is around the clinical reso-
lution of MRI. While CT resolution is currently around 803 µm3 for peripheral scanners —
and cannot be increased because the radiation exposure is already at its limit. Thus, CT
will never be clinically usable to detect microdamage, whereas MRI bears the physical and
physiological potential.
5.4. Contrast Agent Supported Differentiation of Cortical Bone from
Normal and Estrogen Deficient Sheep
There were experiments performed to find differences in estrogen deficient ovine bone ver-
sus normal bone with and without contrast enhancement of the novel MR active contrast
agents. They showed that the contrast agents increased the contrast of hollow structures in
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the bones. The amount of canals per volume, normalized volume of holes and the average
hole size increased all significantly as expected in the same samples when BMM contrast
agents were applied. However, there was no difference found in any of these parameters
between the OVX and the CON group. This might be due to insufficient accurate image
acquisition with the existing equipment. Only a small amount of groups worldwide are
involved in high-resolution MR imaging of bone and there was no prior experience in this
topic from any of the people involved with this study. More experience of the group in
optimizing the MRI sequences, the single MR image acquisition and noise suppression
as well as advanced image post-processing for improved structural feature recognition and
measurement could certainly improve the finding of distinguishing parameters between the
OVX and CON group. Other studies have found, that in measurements of cortical porosity,
there is only moderate correlations between non-destructive HR-pQCT and histologically
assessed values (Boutroy et al., 2011). This indicates the difficulties of comparisons of
low resolution, in vivo usable techniques for investigations of bone quality factors. Never-
theless, this study showed that the contrast and visibility of medium to big voids in bone
is much more pronounced when bone specific contrast agents were used for MR imaging.
X-ray-based techniques for bone imaging, such as µCT, DEXA or X-rays, do not provide
insights into subtle changes in the bone morphology, overall turnover or remodelling due
to physical limitations of resolution and / or specificity.
Experiments using bone specific MR contrast agents, however, have a high potential to
detect more subtle alterations of the morphological structure of bone.
153
CHAPTER 3. CONTRAST AGENTS
5.5. Clinical Applicability
Half of osteoporotically classified fractures do not occur in osteoporotic patients but in
osteopenic patients. Currently, the costs of MRI scan are relatively high. However, the
costs of osteoporotic fractures are still higher.In addition, there are risks associated with
anti-resorptive drugs. Thus there is a need to treat the people who benefit from an interven-
tion — and on the other hand not waste efforts and costs and put on risk those who would
not require it.
It is not yet known if active remodelling sites are labelled specifically with the novel con-
trast agents. The new contrast agents might also serve as markers of turnover in bone as
other novel compounds do (Vitha et al., 2008). As they are Ca2+-chelators, they might be
incorporated in active bone remodelling zones over a period of time. All the fluorochromes
for labelling microcracks known to date have actually been used as markers of in vivo bone
remodelling before they were discovered as potential microdamage markers (Stover et al.,
1993; Lee et al., 2000a).
Figure 3.21 shows the state of the art trabecular bone MR imaging. These resolutions in
combination with contrast agents like the one introduced in this work can be used clinically
in the future to show sites of bone resorption as well as sites of acute bone deposition. The
resolution of clinical MRI scanners is around the size of microcracks (50–400µm). How-
ever, intensity increases in areas of microdamage will still be seen, even if the structures
cannot be identified by their shape. For these experiments, identification of microdamage
will still be supported by the shape of the features observed.
Finally one question remains: Is there actually a need for a novel bone seeking MRI con-
trast agent?
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Figure 3.21.: State of the art in vivo trabecular bone MR imaging with the Virtual Bone
Biopsy (VBB), resolution of 68.5×68.5×102.5µm3 (Benito et al., 2005). Image shows
the same region of bone at baseline and 24 months later in a clinical trial. The VBB enables
subvoxel separation from images of 137×137×410µm3 down to 23×23×68µm3 (Bhagat
et al., 2011).
The answer is not trivial.
Certainly, the introduced MRI contrast agents enabled more contrast in the bones observed.
However, the contrast agent only increases the the visualisation of the water that is already
there in the voids, cracks and vascular canals and the water itself is detected by MRI
scanners. An MRI contrast agent that binds to bone surfaces only emphasizes the water
more. However, with a higher contrast of the water filled voids, the scanning time could be
decreased and the resolution increased. This can enable better viewing of the vasculature.
Contrast agents could also bind over-proportionally to fine cracks compared to vascular
canals with their defined, smooth and therefore small surface. This might enable a clear
distinction between vasculature and damage in the future. On the other hand, novel contrast
agents also need clinical approval.
Last but not least there are always safety issues involved in the use of gadolinium-based
contrast agents. Free gadolinium ions are somewhat toxic (LD50,animals = 100–200 mg/kg,
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Bartolini et al., 2003; Ersoy & Rybicki, 2007; Penfield & Reilly, 2007). Ordinary Gd-
based contrast agents do not bind to anything specific in the body, but are for example
used as markers of higher blood flow or high nutrient supply in cancer. Our contrast agent,
however, is designed to attach in human bodies temporarily or permanently. BMM binds
to high Ca2+-levels — presumably fresh bone formation sites as well as cracks. With the
remodelling this gadolinium will be released back into the blood stream once again. It
is not at all clear if these contrast agents release single, toxic Gd3−-ions when the bone
material they are attached to in a chemical compound is removed with a variety of highly
potent acids and proteins during an remodelling cycle by osteoclasts. Some observations
on stability and acute toxicity of the BMM compounds have been made so far (p. 295).
Careful preclinical studies evaluating both short term and long term toxicity must be carried
out. In vitro assays with osteoclasts might help to gain insights into chemical decomposi-
tion of the compounds and release of toxic remainders such as Gd3−-ions.
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6. Conclusion
1. Novel, calcium-chelating fluorescent contrast agents and were detectable with laser
scanning confocal microscopy and fluorescence microscopy. The contrast agents
effectively label exposed calcium both in scratches and in fatigue induced micro-
damage. Optimum contrast agent binding and fluorescence intensity occurs after 24 h
in 4 mM aqueous solution. With excessive binding time optical quenching can occur,
reducing the efficiency. All proposed contrast agents were fluorescently detectable,
with BMM 66 being the most potent.
2. Novel gadolinium-based compounds, proved to be effective MR imaging contrast
agents by altering the T1 relaxivity of protons. Compared to water, the contrast agents
intensified the signal by a factor of 3–5×. They proved effective even at low doses,
while being insensitive against over-staining and alterations in application.
3. In fatigued compression samples, the MRI contrast agents labelled machined outer
surfaces, vascular canals and macroscopic cracks. However, due to the resolution of
the MRI scanner, direct evidence of microdamage was elusive.
4. MR imaging with contrast agents showed higher intensities and higher numbers of
vascular canals and resorption spaces. However, it was not possible to distinguish
ovariectomized, osteopenic bone from control bone with the existing set-up.
5. With ongoing technical development, MRI contrast agents have a high potential as
non-invasive, in vivo markers of bone quality and quantity and could be useful in
determining fracture risk in osteopenic and osteoporotic patients more accurately.
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4. Effects of Remodelling on Tissue
Level Mechanical Properties
1. Introduction
1.1. Osteoporosis and Osteopenia
In estrogen deficiency bone quality and quantity suffer over prolonged time periods (Riggs
et al., 2002), however, it remains elusive as to how the quality of newly formed bone
changes locally.
Osteoporosis is defined by a deterioration in bone quality and quantity over prolonged
times. This leads to higher fracture risk (Kanis et al., 2000) and associated higher mortality
rates in osteoporotic patients (Johnell et al., 2004; Haentjens et al., 2010). Osteoporosis
is per definition (WHO, 1994) associated with a lower amount of bone mineral density
than osteopenia, however, a much higher absolute amount of fractures occurs in the less
severely impacted osteopenic patients (Pasco et al., 2006).
In the early stages of osteoporosis or osteopenia there is a rise in turnover (Kennedy et al.,
2009a). Newly remodelled basic multicellular units (BMUs), both in cortical as in tra-
becular bone, are often not being refilled fully and lead to higher porosity and decreasing
bone mass in the long term. However, it is not clear if the initial remodelling also affects the
quality of the new tissue. To gain a comprehensive picture of the mechanical competence
of bone at the onset of osteoporosis, it is important to know effects at all levels from the
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organ level to the tissue level and even the mineral phase and molecular level (McNamara,
2010). Ultimately, bone failure takes place at the organ level. But organ level changes can
be subtle during the early stages of estrogen deficiency and osteoporosis / osteopenia. At
a macroscopic or millimeter level changes can be seen more pronounced, such as higher
turnover as well as higher porosity. However, these morphological changes may not affect
the mechanical competence of the bone significantly (Kennedy et al., 2008c). Biological
alterations take place at the cellular and molecular level in the nanometer range. However,
these changes are clustered at the tissue level into single BMU sites build by osteoblasts
under similar influences at the same time. Mechanical changes in early stage osteoporosis
take place at the tissue level of BMU size. Therefore, this study focusses on the exploration
of tissue level mechanical properties in early stage estrogen depleted bone.
This is part of a multidisciplinary study of ovine estrogen withdrawal (Lee et al., 2004 &
section 3.6). The study program involved mechanical testing at a variety of magnitudes,
morphological evaluation as well as cellular and molecular work. For example Brennan
(2008) confirmed a major estrogen decrease due to the ovariectomy procedure, Kennedy
(2007) and Healy et al. (2010) found an increase in cortical bone turnover at 12 and 31
months. Various organ and sub-organ level mechanical tests showed a range of differ-
ences between estrogen depleted and control bone. However, the initial changes occur
at the tissue level within the size range of basic multicellular units like osteons in cor-
tical bone or trabecular remodelling. All tissue level changes range up to a maximum
of ≈ 300×300×4000µm for a single osteon or even smaller for trabecular replacement
sites. Tests with sample sizes of several millimeters in each direction may or may not ade-
quately reflect the ongoing changes. Furthermore, sample sizes one or more magnitudes
bigger than the underlining causal effect may cause a unresolvable mixing of mechanical
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effects. Kennedy et al. (2008c) observed fatigue microcracks to have a higher likelihood
of being drawn towards recently remodelled osteons as well as being stopped there. This
crack blunting effect appeared to increase the fatigue resistance of estrogen deficient bone.
However, from a whole bone perspective, it was not clear whether this was due to an
increased amount of turnover, altered properties of the remaining tissue or different pro-
perties of newly formed tissue due to estrogen deficiency. Brennan et al. (2009) nano-
indented trabecular bone and correlated mechanical values with local mineralization. This
study gave insight into general trabecular differences between estrogen deficient and con-
trol sheep. The fluorescent age labels of the individual tissue were not the focus of this
study so mineralization and mechanical values were not correlated with remodelling age.
The increasing hardness of the superficial layer of trabeculae in the estrogen depleted group
might be caused by increased resorption which thins trabecular struts (Holland et al., 2011).
1.2. Nanoindentation
In this study, nanoindentation was used in connection with epifluorescence microscopy in
order to determine micro-mechanical properties in defined regions of known age.
Nanoindentation is used increasingly to determine mechanical properties of small quan-
tities of hard tissues (Turner et al., 1999; Lewis & Nyman, 2008). Figure 4.1 shows the
principle of the nanoindentation measurements (Lewis & Nyman, 2008). The triangular
Berkovich indenter is commonly used for testing dehydrated bone (Oyen & Cook, 2009).
Dehydrated bone exhibits higher indentation stiffness and hardness (Rho & Pharr, 1999;
Hoffler et al., 2005), but it avoids surface degradation in storage media (Dickinson, 2009).
Consistent measurements for bone indentation requires a minimum indentation depth of
500 nm (Hoffler et al., 2005).
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Figure 4.1.: Schematic of the cross-section of the indent made by a Berkovich indenter
during loading and unloading. Indents are usually in a depth range from 10− 10000 nm.
Image from Lewis & Nyman (2008).
Our first hypothesis was to expect stiffness and hardness to increase with the maturation of
tissue. The second hypothesis was to expect differences in mechanical properties between
the control animals and the estrogen deficient animals due to differences in their remodel-
ling activity.
1.3. Aims
The specific objectives to test these hypotheses were:
1. To develop an experimental technique in which fluorescently labelled bone can be
recorded on a fluorescence microscope and subsequently tested with a nanoindenter
in specifically identified tissue locations.
2. To relate tissue mineralization by means of indentation stiffness and hardness to
the age of the newly grown osteons by identifying age-specific fluorescent labels in
newly grown bone.
3. To compare the indentation stiffness and hardness of tissue from control animals with
tissue of animals in early stage osteopenia due to estrogen depletion twelve months
after ovariectomy.
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2. Material and Methods
2.1. Bones used
Bones were used from previous studies of our group, mainly undertaken by Kennedy
(2007) and Brennan (2008). Only osteons of the posterior cortex of the left metatarsal
were taken for this analysis. Firstly, to eliminate mechanical variation from posterior to
anterior (Rho et al., 2001b) and secondly, because of the higher amount of recent turnover
is this area, enabling a wider choice of specifically labelled osteons.
Figure 4.2.: Base with two embedded samples for nanoindentation. Two cortical bone
samples (A & B) were placed in the middle of the base (D). Further bone pieces of no
scientific value (C) were placed on the periphery as a surface increase to stabilize during the
grinding and polishing process to increase the evenness and surface quality of the sample.
Base diameter: 30 mm.
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2.2. Sample Preparation
Cortices of the left metatarsal were cut with a diamond tipped blade (#330CA, Struers,
Denmark) on a slow speed saw (Minitom, Struers) to 2 mm thick sections and divided
into posterior and anterior part. The posterior cortex was used for further study. Sections
were ground with 400 grit SiC emery paper to achieve an even but relatively rough surface
to facilitate sufficient glue adhesion. Samples were randomized into pairs of one OVX
and one CON per sample holder. Each pair was glued onto a plastic base 30×20mm
with two component epoxy glue (Araldite, Huntsman Advanced Materials, USA). The
two components were well mixed to a paste of homogeneous viscosity, which increased
continuously over time. At a viscosity thicker than that of liquid honey, a < 1mm layer of
glue was spread on the base and the samples pressed into the glue. Due to the high viscosity
at the application time, the unavoidable penetration of liquid glue1 into the pores of the
bone tissue were minimized. It is not expected that the glue penetrated deeper than 200µm
into the bottom of the sample, being far away from the sample top that was designated
for mechanical testing. The glue hardened within 10–20min. The samples were then
successively ground with SiC paper of grit 1200, 2500 and 4000 and polished with 3 µm,
1 µm and 0.25 µm diamond paste (Akasel, Sweden) on soft polishing cloth (PSU-S, Kemet,
UK) under constant water-based irrigation (Aka-Lube, Akasel) on a slow speed grinding
wheel (DP10, Struers) (Fig. 4.2). The samples and the grinding machine were cleaned
thoroughly after each grinding or polishing step to avoid contamination with bigger sized
diamonds and grinding dust which would deteriorate the surface quality. The samples were
air dried after the polishing to avoid surface decomposition (Dickinson, 2009).
1Double-sided adhesive tape did not work well with the thin samples: taping polished sections led to
surface flatness distortions. Whereas, polishing taped samples enabled the tape to contaminate both sample
and polishing equipment and to interfere with a high quality surface finish in a very effective way.
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2.3. Identification of Fluorescently Labelled Osteons
Osteon labels were identified on an inverted epifluorescence microscope (IX 51, Olym-
pus, Japan) with various filter cube combinations (Table 4.1). Images were taken with a
2.5× objective and stitched together to full section sized images with the imaging software
analySIS (Olympus) (Fig. 4.3). The free imaging software Fiji (Schindelin, 2008; Walter
et al., 2010) with the plug-in Cell Counter was used to allocate osteons into labelling cate-
gories according to table 1.2. Identification of osteon colours was done in parallel with the
taken image and life eyepiece vision to ensure conformity.
Filter cube Abbreviation
Excitation Dichroic Emission
filter λ mirror λ filter λ
Ultraviolet longpass UV LP 330–380 400 420 longpass
Blue longpass blue LP 460–490 505 515 longpass
Green longpass green LP 520–550 565 580 longpass
Table 4.1.: Filter cubes of the inverted epifluorescence microscope used in this chapter.
Wavelengths λ in nm.
2.4. Indentation Settings
The samples were mounted on a Nanoindenter (Nano Indenter XP, MTS Systems, US). A
Berkovich pyramid indenter (Hay & Pharr, 2000; Oyen & Cook, 2009) was used with an
elastic modulus of E = 1141GPa, a Poisson’s ratio of ν = 0.07 and a tip radius r < 50nm
(AccuTip, MTS Systems). The allowable thermal drift rate was set to 0.05 nm/s 2.
2The thermal drift rate is — unexpectedly, as contrary to its name — less a measure of a physical thermal
drift of the machine but rather reflects the surface quality of the sample. A low allowable thermal drift rate at
the Nano Indenter XP prevents samples with insufficiently rough surface from being measured through long
timely delays while trying to find a sufficiently low thermal drift rate. The machine checked the drift rate
several times per sample, seemingly when indents exceeded a specific distance from the last set of indents.
Practically this ensured a high quality polished surface at all indented areas.
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Figure 4.3.: Typical nanoindentation samples imaged with an epifluorescence microscope
with different filter cubes to identify differently labelled osteons. Filter cubes: a) UV
longpass, b) blue longpass, c) green longpass. Sample A and B are the same as in Fig. 4.2.
Bar: 5 mm.
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A trapezoidal-type cycle was used for the indentation (Lewis & Nyman, 2008). The inden-
ter loaded to a indentation depth of 800 nm and held there at constant force for 90 s to
decrease the effects of viscoplasticity (Fan & Rho, 2003). The indentation modulus was
measured during the unloading of the indenter between 95 % and 50 % of the maximum
indentation force. The unloading was stopped at 10 % maximal force for 50 s to measure
and compensate for thermal drift.
A continuous stiffness measurement (CSM) method (Li & Bhushan, 2002) was employed
for indentation. The oscillating displacement of the tip was set to 2 nm at 45 Hz. Upon
completion of the indentation, the software calculated hardness and indentation modulus
during the unloading curve according to Oliver & Pharr (1992; 2004). Fused silica was
used to calibrate the indentation modulus.
Figure 4.4.: Schematic of indent locations across osteons. indicates indent location.
The coordinates of labelled osteons were exported from the Fiji plug-in Cell Counter and
transferred to a custom-made MS Excel spreadsheet. Unique reference points were defined
which were visible using both the reflected light brightfield microscope of the nanoindenter
and the fluorescence images with the age labelling. From the reference point coordinates in
both imaging modalities the Excel sheet calculated the matching nanoindenter coordinates
of each individual osteon. Osteon coordinates were confirmed by comparison of the sur-
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rounding patterns of Haversian canals. Osteons whose coordinates could not be confirmed
by the surrounding bone morphology with certainty were excluded. Labelled areas which
did not have the typical round appearance of osteons were excluded. For each existing
fluorescence label 2− 5 osteons per bone were chosen randomly for indentation. Each
osteon was indented 8−15 times, depending on the available size. Indents were differen-
tiated between inner and outer region of the osteon (Fig. 4.4). Distances between individual
indents were 20−30 times the indentation depth.
Initial preparation, microscopy and indentation of the samples was carried out in conjunc-
tion with David Fealey, a summer student working in our laboratory.
2.5. Power Analysis
To determine the sample size needed, two power analyses were carried out. In both type I
error level was set to α = 0.05 . The type II error level was set to β = 0.2. Cohen’s d was
calculated as d = x1−x2s , where x1 and x2 are the two effective means and s the standard
deviation of x1 and x2 (Cohen, 1988). The data used for both analyses were collected by
nanoindentation on tissue of the same animals used in this study (Brennan et al., 2009).
Whereas Brennan et al. (2009) indented individual trabeculae independent of fluorescent
labelling, the focus of this study was on osteons with identified ages. Both studies looked at
early stage osteoporosis ovine bones 12 months after ovariectomy in the stage of estrogen
depletion induced osteopenia.
According to the first study aim, the first null hypothesis was that there would be no
difference between the mechanical properties of osteons of different age. The data of
Brennan et al. (2009) which resemble differently aged BMUs closest are the differences
in indentation modulus of superficial (17.3± 1.3 GPa) and intermediate (21.8± 3.1 GPa)
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layers of trabeculae in the control group. This results in sCON =
√
(n1−1)s21+(n2−1)s22
n1+n2
=√
(20∗10−1)1.32+(20∗6−1)3.12
20∗10+20∗6 = 2.15, dCON =
xintermediate−xsuper f icial
s =
21.8−17.3
2.15 = 2.09 and an
nsheepCON = 6 per animal group. The same analysis in the OVX group results similarly in
dOV X = 2.01 and nsheepOV X = 6.
The second aim of the study, results in the second null hypothesis, that there would be
no difference between osteons of the same age in ovariectomized versus control animals.
The data used here were the indentation moduli of (Brennan et al., 2009) for the super-
ficial layers of the trabeculae in OVX (14.87±1.6 GPa) versus CON (17.27±1.3 GPa). It
was assumed, that the superficial layers of the trabeculae are the most recently remodel-
led areas of trabeculae in both groups and they would therefore most closely resemble
differences between young osteons. This results in ssuper f icial =
√
(n1−1)s21+(n2−1)s22
n1+n2
=√
(20∗10−1)1.32+(20∗10−1)1.612
20∗10+20∗10 = 1.46, dsuper f icial =
xCON−xOV X
s =
17.27−14.87
1.46 = 1.64 and an
nsheep = 7 per group.
From the study of Brennan et al. (2009) it is assumed that the superficial layer of the
trabeculae are more recently turned over than the inner regions. However, the age of the
single areas of interest was not determined by Brennan et al. (2009). Thus the subdivision
of trabeculae into superficial, intermediate and center spans across several different three
month labelling time points. This can potentially lead to averaged means as well as higher
scatter. Our study focusses on identification of individual time points via the identification
of tissue labelled with unique fluorochrome stains. The differences between the tissue
groups are expected to be higher than in Brennan et al. (2009) because of a lower averaging
effect. The scatter is expected to be lower for the same reason. Thus 5 samples per group
(CON and OVX) were chosen for the initial calculation of the total number of indents. For
each of the samples it was tried to find 2−5 osteons of the four most prominent age labels.
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The Calcein Blue labels were present only in minor amounts as expected from Kennedy
et al. (2008b). Each osteon was indented 8−15 times.
ntotal = nindents/osteon ∗nosteons/age ∗nages ∗nsheep ∗ngroups
ntotal = (8 . . .15)∗ (2 . . .5)∗4∗5∗2 = 640 . . .3000
In total 1427 indents were performed of which 1056 indents were included. The indents
were carried out on samples from 6 ovariectomized and 7 control sheep (Fig. 4.5).
Figure 4.5.: Amount of samples, osteons and indents.
The exclusion criteria for indents were:
• No or zero value produced for stiffness or hardness.
• Based on normal plots of stiffness and hardness within single animals as well as
within single osteons, the most severe outliers were excluded. Low stiffness values
— of 0−20% of the expected stiffness — occur for example if the indent appeared
to be on a hidden osteocytic lacuna.
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3. Results
3.1. Hardness
Nanoindentation testing of polished cortical bone resulted in hardness values for a total of
1056 valid indents. Fig 4.6 represents all indents from the control group of sheep in respect
of the age of osteons. The age is given in months post-ovariectomy, the end of the study
was at 12 months, when the bones were harvested.
Figure 4.6.: Indentation hardness in control group.
The hardness of 1 month old osteons was significantly lower than of any other osteonal
tissue (p < 0.01 vs. any other label). Osteons labelled with Xylenol Orange, 3 months
before the end of the study, showed significantly lower hardness than the oldest osteons,
labelled with Oxytetracycline that were 9 months older. There was a trend of more recently
formed osteons being less hard than older ones. However, this trend was only statistically
significant for osteons 3 and 1 month old in the control group.
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Figure 4.7.: Indentation hardness in ovariectomized group.
In the ovariectomized study group the same phenomenon of lower hardness in more
recently grown osteons was apparent (Fig. 4.7). Most dominant in the OVX group was
that the hardness for the most recently grown osteons, labelled with Calcein Blue, was
significantly lower than any older osteons (p < 0.01). Furthermore, 3 months old osteons,
labelled with Xylenol Orange, had significantly lower hardness compared to any older
osteons (p < 0.01).
The one-way ANOVA from the linear regression approach did not show OVX versus CON
as a significant factor. Neither did the post-hoc analysis between the study groups show
any statistical significant differences in hardness in any of the specific osteon age groups
(Fig. 4.8). The 1 month old osteons, labelled with Calcein Blue showed no statistically
significant difference between OVX and CON (p > 0.1).
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Figure 4.8.: Indentation hardness in control and ovariectomized group, differences between
treatment groups. All age groups were not significantly different.
During the experiment, indents were classified as either inner region of the osteon and
close to the Haversian canal or outer region of the osteon. There was no significant differ-
ence between indents of the inner versus the outer region within any of the time specific
labels in any experimental group (graph not shown). Closest to significance were the Oxy-
tetracycline labelled osteons in the control group, where inner region indents showed 9.4%
lower hardness than outer region indents (p = 0.071). Furthermore, regional differences
turned out to be not a statistically significant factor in the one way ANOVA contributing to
the hardness over all different osteon ages.
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3.2. Indentation Modulus
In the second measurement provided by nanoindentation, the indentation modulus, similar
trends as in the hardness values were seen. Indentation modulus was measured for 1056
valid indents.
Figure 4.9.: Indentation modulus in control group.
The indentation modulus in the control animals was significantly lower in 1 month old,
Calcein Blue labelled osteons compared to any older labelled osteons (p< 0.05 vs. Xylenol
Orange and p < 0.01 vs. all others) (Fig. 4.9). None of the other labelled osteon showed
significant differences in their indentation modulus.
Indents on ovariectomized animals showed as well significantly lower indentation modulus
of 1 month old (Calcein Blue) to all other osteons (p < 0.01 vs. all others) (Fig. 4.10). 3
month old (Xylenol Orange) osteons had significantly lower indentation modulus to the
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Figure 4.10.: Indentation modulus in ovariectomized group.
ones labelled with Calcein Green (6 months old) and Oxytetracycline (12 months old, both
p < 0.01). 9 month old (Alizarin Complexone) osteons had significantly lower indentation
modulus than Oxytetracycline (12 months old) osteons (p < 0.05).
Comparison between ovariectomized and control sheep brought significant differences
between the most recently labelled osteons (Calcein Blue, 1 month old, p < 0.01,
Fig. 4.11). There was no significant difference between other labelled osteons.
Indentation modulus showed a tendency to be lower on inner lamellae in the control group
compared to outer lamellae (Fig. 4.12). This difference was significant in the control group
at time zero (Oxytetracycline, p < 0.01, Fig. 4.12). In the ovariectomized group there was
an opposite trend of increased indentation modulus at inner lamellae (Fig. 4.13). Including
a cross-influencing factor for CON & inner lamellae versus OVX & outer lamellae into the
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Figure 4.11.: Indentation modulus in control and ovariectomized group, differences
between treatment groups.
linear regression analysis resulted in a trend, close to significance (p = 0.066). Further-
more, an inclusion of this cross factor brought the differences of Calcein Green (6 months
old osteons) to Oxytetracycline (12 months old osteons) close to significance (p = 0.070)
as well as the difference between the ovariectomized and the control group from p > 0.1
to p = 0.069.
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Figure 4.12.: Indentation modulus in control group by inner and outer lamellae.
Figure 4.13.: Indentation modulus in ovariectomized group by inner and outer lamellae.
176
CHAPTER 4. NANOINDENTATION
4. Discussion
4.1. Recently Remodelled Osteons are Less Mineralized
One of the objectives of this study was to identify age-related fluorescent labels of newly
grown osteons and relate mechanical properties from nanoindentation to the specific age
of tissue compartments. It was found that both hardness and stiffness increased with matu-
ration of the bone compartments. This happened in a similar manner both in control sheep
and in estrogen depleted animals. The absolute values found were consistent with the
literature for hardness (Hoffler et al., 2005) as well as for stiffness (Dall’Ara et al., 2012).
Similar trends were found by Fuchs et al. (2008; 2011), where the most rapid increase in
mineralization was seen in the first 18 days of newly formed bone. Rabbit bone increased
in mineralization, measured by FTIRM and DEXA, further at a slower and relative con-
stant rate for up to one year. Huja et al. (2010) found that the latest grown osteons were
undermineralized compared to older osteons both with quasi-static nanoindentation as well
as with the dynamic CSM method, which was used in this study.
In general, the intrinsic stiffening of bone considerably lags behind the initial mineral
formation in bone tissue (Miller et al., 2007). Therefore, early mineralization does not
necessarily correlate linearly with stiffness. With further increase in mineralization the
stiffness then rises disproportionally. This can also be seen in antler, which exhibits the
lowest stiffness of mineralized biological tissues. Currey (2004) measured red deer antler
with 21.3 weight-% of the mineral phase, compared to the 26.2 weight-% of bovine bones.
Whereas antler had a Young’s modulus of 8 GPa compared to 24 GPa of bovine bone. Thus,
antler, with still 81.3% of the mineral content of bone, showed only 33% of the stiffness
of bovine bone (Zioupos et al., 1996). Other researchers have found similar dispropor-
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tional increases in stiffness with mineralization levels (Rho et al., 2001a). The degree of
mineralization is the major influence on stiffness in bone tissue (Mulder et al., 2007).
The age of bone tissue is reflected in its stiffness (Burket et al., 2011). This is not just the
case between osteons, but there is also a difference between interstitial bone and osteonal
bone (Rho et al., 1999; 2001b; Fan et al., 2002). Hoffler et al. (2005) found that interstitial
bone had increased indentation stiffness by 9% and an increased hardness by 14% com-
pared to osteonal tissue. This reflects the fact that full osteons are on average younger than
interstitial bone, which consists of the oldest compartments of bone.
4.2. Differences in Tissue Properties of Bones from Ovariectomized
and Control Sheep
The second objective of this study was to find differences between tissue from control and
ovariectomized sheep, twelve months after ovariectomy. Significant differences between
the study groups were found in the stiffness, but not in the hardness values, of Calcein
Blue labelled osteons. Calcein Blue labelled the last grown BMUs in the tissue with an
age of around one month. These differences may result from differences in the tissue
mineralization level between OVX and CON tissue. This occurred only in osteons that
were only one month old, so the onset of mineralization in early stage osteopenia might be
altered. Furthermore, mineralization of individual osteons may be affected for longer than
one month but that the effect requires a certain time after estrogen withdrawal to develop.
Brennan (2008) found — in the same animals used in this study — that more recent bone
areas were associated with lower mineralization as well as with lower nanoindentation
stiffness and hardness. Ovariectomy reduced the modulus of the bone, but did not alter
the hardness. However, it was unclear, if the lower mineralization levels in outer layers
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of trabeculae were caused by slower mineralization of new tissue or by a higher amount
of new and less mineralized tissue (Brennan, 2008). Busse et al. (2009) described ele-
vated local mineralization and higher inhomogeneity in osteoporotic trabeculae in humans
along with decreased mechanical properties. Brennan et al. (2011a) confirmed increased
trabecular mineral heterogeneity of estrogen depleted sheep 12 months after ovariectomy.
Interestingly, these effects appeared to be site specific and ranged between no difference up
to 15% increased mineral heterogeneity in three different locations of the proximal femur.
Fuchs et al. (2011) found no difference in BMU mineralization rates for up to one year
between control and ovariectomized rabbits when measured with FTIRM (Fourier Trans-
form Infrared Microscopy). Therefore, they suggested that alterations due to estrogen
depletion, measured as an overall tissue mineralization with BMD values, could be entirely
caused by increased remodelling rather than by microscopic mineralization changes on
single osteons. Vice versa, decreasing the remodelling would cause the BMD to rise. How-
ever, this rise can be explained with the changing amount of turnover rather than differences
in individual BMU mineralization levels over time (Fuchs et al., 2011).
While at the organ level, these effects reflect in patients with higher overall bone forma-
tion rates to have lower bone stiffness (Wang et al., 2008). Linear correlation between the
indentation modulus and indentation hardness was not different between normal patients
and patients with previous vertebral fractures or between patients with high and low bone
formation rates. Thus, osteoporosis or estrogen depletion may not change the relationship
between local bone tissue elastic modulus, bone hardness, and bone mineralization at the
tissue level of similar aged compartments, while it clearly does at the whole bone level
(Wang et al., 2008). Newly formed bone, stays comparable in its mechanical properties
over time between healthy and estrogen depleted individuals — with the difference, that in
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osteoporosis the total amount of both removed bone and replaced bone may significantly
vary. Both the inadequate replacement amount with new tissue as well as the lower stiffness
of a higher amount of new tissue makes up for the overall reduced stiffness in osteoporosis.
Zioupos (2005) associates a higher inhomogeneity of mineralization and stiffness of bone
tissue with a higher likelihood of microcrack appearance. Increased appearance of micro-
cracks leads to a reduced resistance to fracture generally (Schaffler et al., 1995) as well as
specifically in osteoporosis (Dai et al., 2004).
Statistically significant differences were found between OVX and CON in one month old
osteons. This difference turned out from the multiple regression post-hoc comparison of
the osteon ages between the two groups. The multiple regression approach, with osteon
age and group as parameters, did not result in a difference between OVX and CON.
In conclusion, there were differences found in the indentation stiffness in young osteons
between the estrogen withdrawal group and the control group.
4.3. Limitations
This study has a number of limitations.
The bones were tested in a dry state, rather than wet. This was due to the available nanoin-
denter not being equipped with a wet cell. Several researchers have studied the differ-
ences between dry and wet testing in the past. Rho & Pharr (1999) found that dehydration
increased the indentation modulus of bovine cortical bone in nanoindentation by approxi-
mately 15%, while Hoffler et al. (2005) found that drying increased the nanoindentation
modulus by 22.6% and hardness by 56.9%. Embedded dry bone had the same properties
than dry bone. Changes in the mechanical properties between wet and dry samples should
be only factorial, so intra-study comparability is still given in our study. While Ammann
et al. (2007) indicated that dry nanoindentation could be less specific. They found only
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differences in stiffness in strontium ranelate treated rats in wet samples, but not in dry sam-
ples. As well, much of the microdamage seen, especially in SEM studies, could be caused
by the drying processes (Boyde, 2003). The indents done in this study were only 800 nm
deep and should therefore not be affected by microcracks — however, the tissue at a lower
scale could as well be affected in its mechanical properties.
On the other hand, Dickinson (2009) found, that wet nanoindentation may induce problems
as well. When samples were kept in different established bone storage media for more than
one day, their material properties changed markedly. This was attributed to ion exchange
between the bone and the surrounding fluid in the nano range. These effects are avoided
with drying the samples directly after polishing and testing dry.
The samples were glued with a viscous epoxy glue (sec. 2.2). It is normal that the liquid
infiltrates the bone tissue and changes the mechanical properties in this zone. It was tried to
keep this effect as small as possible to receive such a small zone of infiltration that it would
not at all influence the top layer of the sample that was mechanically tested. This was
done by letting the glue set for 1–3min until its viscosity increased and would penetrate
less. However, the real penetration depth was not measured3. It was estimated that the
penetration of glue into the ≈ 1mm thick samples is  500µm and that the top 500µm
sample zone would be unaffected by glue penetration.
In this study, only osteons grown in the last 12 months were tested. While this allowed
precise timely matching within this time frame, interstitial bone as well as osteons older
3Measuring the penetration depth could have been done for example by using coloured glue. The dye
molecules would need to be small (Li et al., 2009), to indicate the worst case penetration depth into the
tissue. Basic Fuchsin with a molecular weight of 337.9 g/mol could work under the premise that it a) mixes
homogeneously in one part of the epoxy glue and in the final epoxy mixture and b) its colour intensity does
not deteriorate significantly during the glue polymerization. The further sample preparation steps and the
mechanical testing would be unaffected. At the end of the testing the sample base and the samples would be
cut lengthwise and the cut surface investigated with fluorescent light.
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than one year were not measured. If interstitial bone would have been tested as well, it
would have been most interesting to evaluate, if interstitial tissue in the vicinity of recently
replaced tissue is different from random interstitial tissue. As well, older osteons with-
out any label, being older than one year, could be tested. Due to the unknown age of
any unlabelled tissue, standard deviation of the mechanical properties would be expected
to increase, leading to a disproportionally larger number of sites and indents to be made.
Overall, including a wider variety of tissue locations would more than double the total
number of indents. The study of Fuchs et al. (2011) indicates that the increase in minerali-
zation and mechanical properties of new tissue approach a constant level after around one
year. Therefore, the one year old tissue in this study can be approximated as a control
group for any older osteons.
The differences found in the latest grown osteons, labelled with Calcein Blue, could be
influenced by several factors.
Labelling of an osteons with a calcium chelating fluorochrome means, that some layer of
the osteon was in an active mineralization phase at the time of the fluorochrome adminis-
tration. The growing time for an osteon in sheep is two to three months (Frost, 1983; Li
et al., 1990; Lee et al., 2002). An osteon which began growing ten weeks before the fluoro-
chrome injection would be labelled with Calcein Blue in the end phase of its mineralization.
Likewise, an osteon which just began to mineralize one or two week before the Calcein
Blue injection would also be labelled. It is likely that osteons that grew and mineralized
already for ten weeks are mechanically different from osteons that are one or two weeks
old. This effect might have influenced the measured tissue properties.
Furthermore, the Calcein Blue label used for the latest grown osteons is relative hard to see
on a fluorescence microscope. Calcein Blue has an excitation wavelength of 370 nm and
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an emission wavelength of 435 nm which lets it appear sky blue. It can only be seen with
ultraviolet excitation and a blue emission filter. The autofluorescence of bone when excited
with ultraviolet light, however, is bright blue. It is hard to differentiate the Calcein Blue
labels from the bone autofluorescence itself. Furthermore, the autofluorescence of osteoid
when excited with ultraviolet light is blue as well. The identification of Calcein Blue is
more difficult than of any of the other fluorochromes in this animal model. Beside a sea-
sonal variation of bone turnover in sheep (Turner, 2002; Arens et al., 2007), the difficult
identification might have had an effect both on the counts of Calcein Blue labelled osteons
in previous studies on this animal model (Kennedy et al., 2009a; Healy et al., 2010) as well
as on the tissue property measurements in this study.
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5. Conclusion
In conclusion, in this study, on compact bone specimens from the metatarsals of sheep
one year post-ovariectomy versus controls, tissue level mechanical properties behaved as
follows:
1. Hardness increased in recently remodelled tissue with the age of the tissue up to
one year. There were no significant differences found between ovariectomized and
control tissue in the hardness behaviour over time.
2. Stiffness increased with the age of the tissue in both experimental groups likewise.
A significant difference between ovariectomized and control tissue was found for the
most recent osteons, grown one month before the end of the study.
3. There was a trend in the control group for lower stiffness on inner lamellae, while
this trend was reversed in the ovariectomized group.
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5. Microindentation of Cortical Bone
1. Introduction
A considerable number of old people break bones (Allen & Burr, 2010). A considerable
number of old people are osteoporotic — by the gold standard definition of the WHO
(1994), a bone mass (BMD) 2.5 standard deviations lower than the average. However,
only 15% of people who are both old and break bones are classified as osteoporotic —
the remaining 85% are osteopenic or even healthy, if judged solely on BMD (Pasco et al.,
2006). Thus, there should be more emphasis taken to develop and measure alternative
fracture risk indicators.
The most common imaging modality to determine bone strength is DEXA. However,
DEXA is a quantitative technique and measures the amount of bone. It is then taken as
a proxy for bone strength, because increased amounts of bone are associated with higher
strength and lower fracture risk. The actual strength of a bone remains unknown in DEXA
scans. The same problems occur with any other pure imaging based modality such as MRI,
CT, µCT, PET. These techniques image bone, but they do not measure mechanical proper-
ties. They can enable the assessment of the structure of cortical and trabecular bone up to a
resolution of 25 µm. Structural information is increasingly combined with Finite Element
Analysis (FEA). These approaches lead to knowledge of structural strength, such as which
trabeculum might break first, while they still do not measure mechanical properties.
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Measuring the strength of human bones is challenging: either material needs to be removed
from a living human or a mechanical testing device has to be inserted in vivo onto the bone
surface. Removing bone from living humans is invasive, expensive and may carry risks
(Cohen et al., 2010).
1.1. Measuring Mechanical Properties of Bone In Vivo
Devices to measure mechanical values directly inside the human body are difficult to
design. Three decades ago an instrument was developed to measure the mechanical pro-
perties of trabecular bone: the osteopenetrometer (Hvid et al., 1984). However, the osteo-
penetrometer can only be applied to exposed trabecular surfaces, such as during knee or hip
arthroplasty (Hvid, 1985). It worked by punching a 2.5 mm diameter tip into exposed tra-
becular bone. Thus, the osteopenetrometer cannot be used to derive mechanical properties
from healthy or osteoporotic subjects for fracture risk assessment.
Recently, Hansma et al. (2006) introduced a new minimal invasive technique for measuring
mechanical properties of hard tissues in vivo. The device, based on Reference Point Inden-
tation (RPI), is named BioDent™ and is commercially available from Active Life Scien-
tific, Inc. (Santa Barbara, CA) for less than US$100,000. The latest version of 2012 is the
BioDent™ Hfc (Active Life Scientific, 2012), in which the H emphasizes on the machines’
usage for hard tissue testing, the fc stands for force control. Reference Point Indentation
uses a fixed point on the testing material as a reference towards the indentation of a testing
probe. Using a small distance between reference probe and indentation probe minimizes
the influences of the elasticity of the entire machine frame and set-up. This reduces both
static measurement errors, such as deformations of the device, and dynamic measurement
errors, such as the transfer of environmental vibrations onto the machine.
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Figure 5.1.: BioDent™ probes. Right: disassembled test probe (front) and reference probe
(back). Left: assembled reference probe and test probe in the BioDent™. The black
micrometer-driven stage is part of the BioDent™ set-up for scientific use to precisely posi-
tion the samples for indentation.
The BioDent™ uses a modified 22 gauge hypodermic needle of outer diameter 725 µm as
a reference probe. Three reference probe tip geometries are available for different appli-
cations. Placed inside the hollow needle is a stainless steel test probe of 375 µm with a
spherical tip of radius 2.5 µm, tapering into a cone with an angle δ = 90◦ (Fig. 5.1 & 5.2).
During clinical application of the BioDent™, the hypodermic needle penetrates through the
patient’s shin skin and is placed onto the medial surface of the tibia. The periosteum layer
is removed by repetitive scraping with the hypodermic needle tip (Fig. 5.2). Three pre-
cycles are performed with low force to ensure bone contact, followed by 20 indents with
the nominal testing force Fnom. Mechanical parameters are derived from the indentation
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Figure 5.2.: The testing principle of the BioDent™. Sequence of testing procedure from
the left to the right. During the periosteum removal the test probe is further retracted than
shown here to protect the tip. Graphic from Diez-Perez et al. (2010).
displacement d, force Fcur and time. The derived parameters are related to classical mecha-
nical properties like stiffness and hardness, but as the test involves a mixture of different
effective mechanical loads, these values cannot be translated into standardized material
properties. Recent equipment developments included hardware and software changes and
the introduction of novel output parameters (Hansma et al., 2008; 2009).
A typical indent of the BioDent™ is shown in Fig. 5.3. The tip penetrates into the bone,
cracks and irreversibly destroys a microscopic amount of tissue. The damaged zone is
small enough to be negligible for the mechanical competence of the entire bone1, but it is
big enough to yield a variety of mechanical values.
The BioDent™ was accurate enough to find differences in femora of mice exposed to
exercise and ageing in vitro (Randall et al., 2009). It has also been used to determine
local compression moduli of rat tibial plateaus in vitro (Gardner-Morse et al., 2010). The
1The irreversible damage caused by a single BioDent™ indent is in the range of naturally occurring
damage in bone. An indent has a diameter of ≈ 200–300µm and a depth of ≈ 150–250µm — naturally
occurring microcracks are in the range of≈100–800µm×30–200µm×1–10µm. Natural damage is removed
by bone remodelling BMUs of ≈100–300µm×1000–4000µm. RPI induced bone damage has been shown
to be removed by BMUs (Kennedy et al., 2012b).
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Figure 5.3.: SEM image of a typical BioDent™ indent in bone compared to a coin2. The
induced damage patterns can be observed in higher magnification (right). From Diez-Perez
et al. (2010).
BioDent™’s forces can be lowered so as to neither break a mouse tibia into two, nor to
punch through the cortex into the marrow cavity and was successfully used as an in vivo
technique that can provide information related to toughness (Kennedy et al., 2012c; Gallant
et al., 2012), elastic modulus and hardness (Gallant et al., 2012). Furthermore, local RPI
initiated bone injury caused targeted intracortical remodelling of single osteons (Kennedy
et al., 2012b). In human clinical application, the BioDent™ derived measurements were
used to distinguish humans with osteoporosis-related fractures from control subjects (Diez-
Perez et al., 2010).
The BioDent™ is still in ongoing development, but it has already shown a high potential
for clinical assessment of bone strength and fracture risk.
2An American dime of 17.91mm×1.35mm depicting Franklin D. Roosevelt (backside).
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2. Aims
• To build a testing set-up for BioDent™ reference point indentation of sheep meta-
carpal cortical bone.
• To measure the mechanical properties of cortical bone from normal, estrogen defi-
cient and drug treated sheep with the BioDent™ device.
• To validate the correct and sensible functioning of the BioDent™ technique. To
analyse raw data and to propose developments and sensible output parameters to
improve error identification, usability and material characterization.
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3. Materials and Methods
3.1. Bones
The bones used came from a study on estrogen deficiency through ovariectomy carried
out in our group mainly by Kennedy (2007) and Brennan (2008). The distal ends of the
left metacarpals were chosen for this study. These bones were chosen, because as forefoot
bones, they are constantly fatigue loaded throughout the lifetime of the animals. Through
the constant fatigue stresses, there is a high turnover in the foot bones and structural mate-
rial changes related to estrogen withdrawal are likely to occur earlier than at other sites.
After harvesting, the bones were frozen at −20◦C and defrosted for 2 h before mecha-
nical testing. The bones were cut longitudinally into an anterior and posterior part with a
diamond-tipped band saw (Mar-Med Inc., Cleveland Brown, US). The anterior cortex was
used for this study. The bones were kept in PBS at room temperature throughout all tests.
3.2. Microindentation
The BioDent™ indents to a nominal force Fnom for a number of cycles O. The current
force Fcur and current displacement d are recorded during the indentation. A schematic
load-displacement curve of the first and last cycle is shown in Fig. 5.4.
The BioDent™ software derives various mechanical parameters from the load and dis-
placement data. These derived output parameters cannot be directly converted into clas-
sical mechanical properties, however, they are comparable with measurements of similar
test set-ups (Hansma, 2009). With an increased use of the standardized instrument scien-
tifically and clinically, a knowledge database will build up for characterization of patients
based on the RPI testing parameters.
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Figure 5.4.: A schematic load displacement curve of first and last cycle from a BioDent™
measurement and a subset of the derived values. Red circles indicate the automatically
detected points for the calculation of derived parameters. The energy dissipation is calcu-
lated as the grey area circumscribed by the load-displacement curve. Graphic adapted from
Diez-Perez et al. (2010).
3.2.1. Periosteal Indentation
The BioDent™ device was used to indent the metacarpals on the anterior periosteal surface.
Indents were placed 2 mm apart, beginning from the end of the cartilaginous joint surface
(Fig. 5.5). The number of indents varied with the available length of the bone from n =
3− 7 indents, with the majority of bones being indented 5− 6 times. Bones were placed
in a weighing dish filled with PBS during the tests. Prior to indentation, the soft tissue
was removed with forceps to expose the hard tissue without damaging the testing surface.
Periosteal soft tissue in in vivo human tests is scraped off with the reference probe itself
(Fig. 5.2). However, it is not expected that the soft tissue has any major influence as the soft
tissue would be compressed or pushed aside during the first cycle. The nominal indentation
force was Fnom = 4−5N for O= 20cycles at a nominal testing frequency fnom = 2Hz.
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Figure 5.5.: Indentation of periosteal surface of a metacarpal. The pencil lines label the
midline of the bone and 2 mm intervals longitudinally. The soft tissue was removed locally
prior to labelling and indentation.
3.2.2. Cross-Sectional Indentation
Transverse sections of 3 mm thickness were cut with a diamond tipped blade on a low speed
rotating saw (Struers, Denmark). The sections were ground with 1200 grit SiC emery paper
immersed in water. Subsequent cleaning of the sections was carried out in an ultrasonic
bath in water for 3 min. Indents were made parallel with the bone’s longitudinal axis into
the middle of the cortex. All sections were from the anterior half of the metacarpal. Sec-
tions were cut 2–5 cm proximal to the distal metacarpal joint depending on availability of
material. Indentation settings were Fnom = 4− 5N for O = 20cycles at a nominal testing
frequency fnom = 2Hz.
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3.3. Statistical Analysis
Linear regression analysis was performed to derive relations of independent factors to the
mechanical values obtained by the machine. Post-hoc analysis of the linear regression,
respectively ANOVA, was performed to compare individual animal treatment groups. The
animal data were normally distributed.
3.3.1. Outlier Identification and Exclusion
In order to gather, present and discuss data, researchers should acquire expertise in the tech-
nique first. Because the experimenter was not a distinguished expert regarding BioDent™
equipment and because “an expert is someone who knows some of the worst mistakes that
can be made in his subject, and how to avoid them.”3 the worst mistakes of the BioDent™
device had to be investigated. Particular attention was paid to error identification because
“mistake, error, is the discipline through which we advance.”4
Data errors occurred relatively frequently with the available BioDent™ instrument. This
was mainly attributed to the relative novelty of the technique, the small number of machines
in the world (11 at the end of 2010, with various hardware and software versions), as well
as the continuous development of hard- and software. Schaffler’s group had experience
with an older version of the set-up, a device for scientific use only and working solely in
displacement control mode, being build in 2009 with continuous software updates through-
out 2010. Before this chapter’s experiments were carried out this device was converted to
load control by the manufacturer. However, it was only the second load controlled Bio-
Dent™ device world-wide and neither the researchers nor the manufacturer had yet gained
3Werner Heisenberg, Physics and Beyond: Encounters and Conversation, 1971.
4William Ellery Channing, The Present Age, 1841.
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experience with this configuration. Criteria for outlier identification were placed, there-
fore, in the discussion section of this chapter rather than in the materials and methods, as
the outlier identification and troubleshooting feedback to the manufacturer resulted from
testing experience and analysis rather than being available or common knowledge prior to
the experiments.
4. Results
The parameters that were available for all indents with the version of the software at the
time of the experiment were the T ID (Total Indentation Distance), IDI (Indentation Dis-
tance Increase), ED (Energy Dissipation), LS (Loading Slope) and the US (Unloading
Slope) (Fig. 5.4 and Table D.3 on p. 308).
4.1. Periosteal Indentation
4.1.1. Total Indentation Distance
The Total Indentation Distance (T ID) is the total distance between the sensing of bone in
the first cycle to the maximum penetration depth in the last cycle. The T ID is a measure
of the total elastic and plastic deformation in the indentation zone as well as of the damage
resistance. A high T ID value indicates a low resistance to penetration.
The results of the T ID for periosteal indents are shown in Fig. 5.6. The control groups of
year one CON 1 and two CON 2 are not statistically different from each other, nor from
the first year ovariectomized group OVX 1 (p > 0.05). However, the OVX 2 group showed
higher T ID than its control group CON 2 (p < 0.05). No statistical difference was seen
between the zoledronic acid group ZOL 2 with either OVX 2 or CON 2 and neither with
any of the year 1 groups (p > 0.05).
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Figure 5.6.: The Total Indentation Distance (T ID) in the periosteal direction.
In addition to the post-hoc analysis differences between the individual groups, the ANOVA
found OVX versus CON to be significantly different, independent of the year (p < 0.05).
4.1.2. Indentation Distance Increase
The Indentation Distance Increase (IDI) measures the increase in maximum depth of the
indentation at the first point of maximum force between the first and the last cycle. IDI
is a measure of the damage and creep that was induced over all cycles, excluding the
initial elastic and plastic deformation of the first loading. A high IDI value indicates a low
resistance to damage and fracture.
Results of the periosteal IDI indents are shown in Fig. 5.7. OVX 2 is statistically significant
different from both control groups (OVX 2 versus CON 1 p < 0.01, OVX 2 versus CON 2
p < 0.05). The trend of the IDI in OVX 1 to be higher than either control group was not
statistically significant (p > 0.05). Neither were the control groups CON 1 and CON 2
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Figure 5.7.: The Indentation Distance Increase (IDI) in the periosteal direction.
different from each other, nor OVX 1 from OVX 2. ZOL 2 was not significantly different
from any other group.
When the standard deviations between individual indents within each animals σIDI,individual
were looked at, the ANOVA showed differences between OVX against CON independent
of the year (p< 0.02). So OVX animals showed higher periosteal material inhomogeneities
within each animal.
4.1.3. Energy Dissipation
Energy Dissipation (ED) is a measure related to the area circumscribed by the load-
displacement curve. ED describes the energy loss into the material either by plastic defor-
mation or by irreversible destruction on different length scales. The rationale of ED is
discussed on p. 336.
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Figure 5.8.: The Energy Dissipation (ED) in the periosteal direction.
The periosteal indentation ED results are shown in Fig. 5.8. In the post-hoc analysis
between the individual different animal groups, various differences between OVX and
CON emerged. In the first year groups OVX 1 had a higher ED than CON 1 (p < 0.001).
In the second year, ZOL had a lower ED than OVX 2 (p < 0.05). Across the years, OVX 2
was higher than CON 1 (p < 0.01) as well as ZOL 2 was lower than OVX 1 (p < 0.01).
Neither of the similar treatment groups differed between the years (CON 1 versus CON 2
p > 0.05, OVX 1 versus OVX 2 p > 0.05). ZOL was not different from any of the control
groups (ZOL versus CON 1 or CON 2 p > 0.05), while ZOL was different from both OVX
groups (ZOL versus OVX 1 and OVX 2 p < 0.05). The ANOVA, independent of the year,
identified OVX to be significantly different from CON (p < 0.001).
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4.1.4. Loading Slope
The Loading Slope (LSRPI), as computed by the BioDent™, is the slope of the loading
curves averaged over all cycles, 20 in our set-up. The loading slope contains both elastic
deformation of the material, which can be described as the material’s Young’s modulus E,
but also any irreversible destruction of the material as well as non-linear plasticity. The
Loading slope of this RPI test cannot be transformed into a Young’s modulus, due to the
destructive nature of the test.
Figure 5.9.: The Loading Slope (LS) in the periosteal direction.
The LS of the periosteal indents are shown in Fig. 5.9. There were no statistically signifi-
cant differences found between any of the groups, neither between any of the treatments,
nor between the years. There was no difference between the control group in both years,
as well as from ZOL to control (all p > 0.05). OVX of any year did not differ from CON
of any year either, nor from ZOL.
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4.1.5. Unloading Slope
The Unloading Slope (USRPI), as computed by the BioDent™, is the slope of the unloading
curves averaged over all 20 cycles. The unloading slope contains mainly elastic recoiling
of the material. Thus the US is the closest parameter in an RPI approach to the classical
Young’s modulus E. However, the US should not be confused with the mechanically pure
stiffness of the Young’s modulus. Due to the nature of the destructive indentation test,
material is irreversibly destroyed during loading and during the constant force plateau due
to creep. Thus the recoiling stiffness measured during the unloading is not, like a Young’s
modulus, measured on an intact material but on a partly destroyed material.
Figure 5.10.: The Unloading Slope (US) in the periosteal direction.
Fig. 5.10 shows the Unloading Slopes of the periosteal indents. There were no significant
differences in US between the two control groups, nor did ZOL vary from any group.
OVX 1 had a higher US than CON 1 (p < 0.05), OVX 2 was lower than OVX 1 (p < 0.05).
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4.1.6. Summary
ZOL 2 OVX 2 OVX 1 CON 2
CON 1 ED⇑**, IDI ⇑** ED⇑***, US⇑*
CON 2 T ID⇑*, IDI ⇑*
OVX 1 ED⇓** US⇓*
OVX 2 ED⇓*
Table 5.1.: Group differences of the periosteal surface indents. Arrows indicate differences
from column to row group. *p < 0.05, **p < 0.01, ***p < 0.001.
Table 5.1 summarizes the statistically significant differences found in the periosteal inden-
tation tests. The two control groups CON 1 and CON 2 did not differ from each other in
any of the analysed parameters. Furthermore, ZOL did neither differ from CON 1 nor from
CON 2. However, ZOL differed both from OVX 1 and from OVX 2 in having a lower ED.
ED was furthermore increased in both ovariectomized groups compared to CON 1. The
two OVX groups differed from each other only by an increase in US for OVX 1. The OVX
groups varied from the CON groups partly by increased IDI and T ID.
ZOL OVX 1 & 2
CON 1 & 2 ED⇑**, T ID⇑*, σIDI,individual ⇑*
OVX 1 & 2
Table 5.2.: Group differences of the periosteal surface indents with groups pooled over both
years. Arrows indicate difference from column to row group. *p < 0.05, **p < 0.01.
Table 5.2 summarizes the statistically significant differences found in the periosteal inden-
tation tests when data were pooled over both years. Parameters from the pooled OVX
group differed from the pooled CON group in ED, T ID and the deviation between indivi-
dual indents per sheep σIDI,individual .
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4.2. Cross-Sectional Indentation
4.2.1. Total Indentation Distance
The Total Indentation Distance of the cross-section indents are shown in Fig. 5.11.
Figure 5.11.: The Total Indentation Distance (T ID) in the cross-sectional direction.
The T ID only varied slightly across the groups and did not reach statistically significant
differences between any groups (p > 0.05).
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4.2.2. Indentation Distance Increase
The Indentation Distance Increase of the cross-section indents are shown in Fig. 5.12.
Figure 5.12.: The Indentation Distance Increase (IDI) in the cross-sectional direction.
None of the groups had a statistically significant difference in IDI from each other. How-
ever, there was a trend for CON 1 versus OVX 2 to be different (p = 0.060).
The deviation of data appeared to increase with the mean. When this is accounted for by
logarithmizing the IDI, then CON 1 versus OVX 2 where statistically different (p < 0.05)
(Masicampo & Lalande, 2012).
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4.2.3. Energy Dissipation
Cross-section Energy Dissipation is shown in Fig. 5.13. The physical meaning of ED is
discussed on p. 336.
Figure 5.13.: The Energy Dissipation (ED) in the cross-sectional direction.
ED between CON 1 and OVX 1 was highly significantly different (p < 0.001). Surpri-
singly, CON 1 and CON 2 also differed (p < 0.05). OVX 2 differed from CON 1 as well
as from OVX 1 (both p < 0.05). ZOL had intermediate values and differed from OVX 1
(p < 0.05).
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4.2.4. Loading Slope
The Loading Slopes in cross-section are shown in Fig. 5.14.
Figure 5.14.: The Loading Slope (LS) in the cross-sectional direction.
The Loading Slope showed a decreasing trend from year 1 to year 2. However, only OVX 1
to OVX 2 showed significant differences (p < 0.05). All groups in year 2 were indistin-
guishable from each other and from CON 1. ZOL was not different from other groups.
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4.2.5. Unloading Slope
Fig. 5.15 shows the Unloading Slopes of the cross-sections.
Figure 5.15.: The Unloading Slope (US) in the cross-sectional direction.
The Unloading Slope in cross-section did not show any significant differences between any
of the treatment groups.
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4.2.6. Summary
ZOL 2 OVX 2 OVX 1 CON 2
CON 1 ED⇑* ED⇑*** ED⇑*
CON 2 ED⇑*
OVX 1 ED⇓* ED⇓*, LS⇓*
OVX 2
Table 5.3.: Group differences of the cross section indents. Arrows indicate significant
differences from column compared to row group. *p < 0.05, **p < 0.01, ***p < 0.001.
Table 5.3 summarizes the statistically significant differences found in the cross-sectional
indentation tests. The two OVX groups differed from each other by OVX 2 having lower
ED and LS versus OVX 1. ZOL differed from OVX 1 in the ED. The numerous differences
of the parameter ED could be related to unidentified computational issues. ED was one of
the not recalculated parameters in the appendices (p. 306).
5. Discussion
5.1. Differences Between Bone from Ovariectomized and Control
Sheep in Periosteal Indentation
The Reference Point Indentation instrument was able to detect differences between the
different treatment groups in this experiment.
The computed parameters IDI and the T ID showed differences after 31 months of estrogen
depletion. In a recent clinical trial, IDI and T ID were the major discriminators between
women after menopause with and without fracture (Diez-Perez et al., 2010). Women with
fracture had higher IDI and T ID, while in our study, estrogen depleted OVX sheep showed
increased IDI and T ID. Furthermore, IDI and T ID were undistinguishable between ZOL
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and CON, which indicates of restoration of bone strength in estrogen depletion with bis-
phosphonate treatment. Interestingly, significant differences in these factors appeared in
the 31 month group but not in the 12 months group. This indicates that a certain amount
of time of estrogen depletion in necessary for certain changes to be detectable. In the
first year of estrogen depletion in sheep, several bone morphology modifications occur,
however, gross mechanical consequences can take a longer time to become measurable
(Kennedy et al., 2009a; Brennan et al., 2011c). There was no difference found in the
amount of recently grown periosteal bone between OVX 1 and CON 1 (data not shown).
Thus any mechanical differences ought to be from mechanical differences in any periosteal
tissue rather than just from differences of the quantity of the most recently laid down bone
lamellae.
The ED for both years differed between OVX and CON animals. Furthermore, ED of
the ZOL group was lower than in both OVX groups and undistinguishable from any CON
group. Although ED has received little attention in the past, it could have the potential of
being a differentiating parameter between CON, OVX and ZOL. This could be of future
clinical use as a determinator for bone fracture risk in treatment.
5.1.1. Intra-Bone Deviations between Ovariectomized and Control Sheep
The data of the individual indents of each animal contained information that differed
between the experimental groups. ANOVA showed differences of the IDI standard devia-
tions within each animal σIDI,individual between OVX and CON independent of the year
in the periosteal direction (p < 0.02). OVX animals showed bigger tissue inhomogeneity
across their individual indents than CON animals did.
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Differentiation based on the tissue homogeneity can be of further future clinical use. On
the other hand, this relation could also be due to optimism bias (Ioannidis, 2005) and
further testing is required to confirm or deny with this finding. Future investigations in this
direction would require more advanced automatic or semi-automatic outlier detection, for
example with the novel parameters proposed (p. 306).
5.2. Zoledronic Acid Treated Sheep Bones Differ from Ovariectomized
Sheep Bones in Periosteal Indentation
The zoledronic acid treated group of animals did not differ from control animals in any of
the measured parameters, while the OVX groups did differ from the CON groups. Further-
more, ZOL differed from OVX 1 and OVX 2 in the periosteal direction in the ED and
brought these values back towards values of the control groups.
This indicates that treatment of ovariectomized and estrogen depleted sheep with zole-
dronic acid may restore mechanical properties back to control values. This may be
due to increased BMU mineralization (Boivin & Meunier, 2002) and maturity (Gourion-
Arsiquaud et al., 2010).
A limitation of this finding was the low number of available animals in the ZOL group
(n= 4), which influenced both less power in differences towards OVX as well as facilitated
non-significant differences towards the CON groups. Further research would be needed for
conclusive influences of drug treatment on individual humans or animals with low estrogen
level related osteoporosis.
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5.3. Differences between Periosteal and Cross-Sectional Testing
The results from the cross-sectional indentations are more heterogeneous than the results
from the periosteal indentations. UScross and T IDcross did not show any significant differ-
ences between the animal groups. EDcross and LScross showed inconsistent results across
the groups. ZOL did not differ from any other group in any of the analysed parameters in
cross-sectional indentations. Some parameters showed the same trends in cross-sectional
direction and in periosteal direction, while some parameters indicated contrary trends.
These differences may be explained by the combination of a) what and how reference
point indentation measures, b) the main orientation of the indented material, c) its specific
microstructure and d) the age of the local tissue.
The first main influence on the output parameters of reference point indentation is its opera-
ting principle. RPI measures by pushing a conical tip into a material and measuring its
resistance to penetration.
On the one hand, this conical tip simply compresses the testing material. The resistance
against non-destructive, elastic compression is generally known as the stiffness.
On the other hand, the material in front of the conical tip is ruptured and irreversibly
destroyed. Therefore, the penetration of the conical tip depends on the resistance against
fracture as well.
So the material’s resistance against penetration in the RPI set-up consists of some amount
of resistance against compression and some amount of resistance against fracture. How-
ever, the RPI testing principle interweaves these resistances and they cannot be clearly
separated by the BioDent™ output parameters.
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Figure 5.16.: The indentation directions in relation to the structure of lamellar bone. Lamel-
lae are structured in parallel sheets comparable to plywood. Fibril orientation within sheets
is predominantly in one main direction with deviations. Squares equal 10 × 10 µm. Image
adapted from Ascenzi & Lomovtsev (2006).
The second main influence on the output parameters is the main tissue orientation and the
tissue homogeneity at micrometer scale of the tested cortical bone.
The cross-sectional indentation primarily splits sheets of lamellae apart. These sheets are
not very homogeneous at micrometer level (Fig. 5.16), however, they primarily build rela-
tively flat sheets. Thus, in relation to the splitting action that the cross-sectional indentation
causes, the tissue is fairly homogeneous. Splitting generally requires a relative low amount
of energy. So the resistance against fracture is low for the cross-sectional indents.
On the other hand, the periosteal indentation penetrates perpendicular to the sheets, which
requires the rupturing of many of the fibres. Again, this structure is far from homogeneous
at the scale of single micrometers, whereas at the size scale of the indenter of three hundred
micrometers these inhomogeneities level out. Thus the structure can be seen as fairly
211
CHAPTER 5. MICROINDENTATION
homogeneous in relation to the periosteal indentation direction and its size. The resistance
against crack propagation on periosteal indents is both high and subject to small variation.
The third influence to the output parameters is the local microstructure at an individual
indent. The tissue homogeneity on a scale of tens to hundreds of micrometers in a certain
direction can be considered as the probability to indent a certain microstructural pattern.
Figure 5.17.: The three fracture modes. In mode I, if the crack direction is parallel to the
fibre direction cracks split the material easily. When there are fibres perpendicular to the
crack direction in mode I there is a much higher resistance5.
The periosteal tissue consist of regular lamellar layers that are placed from the outside
onto the bone. Thus, testing the periosteal bone surface is expected to indent similarly
build structures all the time with similar mechanical properties, while indentation into cross
sections can result in a variety of highly different scenarios with highly different resistances
against penetration.
5Image retrieved on 27.08.2012 under public domain rights from http://en.wikipedia.org/wiki/
File:Fracture_modes_v2.svg.
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To demonstrate the two opposite cases, a Gedankenexperiment6 is undertaken:
The first imaginary scenario is indentation into some fairly parallel portion of lamellar
bone. Any crack propagation would be parallel to the direction of the lamellar layers.
Mechanically speaking, a tensile mode I crack opens in the main direction of the fibres
(Fig. 5.17). The layers delaminate and split apart easily and only a small number of
fibres are ruptured. In this scenario, indentation into cross-sectional bone is relatively easy
because the particular structure is loaded in its splitting direction.
While the second part of the Gedankenexperiment would be to indent right into the
middle of a full osteon. The BioDent™ indentation tip of 375 µm produces indents of
≈200 µm, an osteon around this size would suffice. If this osteon would be indented into
the central Haversian canal, the forces pushing the material apart would produce concentric
tensile forces in the concentric lamellae. Depending on the ascending spiralling angle of
the lamellae this effect would stronger or weaker (Ascenzi et al., 2003). Damage could
occur in a variety of ways, either by mode II delamination and push through of concentric
layers into the depth of the osteon. The shear area would be huge in this case and the shear
loads would be relatively equally distributed over a certain area, so the resistance against
rupture would be quite high. Damage could also occur by squeezing out material at the
probe tip towards the upper surface of the sample. Due to the crossed fibre arrangement
this would require out of plane rotational shear (mode III) with a relative high surface area
and would require high amounts of energy. Damage could also occur if the entire osteon
ruptures from the central Haversian canal towards the surrounding cement line through dif-
ferently orientated lamellae. However, rupturing through osteons in this direction requires
6The German Gedankenexperiment, despite being literally translatable into thought experiment, stayed
in English linguistic use to enable scholars to emphasize urbanity.
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a lot of force and energy (O’Brien et al., 2003; Kennedy et al., 2008c), and any further rup-
ture in the longitudinal direction of the osteon requires the rupture of more fibres against
the grain. This would be tensile mode I, but major parts of the fibres would have to be
ruptured — rather than just intra-lamellarly split. All possible damage mechanisms here
require quite a lot of force and energy. So there are scenarios where the damage resistance
into cross-sections is quite high.
The logical third part of the Gedankenexperiment would be any random mixture of the
aforementioned two pure cases.
Although these Gedankenexperimente7 use the same bulk material and the two extreme
structures described would possess nearly similar values of stiffness in a pure mechanical
compression test on a millimeter level, in the conical probe penetration test of combined
stiffness and crack propagation of the RPI, their outputs can be quite different. From
the microindentation itself, it is not possible to conclude which structural case, or which
mixture, occurred. Thus, the results can vary quite a lot between individual indents if they
are performed into cross-sections of a multi-scale structural material such as bulk bone.
Last but not least, a forth significant factor influencing the RPI output parameters is the
local tissue age.
Bone grows both on its periosteal surface and remodels in the cortex. Because of the
constant periosteal growth, any tissue there is likely to be of a more recent origin.
Newer tissue in the cortex, in the form of softer osteons, is more or less randomly dis-
tributed if considered at the scale of the BioDent™ indenter size and the heterogeneity of
tissue age and mechanical properties in cortical bone increase with ageing (Zioupos et al.,
7The German plural rules add an “e” to Experiment, not an “s”.
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2008) and estrogen deficiency (Kennedy et al., 2009a). Cross-sectional indents can be onto
tissue of any age, which increases the scatter in the results.
Table 5.4 summarizes the four main influences for possible differences between indentation
on the periosteum versus on the cross sections.
testing compression
crack resistance
tissue
new tissue
direction resistance homogeneity
peri- against sheets rupture of many fairly outside
osteal ↪→ medium stiffness fibres required homogeneous ↪→ latest
↪→ high resistance tissue tested
cross- with main fibre delamination quite random
section direction ↪→ low resistance, heterogeneous ↪→ any age
↪→ high stiffness onto full osteon tested
↪→ high resistance,
or any mixture
Table 5.4.: Structural differences of cortical bone for the different indentation directions.
In theory, indentation can be performed into transverse tissue, provided that the microstruc-
ture is taken into account. The RPI induced damage can be labelled in situ with fluorescent
dyes, however, this approach is destructive and cumbersome (Lendhey, 2011; Kennedy
et al., 2012b).
In a recent study, Rasoulian et al. (2013) tested transverse sections of swine bone (age: 1−
48 months, median: 6 months) and found the tissue properties relative consistent. However,
young swine exhibit more laminar cortical bone rather than the predominantly osteonal
bone of the 5−8 year old sheep in this study.
Concluding, cross-sectional testing has the disadvantages of a) a more complex morpho-
logical structure and more diverse damage mechanisms and therefore more prone to scat-
ter and b) random tissue age and therefore a lower sensitivity for local tissue alterations.
Besides these scientific disadvantages, cross-sectional indentation is clinically not prac-
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ticable. Cross-sections of bone cannot be tested unless bone is either a) extracted or b)
exposed from a fracture or operation. The first one is unpopular with most patients while
the second one limits the technique to a small subset of suitable patients.
5.4. Limitations
This study has a number of limitations.
The number of sheep tested was limited. Table 5.5 summarizes the number of sheep per
experiment group and testing direction. The ZOL group lost 20% of its participants with
the death of one sheep before the end of the study (Kennedy, 2007; Brennan, 2008).
group periosteal cross-sectional
CON 1 4 4
OVX 1 7 7
CON 2 7 8
OVX 2 7 7
ZOL 2 4 4
Table 5.5.: Samples per testing direction and animal group.8
One limitation is the use of sheep instead of humans. Ovariectomized sheep have been
established as a model for human post-menopausal osteoporosis (Newton et al., 2004;
Turner, 2007; Arens et al., 2007; Sigrist et al., 2007). However, they differ from humans
in a variety of factors, for example a 4 . . .6 times lower maximum age, a factor of 2 higher
amount of extremities used in principal body movement, less load idle time in front of
screens in contrast with increased free movement and sunshine exposure and finally a strict
vegetarian diet. These differences between sheep and humans vary to a certain extent for
individuals of both species. However, the more predictable life of sheep makes them an
8Thanks to Christoph for pointing out the existence of two vertical numeral palindromes in this table.
Beside provoking mathematical curiosity, this does not appear to be of any scientific meaning whatsoever.
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easier study subject than humans. The time of onset of estrogen withdrawal is of imprecise
nature in human subjects, while in the flock used for this study it is known accurately to
the day (Brennan, 2008). Thus, changes related to estrogen depletion are standardized to a
time line. The harvesting of samples is somewhat easier in sheep than in humans. Both the
whole body mass and the skeletal mass and bone sizes are relatively similar in humans and
sheep (Taylor, 2000). Furthermore, bone remodelling cycles of the two species are similar,
as well as the morphological appearance of the bones (Oheim et al., 2012).
Another limitation to the study was the BioDent™ technique in itself. Many data errors
occurred (p. 299), certain output parameters did not draw a conclusive picture of the under-
lying mechanisms (p. 309, 310 & 317) and the only two parameters that were re-calculated
were strongly suspected to be calculated wrong by a factor around 2 (p. 313). Furthermore,
the device did not offer indications for occurred flaws in the material (p. 324), influences
of the environment (p. 330) or of the machine itself (p. 334). As these findings were not
directly related with the presented data and due to their excessive quantity, these argumen-
tations were shifted to appendix D (p. 299–344).
5.4.1. Error Identification and Data Exclusion Criteria
A variety of errors occurred during the experiments. Some errors were identifiable due
to their specific effect on certain output parameters and/or their visual appearance in the
force-displacement graph. However, the identification of errors during the procedure relies
heavily on the experience of the user, other errors may be detected only in a statistical
analysis after the experiment.
Due to place restrictions a comprehensive discussion of the occurred errors, the conse-
quences, potential counteractions and suggestions for development for future reduction or
total prevention of errors is given in appendix D.
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5.4.2. Load and Displacement Control Issues
The BioDent™ on which this study was performed was recently upgraded to load-control
in January 2011. It was one of the first BioDent™ machines with this feature on trial, while
previous versions were displacement controlled.
However, this first generation of the load controlled BioDent™ turned out to be pseudo-
load controlled. The software did not, as expected, read out force and loop it into a PID
controller (proportional-integral-derivative) for instant force adjustment. Instead it took the
target force for any moment of the test and approximated from a conversion table what the
displacement to this force should be and moved accordingly. The pseudo-load control of
the BioDent™ was obvious in two places.
Firstly, the software still needed a separate load-displacement adjustment table for each
individual pairing of probe and reference probe. This table had to be determined by the user
for each new probe. If this was not performed correctly, the following tests had erroneous
indentation forces. Truly load controlled mechanical testing machines on the other hand
are expected to work independently of testing probe length variations. The sets of probes
and reference probes are machined by the manufacturer with length variations of 200 µm.
The second indicator that the used device was pseudo-load controlled was the shape of
the load-displacement curve (Fig. 5.18). The probe lifted off the bone in each indentation
cycle, as seen by the huge displacement movements with near-zero force between the end
of one cycle until the beginning of the next cycle. Load controlled testing machines in
compression tests are never set up to go to zero force and lift off the sample. This is
because PID controllers in pure load mode react unpredictable to this kind of unsteady
input. Incorrectly set PID controllers can lead to oversteering and severely harm both
sample and probe and any results are usually influenced.
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Figure 5.18.: Raw force-displacement data from the BioDent™ for sample 13 L 2. The
loading of the first cycle is followed by a plateau of constant force and the unloading.
Penetration of solid bone starts at the kink at d = 175µm. The loading and unloading
curves are clearly not linear. In a truly load controlled machine the unloading (solid blue
line) probe would not retract back to d = 105µm after every cycle, but would stop at
F = 0.5N and smoothly begin the next loading cycle (blue dotted line into the left-most
grey line).
From a reverse engineering point it was not clear how exactly the version of the BioDent™
that was used in this study was controlled. Displacement control is necessary for displace-
ment without force — such as lowering the probe before the first touching of the surface
and for retracting after the last cycle. However, during loading at defined loads it is recom-
mended to use load control. Earlier versions of the BioDent™ were purely displacement
controlled by the software. Likely, during the first attempts to build in software-sided load
control, the displacement control elements were not displaced entirely, but a pseudo-force
control was placed upon the previous displacement control. So the probe was actually still
moved in displacement control mode all the time. Following an accurate enough load curve
was done by calculating the displacements in real time from the theoretical loads.
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While pseudo-load control is principally not reprehensible, it can introduce problems both
in the testing procedure and to any derived data. Letting the probe be both displacement
controlled, for the time of zero force when the probe lifts off the bone, as well as pseudo-
force controlled, for the time it indents the bone, is a challenging task in control engi-
neering. True displacement and true force control in one cycle in fast alternation require
complex software monitoring in real time. While pure load control could be realized eas-
ily with software or with hardware control circuits. Unfortunately, this mixed solution
blighted all the benefits of load control and created unexpected handling problems.
The necessity to calibrate every probe — reference probe combination for length variations
is problematic. If the probes are not calibrated correctly, major fluctuations of both the
dynamic and the static maximum force occur. Alterations from the maximum nominal
force Fnom were observed of up to 1 N on a Fnom = 5N test. In these conditions the machine
was prone to produce highly unsteady maximum force plateaus. These jittering forces lead
to misinterpretation of reference points for the calculation of the mechanical values.
Furthermore, the dependency of length differences made it impossible to pair any probe
with any other reference probe and the user’s knowledge threshold required for successful
application of the technique was set unnecessarily high and increased the chances of erro-
neous application. Human in vivo studies will require virgin probes for every patient or
a stock of sterilizable probes. This requires calibration before each patient. Calibrating a
single probe with the pseudo-force controlled BioDent™ of 2011 took considerably longer
than performing the patient’s indentations.
There might be further problems arising from the current control mode in the measured ED
value. The dissipated energy is measured as the area inscribed to the load-displacement
curve. However, in the pseudo-load-controlled version the indenter travelled a far distance
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with low loads. For example in Fig. 5.18 the probe indented the bone at d ≈ 180−200µm.
While after every cycle the probe retracted to d ≈ 105µm (seen as a peak in Fig. D.1,
p. 310). Forces in retraction and extension of the probe were close to zero. But only close:
any friction or inertia in the system itself and in the combination with the tested tissue
altered this force. These force differences between loading and unloading can be seen in
Fig. 5.18 where the blue 1st cycle unloading moves down and to the left at d = 195µm
and F ≈ 0.1N while all further loading cycles (grey) increase their force and displacement
from d ≈ 180µm and F ≈ 0.2N. These small force differences multiplied with large dis-
placements add up to some dissipated energy area and increase the total dissipated energy.
However, this is not dissipated energy that dissipated into the bone tissue, because the
probe was not in contact with bone there. The forces neither come from movement in soft
tissue as the bones used in this study had their soft tissue removed. This ED fraction has
nothing to do with tissue deformation — it is purely artificially dissipated energy, presum-
ably dissipating into the BioDent™ itself. According to Hansma et al. (2009) the friction
should be ≈ 0.02 N. It was estimated that this part of the ED can make up 2-10% of the
total ED values. If this ED part is dependent on internal friction, it may also change from
test to test as slight changes can change friction quite significantly.
This part of artificial ED could get decreased by limiting the ED integral’s left border to
a displacement just around the bone contact distance. This would of course not solve the
problem, just decrease its effect by maybe 80%. While if the indenter would be really load
controlled, instead of pseudo-load controlled, and a minimum load of 10% of the maximum
load would be kept, this problem would disappear entirely.
Furthermore, with real load control the problem of a calibration table would be avoided.
With the pseudo-load-controlled RPI, each individual probe needed an entire table of
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around 20 number pairs to correct the loading curve. The number of parameters a PID
controller in real load control would require would be one value for the proportional cor-
rection, one for the integral correction and maybe one for a differential correction. Most
real world controlling problems can operate with the first two of these factors. These para-
meters would depend on the testing machine’s stiffness, the force application technique and
on the stiffness of the tested material. However, if a BioDent™ is set-up for bone testing
solely, the material stiffness is not expected to vary more than a factor of maybe 3, so the
PID settings will never need to be changed by the user. It would eliminate the possibility
of users affecting the tests adversely by not fully understanding the complex correction
method required for the available BioDent™.
Furthermore, a real load control would eliminate the aforementioned problems of unsteady
maximum force. A load controlled device should be able to follow a wide range of load
curve shapes with high accuracy and steadiness. The load control mode would need to be
active between the first bone contact, continuously throughout all 20 cycles up to unloading
of the last indent. The displacement control would still be needed to lower the probe onto
the bone prior to the first cycle and to retract the probe after the last cycle.
Concluding, if these early development software issues are addressed, a truly load con-
trolled RPI will be much easier to use and produce more reliable and comparable data. The
BioDent™ is expected to increase in clinical popularity and distribution in the next few
years with improving reliability in in vivo bone property measurements.
5.5. Potential of RPI Testing
Overall the Reference Point Indentation is seen as a high potential technique. It offers the
unique benefit of testing the mechanical testing of bone tissue in vivo. Other common tech-
niques rely on estimating properties from bone imaging modalities, such as CT, µCT, MRI
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or DEXA. While a further group of techniques relies on properties of entirely different
body parts, such as Raman imaging of collagen in finger nails, skin or hair (Sahar et al.,
2005; Boskey, 2006; Bauer & Link, 2009; Bonnier et al., 2011; Raghavan et al., 2012).
Further techniques may enable mechanical testing or histology on real bones — at the
expense of an osteotomy. All these techniques suffer from inherent drawbacks. Imaging
techniques measure mainly a quantitative amount of available material as a proxy for
strength — but imaging does not actually measure the material’s quality. Measuring the
quality of other body parts’ contents is the measuring of a material other than bone. After
all, the issue is people that break a bone, not a finger nail. Finally, removing bone from
people is always complicated and has highly limited repeatability.
The BioDent™ on the other hand measures what everybody in bone research was looking
for, but nobody actually measured: in vivo material properties of bone. The only remaining
disadvantage of a required access to bone was addressed by employing a minimally inva-
sive approach through the small size of the testing probe and the choice of the easily acces-
sible tibial plateau as testing area. The techniques’ minimal impact on patients offer the
option of repeatable and regularly tests for long-term follow-up studies. Certain bone para-
meters in this study only showed detectable differences after two and a half years of estro-
gen depletion, so it might be advisable to have risk groups regularly tested in intervals of
around 1 to 2 years to enable medical intervention in a timely manner relative to detected
tissue alterations and fracture risks.
In addition to the testing of bone, potentially other tissues can be examined (Hansma et al.,
2009). Furthermore, in the case of operations, the BioDent™ might prove to be useful as
a late successor of the osteopenetrometer (Hvid, 1985) for testing cortical bone strength
directly during an operation, such as in cases of hip replacements or long bone nailing.
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6. Conclusion
1. The BioDent™ detected differences between animal groups. Several parameters
from periosteal indentation indicated more brittle behaviour and easier crack pro-
gression in bones of sheep 12 and 31 months after ovariectomy versus control.
2. Treatment of ovariectomized sheep with zoledronic acid reversed some trends
towards control values.
3. Indentations into cross sections of cortical bones resulted in fewer clear differences
between treatment groups. This was expected from the proportionally less remodel-
led and estrogen depletion-affected tissue in conjunction with a more diverse tissue
morphology and the different testing direction to tissue orientation between mid-
cortical versus periosteal bone.
4. True load control would be recommend for more reliable measurements and
improved handling.
5. The BioDent™ outcome parameters LS and US should be double-checked for their
mathematics.
6. Novel parameters are proposed for additional, advanced mechanical characterization
to improve our understanding of bone damage mechanics and as further potential
predictors of bone strength in healthy and diseased calcified tissue.
7. New parameters are proposed as objective and automatable criteria for outlier detec-
tion and for instrument, operator and environmental quality control.
8. The BioDent™ is still in development, but it already shows a high potential for future
clinical diagnosis and monitoring of bone quality related diseases and fracture risk.
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1. Microstructure, Remodelling, Mechanical Properties
and Bone Failure
The main objective of this work was to investigate the qualitative factors that influence
the failure of cortical bone. In general, failure in bone occurs in a wide size range from
diffuse damage (< 5µm), through microcracks (≈ 5−1000µm), stress fractures (≈ 1000−
5000µm) to the fracture of entire bones (≈ 5000− 50000µm). Bone exhibits specific
structural characteristics for each size magnitude (Fig. 1.1). The failure mechanics, the
damage extent, propagation and arrest vary with the specific structures.
The size range of 1− 1000µm is of major importance in bone as constituting both the
dimensions of naturally occurring microdamage and of the structures interfering with
damage. Scientific research is aiming for understanding the how and why (Alon, 2009). In
bone failure the hows and whys are associated with the structural size range of 1−1000µm.
Therefore, my work is focussed both on structures and damage at the sub-millimeter range.
In chapter 4 nanoindentation was used to investigate the mechanical properties at a size
range of 1− 50µm in single osteons with respect to tissue age and ovariectomy (OVX)
induced osteopenia. Differences in stiffness and hardness indicated an increasing minera-
lization and tissue maturation over time. On the other hand, there were no differences
between the tissue of OVX and control animals, indicating that at the level of individual
osteons the remodelling may not alter the mechanical properties significantly — at least in
the early stages of osteoporosis. Osteons older than 12 months were not tested.
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Osteons, as macro-fibres in the bone matrix, are one of the key features of bone as a multi-
level fibre reinforced material. Nevertheless, osteons are also only one of the many levels
of structures that are involved in damage. The nanoindentation study found properties of
individual osteons, that were not altered significantly between the OVX and control groups.
So the altered mechanical competence of osteopenic bone on the organ scale are caused not
by differences at the level of individual osteons, but at one structural magnitude above.
At the structural level above single osteons is the interaction from several osteons and inter-
stitial bone. The majority of the microcracks in cortical bone occur within this conglomer-
ation level (Schaffler et al., 1995) and the inhibition of damage and the resistance against
failure is particularly important at this level. Therefore, the fracture resistance experiments
of chapter 2 were performed at sample dimensions that allowed the observation of crack
propagation at the level of osteons and interstitial bone. The micro-tensile tests showed a
significant decrease in fracture resistance in the OVX group. It is not clear, to which local
structural alterations in each individual sample this increase can be attributed.
2. Clinical Applicability
Clinical applicability is of major importance in medical research. Chapter 2 and 4 focussed
more on gaining basic knowledge about mechanical properties of bone. The micro-tensile
fracture tests did show differences in the failure behaviour of early stage osteoporotic bone,
however, such a test is not applicable for living patients. The demand for a clinical tech-
nique that generates reliable and meaningful measures of bone strength has made a big
step forward with the introduction of the BioDent™ (Hansma et al., 2006). In chapter 5,
this novel device was used to test ovariectomized (OVX), control (CON) and zoledronic
acid treated (ZOL) sheep bones 12 and 31 months after ovariectomy. The Reference Point
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Indentation (RPI) technique did show differences between the different treatment groups in
many of the parameters. OVX bones were in general less resistant to indentation than CON
bone, which was attributed to increased brittleness of the outmost periosteal cortex. These
trends were partly reversed in the 31 month group by the administration of zoledronic acid.
This was in agreement with both expectations and literature.
Indentation into cross sections of cortical bone were inconclusive. Due to the device’s
design for clinical use, the BioDent™ does not allow for sub-millimeter placement. There-
fore, indenting into tissue that is inhomogeneous and would require additional local struc-
tural classification did not provide sensible data. The microstructure and its interaction with
the RPI induced damage could be visualized with fluorescent dyes, however, this approach
is destructive and technically cumbersome (Lendhey, 2011; Kennedy et al., 2012b).
Limitations of the BioDent™ technique included the non-transparency of algorithms and
several computation errors. The RPI parameters are difficult to set into physical context and
compare with established parameters of mechanical competence. Numerous suggestions
were made to extract further information from the raw data (Appendix D).
2.1. Non-Invasive, Non-Ionizing Assessment of Bone Quality
The fracture risk related to osteoporosis is most commonly estimated with DEXA data,
based entirely on bone quantity (WHO, 1994). However, any low quality material will
eventually fail, with the pure material quantity being just one of several factors determining
fracture risk (Sievänen, 2010). The clinical assessment of bone strength by mechanical
means, as utilized with RPI (chapter 5), is a huge step towards a more comprehensive view
of individual bone state. Further important advances have been expected from clinical
methods for over a decade (Prendergast & McCormack, 2002). Meanwhile, Positron Emis-
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sion Tomography (PET) was shown to have some reasonable potential (Li et al., 2011).
Ultrasound techniques offer some potential (Zacharias et al., 2009). CT and microCT have
limited potential as the radiation doses involved are prohibitive and the amount of radio-
opaque material is too small to be detected (p. 17).
MRI is another potent method for bone damage detection, diagnostically useful both in
preventive assessment of osteoporotic patients and in suspected stress fractures. MRI has
principle advantages regarding the diversity of operation modes, which provides informa-
tion about a plethora of substances and tissues, visual information in three dimensions
and is non-invasive and non-ionizing and therefore considered — as far as known — non-
harmful. Based on their water content, the morphology of hard and soft tissues can be
outlined up to resolutions of 23× 23× 68µm3 (Bhagat et al., 2011). Differentiation of
the void spaces into water-filled blood vessels and fat-containing bone marrow allows for
further specifications in the bone structure (Goldenstein et al., 2010).
The novel Ca2+-binding lanthanide complexes of McMahon et al. (2009; 2011) that were
used in chapter 3 open the door to a range of new applications. These contrast agents enable
the measurement of a feature of bone quality: exposed surfaces, including cracks. Their
Ca2+-binding abilities were verified in section 3.4.1 on the basis of fluorescent lanthanides
in bone scratch tests. This paved the way for further investigations into the europium
based components, that were shown to successfully alter magnetic resonance properties
of bone surfaces, as depicted by 3D MR imaging (section 3.4.2). Based on the possible
visualisation of Ca2+ surfaces in bone, efforts to detect damage caused by fatigue loading
were undertaken (section 3.4.3). However, the detection was limited by the available MRI
resolution of the current set-up of 1043 µm3 in relation to the size of microdamage in bone
that features cavities of only around 3µm open width (Larrue et al., 2011).
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Despite the difficulties with MR imaging, the future potential of the novel contrast agents
is evident. With further investigations into more appropriate and higher resolution tech-
niques, the contrast agents can be utilized both as detectors in stress fractures as well as
in the damage burden, bone removal, empty/old BMU canals and active BMUs in osteo-
porosis and other bone diseases. The potential of the novel BMM compounds were merely
scratched with this study and further investigations should be carried out.
3. Future Research
The essential difference between healthy and unhealthy bone is simple: perform or perish1.
Unfortunately, this binary outcome is too simplistic to work with. The mechanics of ageing
bone and improving its performance is a “wicked problem” (Rittel & Webber, 1973), that
is intrinsically complex, unlikely to be fully understood and solutions are hence difficult
to define. Despite the lack of a full comprehension of the problem itself, early solutions
were necessary, even if they were not perfect2. Future bone research will deepen the under-
standing of the basic problem itself, develop new solutions and refine existing ones, further
discovering the weaknesses of the present solutions and tending towards higher individuali-
zation to enable the most adequate treatment for specific cases rather than for average group
1The writing on the wall for osteoporotic patients: !Nיֵסרַפוּ לִקְתּ א¦נְמ א¦נְמ (“Mene mene tekel u-parsin”) was
originally interpreted to “your days were counted, you were weighed and seen as too light and your kingdom
and you will be broken in two” (≈ 2nd century BCE. Bible, Book of Daniel, Ch. 5:25-28), changes to “your
days were counted, your bones were weighed and seen as too light and your bones and you will be broken
in two”. King Belshazzar (†543BCE) died in the night of the prediction, presumably with broken bones —
however, the sources name manslaughter, not osteoporosis.
2Imperfect, former golden bullet solutions follow Adams (1979): "I think the problem, to be quite honest
with you, is that you have never actually known what the question is." and Scheifler & Gettys’ (1996) solving
strategy: “If a problem is not completely understood, it is probably best to provide no solution at all.” Wicked
problems, however, compared to technical problems of moderate complexity, have to be solved differently:
partially, temporarily and with the risk of unforeseeable long-term drawbacks.
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conditions. The pillars of future fracture prevention and treatment lie in multidisciplinary
approaches of basic and clinical research, health care, health politics, public education and
personal action.
3.1. Determination of Fracture Risk
Clinicians and patients want to know who is at risk and how great that risk is. Future
efforts in the detection of fracture risk will move towards earlier and more precise detec-
tion to enable timely intervention. The number of false negatives — patients, that have a
significant fracture risk but are not identified with it and subsequently suffer a fracture —
should be low. Vice versa, false positives — patients, identified with a risk that they do
not have — should be reduced. Every patient on an unnecessary treatment is exposed to
the disadvantages of the intervention and is an additional cost factor in the health system
(Stevenson et al., 2005; Lekander et al., 2008). The current standard of the WHO (1994)
of a DEXA based osteoporosis classification and estimation of fracture risk is suboptimal.
Pasco et al. (2006) found that only 15% of fractures originate in women who were clas-
sified as osteoporotic, compared to 48% of fractures which occurred in “only” osteopenic
patients. Reference Point Indentation (chap. 5) is a very potent fracture risk identification
technology as it derives result from the mechanical competence of bone — rather than
extrapolating from proxy measurements such as the BMD.
3.2. Prevention
Patients at risk need timely intervention before damage happens. The standard preventive
measure is the use of bisphosphonates, which reduce bone turnover (Russell, 2011). How-
ever, severe interference with bone turnover can result in adverse effects years later, such
230
CHAPTER 6. DISCUSSION
as osteonecrosis of the jaw (Pautke et al., 2012) or atypical femoral fracture (Ettinger et al.,
2013). Future treatments based on the reduction of bone removal have to find a balance
with a long-term continuation of bone maintenance and bone health. Furthermore, studies
on medication, initiating the inhibition of bone remodelling, should be carried out as long-
term studies both in animals and clinically. Study durations of less than 3−5 years over-
emphasize the early positive effects and under-estimate long-term adverse effects. Last but
not least, scientists and clinicians must be cautious about publications by those financed by
the pharmaceutical industry. The authors’ affiliations and financial dependencies may bias
their scientific neutrality, as Shane et al. (2010) demonstrated.
3.3. Intervention after Fracture
For patients who have suffered osteoporosis-related fractures, efforts — surgical proce-
dures, implants, drugs and rehabilitation — will be intensified as health insurance compa-
nies, hospitals and patients all benefit from decreases in the time and expense in hospitali-
zation. Patients want to spend a short time in hospital for their own convenience, all others
act on financial pressure. This bears the benefits that companies will participate further in
the development of new solutions and clinicians are eager to test them.
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3.4. Affordability of Medical Treatment
Life saving medical treatment is a declared human right3. However, availability of the best
medical treatment is wealth dependent. Income inequality — nationally (DeBacker et al.,
2013) and internationally (CIA, 2009; OECD, 2013) — reflects in inequality in medical
treatment and outcome (Wilkinson & Pickett, 2009). A national example was given by
Quah et al. (2011) for the US, where patients who were less financially fortunate showed
higher mortality rates following osteoporotic fractures. To advance osteoporotic health
outcomes for citizens, additionally to scientific and medical progress, political efforts are
required in the future. However, this is beyond the focus of this work.
3.5. Personal Prevention
Individuals can decrease their own risk of bone fractures. The main method to achieve
higher peak bone mass is a healthy lifestyle. Do sports and exercise (Greendale et al.,
1995; Eleftheriou et al., 2012) particularly during teenage years to increase the peak bone
mass (Rideout et al., 2006) and to improve balance and strength (Lin & Lane, 2008), give
up smoking (Taes et al., 2010; Eleftheriou et al., 2012), enjoy one drink a day rather than
three plus (Berg et al., 2008), eat less fatty beef (Zeng et al., 2013) and avoid becoming
underweight (Hannan et al., 2000; De Laet et al., 2005). Unfortunately, these methods have
two major disadvantages: a) pharmaceutical companies gain no benefits and would there-
fore neither promote nor sponsor such efforts and b) living a healthy lifestyle is difficult
3“Everyone has the right to a standard of living adequate for the health, and well-being of himself and
his family”, UN Declaration of Human Rights, 1948. The International Covenant on Economic, Social and
Cultural Rights of the UN (1966) guarantees the “right of everyone to the enjoyment of the highest attainable
standard of health” and “the prevention, treatment and control of epidemic, endemic, occupational, and other
diseases; and the creation of conditions which could assure to all medical service and medical attention in
the event of sickness.”
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to achieve for some people due to financial issues (Glanz et al., 1998), lacking education
and role models (Curry & Hogstel, 2001) and the inconvenience to switch to a healthier
lifestyle (Harvard Health Publications, 2007).
Apart from physical and physiological prevention, patients may partly relieve the burden of
osteoporosis psychologically by acceptance. A rising number of people with osteoporosis
is not a sign of bad health, but of good health. In the industrialized countries a century
ago and nowadays in the developing countries people die from malaria, lower respiratory
diseases (e. g. tuberculosis), diarrhoeal diseases, meningitis, civil war and HIV (Lozano
et al., 2012). In industrialized countries up to 90% of people die from age-related diseases,
such as cardiovascular disease, cancer, Alzheimer or osteoporosis (Lopez et al., 2006).
“50% of women and 20% of men will suffer an osteoporotic fracture” (Kanis et al., 2000)
relativises to: “The health system you live in has reached a level where it prevents many
avoidable diseases, so you will get old and have to face age-related diseases — including
skeletal issues for a significant fraction of people.” Once a sufficient level of health care
is reached, scientific progress in prolongation of life does not leap forward dramatically
any more. Avoiding, preventing or treating one age-related disease in a patient still adds
a number of life years, but eventually the patients will suffer another or even the same
age-related disease. The basic issue of human ageing cannot (yet) be stopped and neither
can age-related diseases — like osteoporosis. The future threat of potential bone fractures
can be a mental burden approachable by grief (Kübler-Ross, 1969) — however, healthier
would be acceptance4 (Wong, 2002).
4As Voltaire (in a letter to Abbé Trublet, 1761) formulated it: “Je me suis mis à être un peu gai, parce
qu’on m’a dit que cela est bon pour la santé.”, respectively translated (Bray and Lane, 1979): “I have begun
to be somewhat merry because I have been told that that is good for one’s health.”
233
CHAPTER 6. DISCUSSION
4. Conclusions
1. An in vitro testing protocol has been established for a real-time observation of pro-
pagating cracks and the initiation of microdamage in thin bone sections. Bones from
ovariectomized sheep showed decreased fracture resistance and strength.
2. Novel contrast agents for labelling calcium surfaces in bone were successfully
detected with fluorescence microscopy. A water-based staining protocol was estab-
lished and optimized to compare the efficiency of chemical variants.
3. A protocol was set up for an MRI detection of gadolinium-based bone contrast
agents. The compounds were detectable on bone surfaces, wide canals and macro-
cracks but not in microdamage, for which further optimization would be required.
4. Mechanical properties of individual osteons were determined with nanoindentation.
Stiffness increased in the first months of osteonal maturation with little difference
between ovariectomized and control animal tissue.
5. Reference point indentation of periosteal bone on a submillimeter scale differed
between control, OVX and ZOL animals. OVX was associated with higher brittle-
ness and easier crack propagation. Zoledronic acid treatment of ovariectomized ewes
showed reversal trends towards control group characteristics. The heterogeneity of
transverse sections of long bones resulted in high scatter with little differences. Tech-
nical issues were addressed and novel parameters proposed to extend the power of
the application towards becoming a new clinical standard technique.
6. The importance of microstructure in the resistance and failure of cortical bone was
stressed throughout this thesis. Clinical fracture risk detection methods require more
attention regarding the microstructure.
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A. Appendix to Introduction
Over the last 6 decades numerous compounds have been used to label either bone model-
ling or remodelling or microdamage. Some were discovered serendipitously, some were
included in similarity searches, some were specifically synthesized for this purpose.
Tables A.1 & A.2 list fluorochromes that were used in the past. Further information about
fluorochrome use in calcified tissues can be found in Hall (1992), van Gaalen et al. (2010)
and Pautke et al. (2005; 2007; 2010). There are still numerous compounds that may be
effective in labelling bone remodelling or microdamage — e. g. Molecular Probes (1998)
lists 31 calcium binding compounds.
The fluorochromes that were used in the BFL project to label bone turnover in vivo are
listed in Table 1.2, the fluorochromes for scratch tests in Section 3.3.1 and Tab. C.1. The
fluorescence microscope filter cubes for scratch testing and the microcrack study are listed
in Table 2.2, the filters for the nanoindentation study in Table 4.1.
Among the compounds that are chemically effective, only the tetracycline family is
approved for human use, such as oxytetracycline (Pautke et al., 2010), chlortetracycline
(Pautke et al., 2010) and doxycycline Hiramatsu et al. (2013).
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Fluorochrome
molecular Absorption Emission in vivo remodelling, in vitro microdamage,
weight max. λ max. λ dosage concentration
Basic Fuchsin 337.9 540 630 n.a. Frost (1960), Rost (1992)
GRLP, Lee et al. (1998)
Oxytetracycline 460.4 390 560 Milch et al. (1957), Frost et al. (1961) Lee et al. (2000b), 0.5 mM
Rahn (1977), 30 mg/kg
Chlortetracycline 515.3 506 Ghosez (1959)
Pautke et al. (2010), 60 mg/kg
8 Tetracyclines* 480-515 390-425 520-560 Pautke et al. (2005), 30-60 mg/kg Aaron et al. (1984)**
Alizarin Complexone 385.3 530-560 580 Harris (1960),Rahn & Perren (1972) Lee et al. (2000b), 0.5 mM
Rahn (1977), 30 mg/kg
Calcium Green 622.51 505 532 Suzuki & Mathews (1966) i.v. Lanyon et al. (1982)
Rahn (1977), 10 mg/kg i.v. Stover et al. (1993), 15 mg/kg
Lee et al. (2000b), 0.5 mM
Calcein Blue 321.3 370 435 Rahn & Perren (1970) Lee et al. (2000b), 0.5 mM
Rahn (1977), 30 mg/kg O’Brien et al. (2002), 0.1 mM
Xylenol Orange 760.6 Na 546 580 Rahn & Perren (1971), 90 mg/kg Lee et al. (2000b), 0.5 mM
Table A.1.: Common bone fluorochromes, sorted by appearance. GRLP: green fluorescence light. Na: Na-salt. i.v.: in vivo. Molecular
weight in g/mol. λ : wavelength in nm, from Olympus FluoView Resource Center (2009). *Pautke et al. (2010) used chlortetra-, demeclo-,
doxy-, metha-, mino-, oxy-, rolitetra- and tetracycline. **Aaron et al. (1984) used tetracycline.
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Fluorochrome
molecular Absorption Emission in vivo remodelling, in vitro microdamage,
weight max. λ max. λ dosage concentration
Alizarin Red 240.2 530-560 580 Harris (1960)
Uranin / Fluorescein 332.3 Na 494 521 Suzuki & Mathews (1966) conf., Zioupos & Currey (1994)
DCAF green Suzuki & Mathews (1966)
Olerud & Lorenzi (1970), 20 mg/kg
Hematoporphyrin 598.7 530-560 580 Coutelier (1964)
Olerud & Lorenzi (1970), 300 mg/kg
Pautke et al. (2005), 300 mg/kg
Procion Red H8B 992.1 546 > 600 Solheim (1974)
Calcium Crimson 590 611 Parkesh (2004)
Calcium Orange 1087.3 K 549 576 Parkesh (2004)
Fluo-3 769.5 485 503 Parkesh (2004)
BAPTA 476.4 200-325 410-550 Pautke et al. (2005), 75 mg/kg
Table A.2.: Less common bone fluorochromes, sorted by appearance. conf.: confocal microscopy. Na: Na-salt. K: K-salt. Molecular
weight in g/mol. λ : wavelength in nm, from Olympus FluoView Resource Center (2009).
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B. Appendix to Microcrack Study
1. Complete Elliptic Integral Notations
The published analytical solutions (eq. 2.10) for the stress intensity factors of two collinear
cracks caused confusion because they did not fit to each other (Table B.1). This was mainly
due to the different notations of the complete elliptic integrals, which can be expressed
either based on the so-called parameter m (eq. B.1b) or on the elliptic modulus k (eq. B.1a),
which may cause confusion, if concrete values are inserted into the functions1.
K(k) =
∫ pi/2
0
dθ√
1− k2 sin2θ
, or (B.1a)
K(m) =
∫ pi/2
0
dθ√
1−msin2θ
(B.1b)
with: m = k2 (B.1c)
Rubinstein (1985) used the K(m) definition of Abramowitz & Stegun (1964), while Rose
(1986a;b) used the K(k) definition to calculate K(k′) 2. Unfortunately, both notations are
used and are notoriously known for causing confusion. Additionally to the notational dif-
ferences, there were also real mistakes in the formulae of Rubinstein (1985) and Rose
(1986b) (Table B.1).
1For example: K(0.5), defined in the K(k) notation, is different from K(0.5), defined via K(m). This
reflects in computation, e. g. MatLab (used by Gommerstadt, 2009) and Wolfram|Alpha (used in this work)
use the K(m) notation, and lead to different results e.g. for: “EllipticE(x)/EllipticK(x) where x=0.5” versus
the almost identically appearing: “EllipticE(k)/EllipticK(k) where k=0.5”.
2Original notation in Rubinstein (1985): KI(0)KI(∞) =
√
a/b · E(1−a/b)K(1−a/b) and in Rose (1986a):
KI(0)
KI(∞)
= C/k, with
C = E(k
′)
K(k′) , k
2 = a/b, k′ = (1− k2)1/2. For anybody who is not familiar with these finer points of elliptic
integrals, this leads to the inevitable and confusing contradiction of: 1− a/b =√1− a/b .
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These mistakes were corrected in subsequent publications, however, no author stated either
errors or their corrections. The complete elliptic integral of the second kind K(m) or K(k)
shall not be confused with the stress intensity factor K, KI, K0 or K(∞). Rubinstein (1985)
stated no restrictions regarding a or b in relation to the sample width 2 ·w.
Rubinstein Rose Rose Rubinstein Gommerstadt
Parameter (1985) (1986a) (1986b) (1999) (2009)
KI(0)
KI(∞)
· 1√
b/a
= e(m) e(k) 4
√
a/b ·e(k) e(m) e(k)
KI(a)
KI(∞)
·
√
1−a/b√
b/a
= e(m)−1 e(k)− a/b e(m)− a/b e(k)− a/b
KI(b)
KI(∞)
·
√
1− a/b = 1− e(m) 1− e(k) 1− e(m) 1− e(k)
refer to:
Rubinstein (1985) 1  1,2 1
Rose (1986a)   
Rose (1986b) 1
correct formula: 3  4  
Table B.1.: Analytical solutions for stress intensity factors for collinear edge cracks.
Common row factors were moved to the KI side. Check symbols: = correct, same
as reference, = not correct, = not mentioned. First symbol: KI(0), second: KI(a),
third: KI(b). e(k) = E(k)/K(k) is equal to e(m) = E(m)/K(m), however, k =
√
1− a/b and
m = k2 = 1− a/b.
1 Author does not mention the wrong formula in the reference.
2 Corrected wrong formula of Rubinstein (1985) but does not mention this.
3 In a range m = 1− a/b = [0,1], the resulting e(m) is in a range of e(1− a/b) = [0,1]. Therefore, the
term e(1− a/b)−1 is negative for any case of a/b. However, stress intensity factors never get negative.
Therefore, Rubinstein’s (1985) KI(a) is wrong.
4 A confusion in the complicated square root notations:
K(0)/K(∞) = E(k′)/
{
k1/2 ·K(k′)
}
, with k = (a/b)1/2, k′ = (1− k2)1/2.
Interestingly, this would get correct if the notation would have been with m instead of k:
K(0)/K(∞) = E(m′)/
{
m1/2 ·K(m′)
}
, with m = k2 = a/b, m′ = 1−m = 1− a/b.
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C. Appendix to MRI Study
1. Toxicity of BMM Compounds
The toxicity of the novel BMM compounds (p. 110) is not known. As toxicity was not
a primary concern nor aim in these early concept studies there were no efforts towards
determining toxicity. However, a small amount of side-observations were made.
1.1. Compound Stability
Free gadolinium ions are highly toxic. However, according to Brian McMahon and Thor-
finnur Gunnlaugsson, the complex chelating the central gadolinium ion is supposedly fairly
stable and should avoid its release (Fig. 3.2, p. 111). The chelating complex itself is pro-
posed to be non-harmful as similar compounds have been proven to be clinically safe.
The stability of BMM compounds is currently not sure. One experiment in which the
fluorescent compound was not detected in scratches was attributed to storage of water
dissolved compound for a span of several months. It was thought that the iminodiacetate
groups lost their activity during that time. Dry stored BMM kept its ability to bind to
scratches and to fluoresce for months. Further studies on the stability of the compounds
were not undertaken.
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1.2. Acute Toxicity
At the time of the MRI experiments, the locust1 was introduced in TCD as a new in vivo
model for brain studies by Dr. Christian Kerskens, Rustam Rakhmatullin and Nikoletta
Adler. One of their early aims was to find potential and appropriate MRI contrast agents.
As the BMM compounds were readily available, a number of aliquots were prepared with
respect to the dosages of common fluorescent compounds (Table C.1).
Compound Dosage
Name
M in vivo1 in vitro2
g/mol mg/kg mM mM
Alizarin Complexone 385 30 0.078 0.5
Xylenol Orange 760 90 0.118 0.5
Calcein Green 622 10 0.016 0.5
Calcein Blue 321 30 0.093 0.1
Oxytetracycline 460 30 0.065 -
Table C.1.: Fluorescent contrast agents, their molecular mass M and their dosages used in
vivo to label bone turnover and in vitro to label bone microdamage.
1 In vivo labelling of turnover (Rahn, 1977).
2 In vitro labelling of scratches and fatigue microdamage (Lee et al., 2000b; O’Brien
et al., 2002).
To stain surface scratches on bone, most fluorescent dyes require exposure times of 30 min
at 0.5 mM (O’Brien, 2000), but overstaining and quenching can occur already with 0.5 mM
after 30 min, 60 min and 240 min (p. 126).
BMM 114 enabled MRI contrasts in vitro, which were similarly visible at 0.3 mM, 1 mM
and 4 mM (p. 130 & 145). The minimal concentration to receive an MRI signal appears
to be low but is not exactly known (p. 130). Higher concentrations did not cause adverse
quenching effects. The required concentrations for good visibility of the fluorescent based
1Locusts, as insects, did not require ethical approval for experiments.
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BMM compounds was 1–8× higher than the 0.5 mM of O’Brien et al. (2002) (p. 128). The
in vivo dosages were therefore planned to be 1.1–31× higher compared to the in vivo test
of Rahn (1977) and the in vitro test of O’Brien et al. (2002) (Table C.2).
For a single injection, locusts tolerate ≈ 10% of their body weight. The body weight of
an average locust was 1.2–2.5g, the injectable amounts were ≈0.1–0.2ml. The molecular
weight M of BMM 114 is 1164 g/mol.
BMM 114 in locusts Dosage vs. Rahn (1977)
Dosage mg BMM 114 in Xylenol Calcein
mg/kg mM 0.3 ml aliquot Orange Green
1 0.000859 0.0030 0.73% 5.3%
3 0.00258 0.0090 2.18% 16%
10 0.00859 0.030 7.28% 53.4%
30 0.0258 0.090 21.8% 160%
100 0.0859 0.30 72.8% 534%
300 0.258 0.90 218% 1601%
Table C.2.: Theoretical injectable BMM 114 dosage for locusts. Aliquots of 0.3 ml were
made up for a maximum locust weight of 3.0 g, the final injection amounts were 10% of
the locust’s body weight.
Two locusts received the highest available concentration of 300 mg/kg BMM 114 and sur-
vived for at least 7 days. Therefore, it is assumed that LD50 of BMM 114 is somewhere
higher than 300 mg/kg. This agrees with Penfield & Reilly (2007), that the LD50 of chelated
Gd is around a factor 100 higher than of free Gd3−-ions with LD50,animals = 100–200 mg/kg.
For future toxicity testing the method of Noever et al. (1995) may be considered.
2. Tested Fatigue Samples
Table C.3 lists the fatigue samples that were used in the MRI study (Sec. 3.3.2, p. 119).
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# Contrast agent(s) Aim
MRI & nf at
Histology 110 MPa
4 Xylenol Orange, 0.5 mM microdamage creation by this set-up - ≈ 2000
2 BMM 66, 1 mM dye penetration into bones Fl 6709
3 BMM 114, 4 mM dye penetration into bones MRI 5119
5 BMM 66, 1 mM dye penetration into bones Fl 29891
9 BMM 66, 1 mM dye penetration into bones Fl 31777
25 BMM 66, 4 mM dye penetration into bones with higher concentration Fl 884
30 BMM 114, 4 mM negCON for damage MRI -
31 PBS negCON for contrast agent in MRI MRI 434
6 BMM 114, 4 mM dye visibility at 4 mM MRI 5010
7 BMM 114, 4 mM dye visibility at 4 mM, huge amount of damage MRI 197
11 BMM 114, 1 mM dye visibility at 4 mM MRI 85
20 BMM 114, 4 mM Plexiform bone, 4 mM MRI 12625
21 BMM 114, 1 mM Plexiform bone, 1 mM MRI 8534
29 BMM 114, 4 mM AlizC coverage on outer surface MRI -
16 BMM 114, 4 mM XylO coverage on outer surface MRI -
32 BMM 114+66, 4 mM fluorescence after MRI MRI + Fl 2825
18 BMM 114+66, 4 mM fluorescence after MRI MRI + Fl 18945
Table C.3.: List of fatigued MRI samples. Fl: fluorescence microscopy performed. nf : number of cycles to
failure, normalized to 110 MPa.
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D. Appendix to Microindentation Study
During the experimental work with the BioDent™ and in the subsequent analysis of the
output parameters and raw data, various patterns emerged that were not revealed through
the existing BioDent™ parameters. These raw data patterns led to the design of novel
parameters.
However, the discussion of the existing BioDent™ parameters and the subsequent proposal
of technical novelties did not appropriately fit to the data based content of chapter 5 and
was relocated into this appendix.
1. Error Identification, Exclusion Criteria and
Troubleshooting
Due to the comprehensive quantity and quality of error identification the following sections
were moved to the appendices rather than being included in the discussion (p. 217).
1.1. Identification of Errors and Outliers
Most output parameters showed several severe outliers (Table D.1). However, indents with
one clear outlying parameter did often not show further abnormal parameters. Therefore,
most exclusions of outlier data were done for the suspicious parameter and not for all
parameters of an indent. Most of the data abnormalities in this study were uncorrectable
and led to data exclusion rather than correction.
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parameter total normal indents outliers
name unit dir. ∑ mean ± SD ∑ value ∑ co-occurrence
IDI µm
P 171 9.9±6.7 171 -
T 153 7.9±5.0 153 -
T ID µm
P 171 35.4±13.9 167 > 99 4 4×LS
T 153 26.5±7.2 143 > 59 10 1×ED, 1×LS
ED µJ
P 147 29.8±4.8 147
< 15
-
T 153 26.3±5.8 151 2 1×US, 1×LS
US N/µm
P 147 1.86±1.06 147
< 10
-
T 153 2.53±0.80 152 1 1×ED, 1×LS
LS N/µm
P 147 0.50±0.19 128 < 0.05 19 4×T ID
T 148 0.72±0.20 142 < 0.05 4 1×T ID, 1×ED
> 1.5 2 -
FCID µm
P 30 33.7±6.81 30
< 20
-
T 32 28.1±2.08 31 1 -
CID µm
P 30 3.81±0.61 30 -
T 32 3.21±0.31 32 -
avCID µm
P 30 1.22±0.12 30 -
T 32 0.99±0.09 32 -
∣∣∣kˆ×σkˆ∣∣∣ - P 30 0.18±0.07 27 > 0.5 3 -T 32 0.23±0.10 25 7 1×FCID
PMMA 19 0.36±0.05 15 4 4×σ jˆ
σ jˆ -
P 30 7.66±2.31 27
> 15
3 -
T 32 8.17±1.72 26 6 1×FCID, 1×T ID
PMMA 19 9.32±1.76 15 4 4×
∣∣∣kˆ×σkˆ∣∣∣
Table D.1.: Outliers per parameter. Averages are based on non-outlier data. dir: direction,
P: periosteal, T: transverse. The PMMA indents can only be used for the novel computed
parameters
∣∣∣kˆ×σkˆ∣∣∣ and σ jˆ to validate their concept. Parameter descriptions: Table D.3.
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Table D.2 lists the most frequent errors, how they could be detected and their causes and
possible counteractions as far as they are known.
Some errors were attributed to the algorithms, which calculate the points in the load-
displacement curve (red circles in Fig. 5.4), failing to obtain sensible points. Derived para-
meters from erroneous computed points were one of the most frequent sources of error.
Individual erroneously calculated points could be corrected by manual user interference
and subsequent re-calculation. However, the available software did not provide this fea-
ture. With further development of software-sided point recognition with increased stability
and better error tolerance, some of these problems are expected to be solved soon.
Material inhomogeneities, such as cavities, caused further unexpected results, but were
identified with novel analysis tools (p. 324).
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Indicating parameters F-d-curve appearance Cause
Data
Possible adjustment
Discussed
exclusion thoroughly
LS < 0.05, 1 calculation point wrong algorithm problems, 2, 3 maybe recalculate points
LS < 0.05, 1 F spike at start of O1 not sure maybe adjust first
T ID > 100, 1 or in all cycles calculation point
LS < 0.05, 1 not sure maybe not sure
CID < 0.7, 1
T ID+20 . . .50, 1 hump, 4 collapsing void, 2, 4 yes none p. 324
IDI+10 . . .50, 1
T ID > 100, 1 jittering maximum force, 5 probe not adjusted, 2, 3 likely readjust probe, p. 218
Fmax >±0.4 from Fnom, 1 repeat measurement
5 wave patterns, 5 heavy machinery maybe check environment p. 330
interference, 2, 3
Table D.2.: Possible error identification criteria and potential counteractions based on the BioDent™ of 2011. +: increased against
representative indents. Units: LS in N/µm, CID, T ID and IDI in µm, F in N
1 Automatically detectable with control chart (p. 303).
2 Deduction of cause possible with Pareto chart and fish-bone diagram (p. 303).
3 90% of these incidences would be avoidable with implemented control charts.
4 Automatically detectable with the novel hump number (p. 324 & 328).
5 Automatically detectable with the novel scattered jerk criterion (p. 330 & 332).
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1.2. Recommendations for Near Real Time Error Detection
To detect errors in real time, to fix errors and to enable counteraction for subsequent
indents, a number of tools from the Seven Basic Tools of Quality (Ishikawa, 1990) are
suggested to be implemented into the BioDent™ software:
Control chart A plot of each output parameter in relation to time. When control charts
are updated on the fly at the end of each individual indent, they are the most useful
tool to recognize errors immediately. Control charts can be analysed by computer
algorithms and require a minimum of user knowledge. It is strongly advised to
include fully automatically analysed control charts into the BioDent™ software.
Additionally, his would require the option for manual exclusion of irretrievably
faulty indents from the control chart statistics to avoid erroneous skewing.
Fish-bone diagram Ishikawa (1976) introduced cause-and-effect diagrams, since named
Ishikawa diagrams, but commonly known as fish-bone diagrams. They provide an
overview of potential sources of error.
Pareto chart The wealth of information provided by fish-bone diagrams, can be plotted
against their frequency of occurrence in a Pareto chart, to provide the most effi-
cient way to identify the most likely problem source (Juran, 1962). Pareto charts
should be the second step once an error is indicated manually or by the control
chart analysis.
Check sheet Of the 5 uses for check sheets in quality control that Ishikawa (1990) recom-
mended, the following appear most useful:
• Check sheets can be used to quantify errors by type, cause and effect. To
gain data for Pareto charts, each error needs recording with an error check
sheet. The error check sheet is based on the fish-bone diagram and should
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appear every time an error is identified. This registration of errors builds the
main knowledge base for future improvements and error minimization.
• Check sheets can further be used to keep track of the completion of steps in
a multi-step procedure. A software provided procedural check list or Stan-
dard Operating Procedure (SOP) increases the standardisation and quality of
outcome of experiments and decreases adverse user-influence.
Local Outlier Factor The Local Outlier Factor (LOF), introduced by Breunig et al.
(2000), shows high sensitive in outlier detection in multi-dimensional data sets.
LOF is applicable to more diverse reference data sets (e. g. the combined data of
several peer-reviewed publications with different Fnom, species, bone types, testing
directions and disease status). The theory behind LOF is complex, but the pre-
sented results to the end-user are easy to interpret.
Implementation into the BioDent™ software of these methods would be very advisable.
The control chart is the only method that needs to be active continuously and can run fully
automatically and invisibly in the background and only claim the user’s attention when
an error is detected. Furthermore, both the control chart and the other information should
always be available upon user request. The other mentioned methods are required once an
error has been detected.
The influence of the above suggested Basic Tools of Quality on the user can be minimal
and undisturbing. On the contrary, the user would only notice their existence in the case of
trouble — and then both the initial automatic indication of problems and the systematically
and assisted trouble shooting will be invaluable advantages that serves to decrease trouble
and user frustration significantly. A further benefit is the continuous knowledge gain of
sensible and valuable information to fix future problems or avoid the majority of them.
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1.3. Benefits of Outliers
On the other hand, certain abnormal behaviour can provide valuable diagnostic informa-
tion. For example, humps appearing in the first cycle indicate cavities in the tissue that
slowly or suddenly collapse (see p. 324). Up to now, humps disturbed the resulting para-
meters, skewed the statistics and were often not even recognized by the user. However, a
specific recognition and analysis of these cavities could give additional valuable insights
into bone porosity and brittleness. The appearance of humps, indicating collapsing cavi-
ties, varied in this study between 0 out of 7 indents and 2 out of 5 indents (0%−40%) per
indented bone. Their appearance is too inconsistent for judgements solely based on them,
but humps can add value to the set of data from each patient — rather than being excluded
from analysis generally. Analysis of these phenomena could be part of clinical studies with
more participants and with an ultimate outcome of broken bones.
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2. Proposed Parameters for Quality Control and Material
Property Description
The BioDent™ calculates a variety of parameters describing the material properties. The
parameters that were available for all experiments in this study were the IDI, T ID, ED,
LS and US (see Fig. 5.4, p. 192). In later versions of the software, during 2011 and 2012,
there were further parameters introduced:
• The CID 1st (Creep Indentation Distance of the 1st Cycle in µm) is the penetration
distance during the phase of constant maximum force in the 1st cycle O1.
• The avCID or Avg CID 1st-L (Average Creep Indentation Distance from 1st to last
Cycle in µm) is defined as the average of the sum of the penetration distances during
the phases of constant maximum force throughout all cycles.
• The TDD (1st) (Touchdown Distance in the 1st Cycle in µm) is the distance that the
probe takes to touch the sample’s surface in the 1st cycle O1. This parameter was
introduced to compensate for different probe to reference-probe pairing lengths.
Due to the lack of these new factors for the larger part of the data set of this study they were
not used in the analysis. For alternative parameter names and abbreviations see Table D.3).
The 2012 version of the BioDent™ H fc with the novel length adjustment offers an addi-
tional tuning mode, with the benefit that inevitable manufacturing variations can be com-
pensated for and do not lead to potential PID controller disturbance (sec. 3.5.4.2). However,
the BioDent™ H fc does not save the raw data during this tuning mode. Thus, later error
search and identification could be impeded.
Additional novel output parameters can be computed from the existing raw data. The Bio-
Dent™ offered to export the raw load and displacement data of individual tests. With a
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number of raw data sets further potential parameters were developed in this work. Estab-
lished and novel proposed parameters fulfil one or several of the following functions:
1. As quality control of:
a) specific experimental set-up
b) environmental influences
c) user mistakes
d) BioDent™ hardware
e) BioDent™ computation
2. To identify unusual indentation patterns and as outlier criteria.
3. To describe material characteristics.
Between 2010 and 2013, most BioDent™ output parameters (Table D.3) described material
characteristics (IDI, TID, LS, US, ED). The only parameter that does not describe material
properties is the maximum force Fmax, that can be potentially used to identify user mistakes
and computational issues (p. 334).
Some existing parameters caused irritation (p. 310, 311, 313 & 336).
Furthermore, explanations are given of which particular novel RPI parameters could be
of value and why, how they can be computed in principle from the existing raw data and
finally, some expected values for certain testing situations (p. 317, 324, 328, 330 & 336).
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BioDent™ Hfc, 2012 (Active Life Scientific, 2012) BioDent™ (build 2010) used in this work
Abbreviation Current name Unit Available 1 Abbr. Name
IDI (1st-L) Indentation Distance Increase µm yes IDI Indentation Distance Increase
ID (1st) First Cycle Indentation Distance µm 62/324 - -
TID (1st-L) Total Indentation Distance µm yes T ID Total Indentation Distance
Avg ED (3rd-L) Average Energy Dissipated µJ yes ED Energy Dissipated
Avg US (1st-L) Average Unloading Slope N/µm yes US Unloading Slope
Avg LS (1st-L) Average Loading Slope N/µm yes LS Loading Slope
CID (1st) First Cycle Creep Indentation Distance µm 62/324 - Creep Indentation Distance
Avg CID (1st-L) Average Creep Indentation Distance µm 62/324 avCID -
US (1st) First Cycle Unloading Slope N/µm no - -
TDD (1st) (First Cycle) Touchdown Distance µm no - -
Avg Max F (1st-L) Average Maximum Force N yes F Average Maximum Force
2 Reference Force N or g, 3 yes - Reference Force
2 Nominal Testing Force N yes Fnom -
2 Testing Force N 62/324 Fcur -
2 Testing Displacement µm 62/324 d Displacement
2 Testing Frequency Hz yes fnom (Nominal) Testing Frequency
2 Sampling Frequency Hz yes fsampling Sampling Frequency
Table D.3.: BioDent™ parameter names and abbreviations may be subject to change. Brackets may be omitted.
This study used the 2010 parameter names and abbreviations. BioDent™ may use F nonspecifically for any
force parameter, this work introduced clarifying indices. Parameter explanations in Fig. 5.4 & p. 306.
1 Yes: parameter data were available in the full data set. 62/324: Only available in 62 of 324 indents.
2 Parameter is not an output parameter and has no official abbreviation.
3 The BioDent™ Hfc measures this force with a weighing balance, which displays grams instead of Newtons. Hence, a significant
amount of upcoming publications are expected with a weight unit for this force parameter.
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2.1. First Derivative of Load with Respect of Displacement
The raw load-displacement data are plotted by the BioDent™ software automatically
(p. 219). However, if the load-displacement data are smoothed (p. 320) and derived once
numerically (Fig. D.1), intrinsic data patterns emerge which can indicate what the data
actually mean and how they should be described appropriately. Surprisingly, this kind of
data analysis appeared to have not been done before, so that the following 30 pages belong
to the category: “discovery consists in seeing what everybody else has seen, and thinking
what nobody else has thought.”1
2.1.1. The Loading Slope LS is Not a Single Number
The LS computed by the BioDent™ caused irritation. Fig. D.1 shows the first derivative
of the load with respect to the displacement ∆F∆d of a representative sample. Both LS and
US are averages of the first derivative curve. To describe the indentation resistance of
the material during loading and unloading with only one parameter each is pragmatic.
However, the derivative graph suggests that this is an insufficient characterisation, as the
LS is unambiguously not constant. For example all the real LS values, in a range similar to
the one enclosed by red crosses in Fig. D.1, are averaged into one single LSRPI value, while
the graph shows a ±20% range to a mean value. This variation is not mainly the object
of random scatter but follows a clear upward trend pattern. It might be inappropriate to
describe data with an obvious trend only by a single mean value LSRPI . Depending on the
kind of non-linearity of the loading slope, more parameters should be added to describe the
material’s resistance against indentation conclusively.
1Albert Szent-Györgyi de Nagyrápolt, 1962, in Irving J. Good (ed.), The Scientist Speculates: an anthol-
ogy of partly-baked ideas.
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Figure D.1.: First derivative of the load with respect to the displacement ∆F∆d . The red
crosses indicate the range of constant loading in cycle 1. The peak left from the first red
cross indicates the initial contact with the bone, the drop after the right most red cross starts
the plateau phase of constant maximum force. The blue unloading slope of O1 is highly
off a horizontal line, which would have indicated the constant being actually constant. The
middle part of the black loading slope (LS) is neither constant. Data were smoothed over
15 data points to lower scatter. Sample (13 L 2) and colour scheme as in Fig. 5.18.
2.1.2. The Unloading Slope US is Not a Single Number
The issue of non-linear load-displacement slopes appeared even more pronounced at the
unloading slope (in Fig. D.1 the blue versus the black line). The sample’s unloading slope
ranged from US ≈0.15 N/µm to US ≈0.5 N/µm. If this is averaged into one value, the result
highly depends where the start and finish of the averaging range is set. Fig. D.2 shows the
raw unloading part of cycle 1 from Fig. 5.18 (p. 219).
The slopes are calculated within a defined range. To achieve more precise values, a wider
range is beneficial. On the other hand, a wider range may include irregularities of the
touching of the probe or of the constant force plateau (Fig. D.1). The red crosses in Fig. D.1
mark the edges of the range of the calculation performed. Their lower boundary was placed
310
APPENDIX D. APPENDIX TO MICROINDENTATION STUDY
Figure D.2.: Non-linearity of the unloading slope in the raw load-displacement data. The
US depends much on the force range: US4.75−1N,O1= 0.384 N/µm (blue dash-dot line),
US4.75−3N,O1= 0.479 N/µm (bright blue dash-dot-dot line). The raw data were not smoothed
and thus appears stepped.
at 1 N — as most indents had the initial indentation phase of unsteady derivatives finished
before 1 N. The upper boundary was placed at 4.75 N — as being 95% of the nominal,
respectively maximum force of Fmax≈Fnom = 5N. This was chosen because the derivatives
were not influenced by the constant force plateau up to 95%×Fmax and a percentage of
Fmax is reproducible independently of the nominal force, which may be subject to change
between studies. So the included data for the slope calculation had a normal range of
∆FUS = [4.75− 1]N (≡ 75% of the absolute force range ∆Fabs = [5− 0]N). The slope
calculation boundaries in this work are not identical to the internal BioDent™ computation.
This is due to the fact that the BioDent™ does not disclose the mathematics behind the
calculation. However, similar results would be expectable (p. 313).
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To quantify the effect of the non-linear data behaviour, the calculation range was reduced
from ∆FUS = [4.75− 1]N (≡ 75% of ∆Fabs) to ∆FUS = [4.75− 3]N (≡ 35% of ∆Fabs).
This vast range alteration increased the unloading slope by +24.8% from US4.75−1N,O1 =
0.384 N/µm to US4.75−3N,O19 = 0.479 N/µm. So the stiffness calculation as a single slope
parameter LS or US might not be the most stable parameter if the range is calculated on the
fly and not defined rigorously. The average USO1−20 and LSO1−20 over all cycles were not
seen to be increased by more than +20%, independent of how the range ∆FUS was set.
Concluding, both the loading slope LS and the unloading slope US are not constants and
should therefore not be treated as constants in their computation, statistics and in human
perception. There should be at least a second parameter to describe their non-linear
behaviour. The loading slope increased nearly linearly. Thus, the loading slope can be
derived once more and still be 6= 0 2. This second derivative of the load with respect of
the displacement is called the curvature: k = ∆
2Floading
∆d2 . The average curvature could be a
valuable second curve characteristic parameter, both for LS and US. The curvature should
be averaged in a cycle range of ∆Ok = [3,20] (p. 317).
It is not yet clear how to treat the intercepts of the curves — a third parameter describing
the slopes of the load-displacement data might be needed3. Neither is it clear, how to set a
sufficiently sensible and repeatable force range for the calculation. But it is certainly true
that one parameter each for a curve, that is not a straight line, is inadequate.
2The 3rd derivative of the loading curve is normally negligibly small: jloading =
∆3Floading
∆d3 ≈ 0. However,
the 3rd derivative can still serve as an indicator of environmental influences on the test set-up (p. 330).
3To describe any parabola, 3 unique parameters are needed, i. e. y = ax2 + bx+ c. As RPI produces
parabola shaped load displacement data, there is a need for 3 parameters. However, the data point at Fnom
and ID 1st provides this 3rd information. Mathematically speaking: a system of linear equations to describe a
2nd order polynomial can be sufficiently solved with a) the slope m (in respect to a known ordinate interval),
b) the curvature j (in respect to a known ordinate interval) and c) one point on the curve (which is not placed
congruently on any of the aforementioned interval’s borders).
312
APPENDIX D. APPENDIX TO MICROINDENTATION STUDY
2.1.3. The BioDent™’s LS and US Values were Not Reproducible
It was noted that the BioDent™ computed slopes did not match with slopes calculated from
the raw data. Therefore, US and LS were recalculated from raw force and displacement
data sets with MS Excel. Raw data were taken from 6 different animals, 13 randomly
individual indents were chosen that showed no testing abnormalities. The recalculated
parameters were called LSPM and USPM 4. Table D.4 shows the recalculated slope values,
the original BioDent™ values and the ratio between them. The ratios LSRPI/LSPM and
USRPI/USPM were calculated for each indent individually.
parameter
cycle force data range mean±SD
range, ∆O range, ∆F in N/µm in N/µm
LSRPI 1−20 n.a. 0.472−0.919 0.678±0.150 }p < 0.001LSPM 3−20 1−4.75 N 0.333−0.466 0.397±0.048
LSRPI/LSPM 1.409−2.135 1.695±0.234
USRPI 1−20 n.a. 1.023−2.378 1.651±0.494 }p < 0.001USPM 3−20 4.75−1 N 0.414−0.600 0.512±0.067
USRPI/USPM 2.473−3.964 3.158±0.550
Table D.4.: The recalculated slopes LSPM and USPM compared to the BioDent™ computed
slope values LSRPI and USRPI. The BioDent™ values were significantly increased com-
pared to the recalculated values.
There were significant differences (p < 0.001) detected between the PM recalculations and
the BioDent™ computations. The LS and US of the BioDent™ were higher by factors of
1.695 (LS) and 3.158 (US) respectively, which raised the eyebrows as much as concerns.
The spread of the results amongst the group of the 13 recalculated indents was much
wider in the RPI calculation with σLSRPI = 22% and σUSRPI = 30%, while the recalculation
resulted in only half this variation with σLSPM = 12% and σUSPM = 14%. This indicates that
4The index RPI indicates the BioDent™ reference point indentation values. The index PM indicates
values recalculated by Peter Mauer.
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the force range criteria of the PM calculation (p. 310) may be more conservative but appar-
ently more stable. Parameters with lower random spread due to the computation technique
should in general be easier to compare between different experimental groups. High varia-
tion in the USRPI computation method might have influenced the findings of Gallant et al.
(2012), who found that the US related to traditionally measured mechanical properties only
in one out of three experiments (not significant in dog ribs and in rat femur, significant rela-
tion in rat lumbar vertebrae). Aref et al. (2013) computed several parameters themselves
(ID, IDI, T ID, CID, ED, US) and provided graphical comparison with the BioDent™
computation. Coincidentally, they only showed comparison charts of ID, IDI and ED, but
not of the disputable US.
As the raw data were not available for the full data set, full PM recalculation and compari-
son were not performed.
Beside the observation that highly significant differences occur between the two calculation
methods, it is currently unknown why these mismatches arise.
A variety of factors could influence these observations:
• Cycle range differences. The BioDent™ computes LSRPI and USRPI over all 20
cycles (Active Life Scientific, 2012). While LSPM and USPM were calculated in a
range ∆OLSPM = [3− 20] and ∆OUSPM = [3− 19]. The slopes of cycle one and two
showed lower values (Fig. D.3 & D.4) with non-predictable behaviour and random
influences (p. 324). The slopes of O1 & O2 are lower by ≈ 10− 80% compared
to O3− 20. Thus, LSRPI,O1−20 and USRPI,O1−20 were expected to be decreased by
≈ 1−8% compared to LSPM and USPM. USPM was calculated up to cycle 19 because
cycle 20 was influenced by the smoothing technique (p. 320). However, as cycle 20
and 19 are very similar, it is estimated to cause a decrease of USPM by less than 1%.
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• Force range differences. The range of forces ∆FLSRPI and ∆FUSRPI that the Bio-
Dent™ uses for the computation is not known, although it is expected not to vary
hugely from the ranges used here. For a force range of less than half of the force
range used here, an upward variation of LSRPI and USRPI would be expected to be
less than +20% (p. 310). For any sensibly chosen force interval, the changes were
expected to be less than +10%.
• Mixing of data sets. There is a chance of raw data confusion during the data export
or transfer. If data sets were mixed up, this would emerge in a comparison of the
same parameter from PM and RPI computations, such as: USRPIUSPM ≈ 1.0. In 13 ran-
domly chosen indents showed the same trends of LSRPI LSPM and USRPIUSPM
with no exception. Therefore, data confusion was considered unlikely.
• Manual double-check. The recalculation of values was done in MS Excel 2003,
where formulae were easy to control. Results were double-checked with paper and
pen from force-displacement sets directly taken from the raw data5.
• Cross-check with derivative data. In addition to the calculation of slope values
from F and d, slopes can be directly read off as the ∆F∆d values in derivative graphs
6.
• Computational differences. The smoothing technique employed in this work
(p. 320), was not expected to change the slopes in any direction by more than ±3%.
On the other hand, there is no information available on the internal BioDent™ com-
putation and smoothing techniques.
5The naturally critical scientific reader, who feels encouraged to re-calculate this, may take “raw” data
for LSO1 from the red crosses’ coordinates in graph 5.18 (p. 219).
6The slope of Fig. 5.18 derives to the ordinate in the 1st derivative graph (Fig. D.1, p. 310). The reader
may estimate LSO1 as the average y-value between the red crosses. As LSRPI averages the cycles 1−20, one
may average all grey lines which show the same pattern than the black line.
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• Possible computation errors of the BioDent™. There is no proof available at the
moment that the BioDent™ calculated LS or US correctly7.
The PM recalculations were double-checked for plausible values by hand from the raw
data as well as compared with derivative graphs. The potential PM upward variation due
to different force ranges was expected to be less than +10%. The RPI downward shift due
to different cycle ranges was expected to be less than 8%. Data confusion was seen as very
unlikely. Smoothing techniques were expected to make differences of less than ±3%. On
the other hand, in the unlikely case that the BioDent™ itself calculated wrong, there was
no proof available.
In such cases — the fictional but nevertheless admirable problem solver — Sherlock
Holmes would have suggested: ”When you have eliminated the impossible, whatever
remains, however improbable, must be the truth” (Conan Doyle, 1892).
Thus, I hypothesize that, after the relatively sure exclusion of the possibility that the PM
recalculations were faulty, whatever remains, however improbable, must be that the Bio-
Dent™ did not calculate LS and US correctly.
Furthermore, as this seemed to be caused by a systematic software error, it seemed equally
(im-)probable, that the BioDent™ actually never calculated any LS or US correctly for any
sample in any place in the world in the past few years.
7The BioDent™ computed LSRPI,#13L2,O1−20 = 0.487 N/µm versus LSPM,#13L2,O3−20 = 0.346 N/µm and
LSPM,#13L2,O1 = 0.137 N/µm. The US (blue lines, Fig. 5.18 & D.1) was USRPI,#13L2,O1−20 = 1.155 N/µm
versus USPM,#13L2,O3−19 = 0.440 N/µm and USPM,#13L2,O1 = 0.400 N/µm.
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Double-Checked Parameters Of the available 5 BioDent™ output parameters, only LS
and US were recalculated more rigorously. Programming the recalculation of the other 3
parameters requires different mathematics and the detection of appropriate points is more
complex and was beyond the scope of this research.
Nevertheless, IDI was double-checked on the raw data graphs of a number of samples and
not found to vary significantly from IDIRPI. T ID is hard to check because the starting point
is not known. LS suffered often (19 out of 147 periosteal indents ≡ 13%) from incorrectly
computed end points (p. 300). The specific problems of ED are discussed later (p. 336).
2.2. Slope Dependency on the Logarithm of the Cycle Number
Figure D.3.: Loading slope LSPM,1−4.75N (blue solid line) increase with respect to the
loading cycle with differently fitted trend lines. The RPI uses numerical averaging of all
data (orange dash-double-dotted line)8. Trend lines exclude cycle 1 (blue dotted line).
8The horizontal fit was calculated as an average of all the LSPM,O points. This is the same technique —
in terms of a single averaging value — as the used by LSRPI, but not the same value, because LSRPI appears
to be off by a factor of 1.7 (sec. 2.1.3).
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Figure D.4.: Unloading slope USPM,4.75−1N (blue solid line) increase with respect to the
loading cycle with differently fitted trend lines. The RPI uses numerical averaging of all
data (orange dash-double-dotted line)9. Trend lines exclude O1 (dotted line) and O20.
The resistance against penetration increased within individual cycles with the indentation
force (sec. 2.1.2). Furthermore, LSPM,1−4.75N (Fig. D.3) and USPM,4.75−1N (Fig. D.4) were
non-constant and non-linear with respect to the cycle number O. Logarithmic trends fitted
perfectly for LS (R2log,LS1−4.75N = 0.994) and US (R
2
log,US4.75−1N = 0.995). Linear trend lines
fitted inferior (R2lin,LS1−4.75N = 0.869, R
2
lin,US4.75−1N = 0.919). The single value average LSRPI
and USRPI (horizontal lines) of the BioDent™ inadequately represented the data.
The shown sample 13 L 2 had its first cycle slopes fit well with the logarithmic trend lines,
while most samples had much lower LSO1 and USO1 values. This is thought to be due to the
initialization, and the not yet stabilized, crack growth in O1. In cycles 2−20 the additional
destruction achieved much better predictability. Therefore, the trend lines exclude cycle 1.
Cycle 20 was excluded in US due to smoothing technique limitations (p. 320).
9Similar to Fig. D.3, the horizontal fit represents the average of USPM,O and not of USRPI, which appears
to be 3.2 times higher (sec. 2.1.3).
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The increasing slopes over time can be explained by a number of effects:
• densification causes an increasing compression modulus,
• additional crack propagation gets more difficult in later cycles as more energy is
required to compress already damaged material, thus the easy penetration by further
destruction of material is reduced in later cycles,
• elastic recoiling effects by interstitial fluid may decrease with prolonged testing as
more fluid is pressed out already, thus the elasticity of the bulk material increases.
The effect of increasing resistance against penetration with ongoing indentation is more
pronounced in the loading slope than in the unloading slope. Between cycles 2 and 19 the
LS1−4.75N,13L2 increased by 43.1%, US4.75−1N,13L2 increased by 11.7%.
A limitation to the PM calculations was that LS1−4.75N and US4.75−1N were computed as
single averaging parameters in each cycle and not, as the earlier proposed, two or more
curve describing parameters — such as the 2nd derivative curvature k = ∆
2Fˆ
∆ dˆ2
or intercepts
(p. 309). It was not calculated, how curvature values behave in relation to individual
cycles. However, it is not expected that the principal logarithmic relation of LS1−4.75N
and US4.75−1N over time changes with modifications of the LS and US calculation methods
and additional derivative characterizing parameters.
In conclusion, the newly discovered cycle dependency of the load-displacement slopes
render any description of the loading and the unloading events with a single parameter as
inadequate. Instead, there should be more values computed, both within individual cycles
and spanning across all cycles. This single investment of theoretical analysis and pro-
gramming effort will pay off for researchers and clinicians world-wide in additional know-
ledge gain and precision for describing the material properties and damage characteristics
with BioDent™ equipment. Aref et al. (2013) recently found single cycle parameters to
differentiate better than the BioDent™’s all cycle averaging parameters.
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2.3. Comparative Qualitative and Quantitative Curve Sketching
With the raw load-displacement data of the BioDent™, curve sketching analysis was per-
formed (see e. g. Spivak & Pig, 1995). Fig. D.5 illustrates a number of specific load-
displacement curve characteristics. The first row shows the load over displacement graphs,
the middle row the first derivatives ∆F∆d and the lower row the second derivatives
∆2F
∆d2 of
the load with respect to the displacement. The main features can be seen in the first cycle
loading (black) and the unloading (blue). Cycles 2−20 (grey) repeat these features but are
not necessary for understanding the following concepts.
In general, all these new concepts were developed with basic derivative mathematics (Spi-
vak & Pig, 1995), visual pattern recognition and subsequent proofing of yet undiscovered
prediction parameters. As Albert Einstein suggested: “You have to learn the rules of the
game. And then you have to play better than anyone else.”10
2.3.1. Smoothing and Normalization
For the following curve sketching graphics and calculations, the raw data were smoothed.
This was necessary because the original data are in the range of the displacement sen-
sor resolution (see the fixed displacement steps in Fig. D.2). Stepped data usually do
not severely affect averaging, but it obstructs numerical derivation. Therefore, smooth-
ing of the raw data was done by a so-called moving average over 51 original data points
around a center point11. First, second and third derivatives were calculated over 15 of these
smoothed data points.
10Potentially wrongly attributed to Albert Einstein.
11Other methods of smoothing, for example a wide one-dimensional Gaussian filter convolution, could
be more appropriate, but optimizing raw data smoothing algorithms was beyond the scope of this research.
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Data normalization was performed to compute most of the novel describing parameters.
Normalization of the displacement d to dˆ compensated for different sample stiffnesses,
respectively indentation resistances. Otherwise, increased indentation resistances lead to
over-proportionally increased derivatives, especially of the higher order derivatives ∆
2Fˆ
∆ dˆ2
and ∆
3Fˆ
∆ dˆ3
. Without numerical normalization, proper analysis allowing objective comparison
and judgement of the absolute derivative values is impossible. Normalization of the force
F to Fˆ makes the calculations independent of the nominal loading force. Thus, these
methods are applicable in a variety of experimental set-ups without major adaptations.
Previous studies used loading forces of Fnom = 1.85N for mice (Randall et al., 2009),
Fnom = 5N for mice femora (Kennedy et al., 2012b) and rat vertebra bodies (Gallant et al.,
2012), Fnom = 5N for sheep in this study, Fnom = 10N for rat femora and dog ribs (Gallant
et al., 2012) and up to the machine’s own weight Fnom = 11N for human tibia (Diez-Perez
et al., 2010). In a range of ∆F = [1N, 95%×Fnom] the first cycle loading values FO1 were
normalized to ∆FˆO1 = [0, 1], the corresponding cycle 1 displacements dO1 were normalized
to ∆dˆO1 = [0, 1]. The normalized load was then numerically derived 3 times with respect
to the normalized displacement ( ∆Fˆ
∆dˆ
, ∆
2Fˆ
∆dˆ2
and ∆
3Fˆ
∆dˆ3
).
Novel quantitative parameters were created, based on the qualitative analysis of the load-
displacement curve sketching. These parameters describe certain indentation characteris-
tics and can be used for relative objective identification and automated application. Para-
meter values are subject to changes of the numerical methods of smoothing, normalization
range and derivation. However, due to the normalization of both involved data rows (dˆ and
Fˆ) the suggested absolute values will not change substantially and can be used as an initial
orientation in future implementations.
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Figure D.5.: Curve sketching of RPI raw data. Left column (A−C): representative normal
sample, middle (D−F): hump in cycle 1 (d1), right (G− I): wave patterns. Upper row
(A,D,G) shows load over displacement, middle row (B,E,H) the first derivative and the
lower row (C,F, I) the second derivative of the load with respect to the displacement. Small
letters mark specific curve characteristics to be explained in the text.
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2.3.2. Expected Curve Appearance
The first column (A−C) of Fig. D.5 shows a representative sample (13 L 2) of normal
appearance. At point a1 the indenter touched solid bone for the first time. In the load-
displacement-graph A this is seen as an abrupt change in slope. In the first derivative B this
shows up as a sudden, steep increase at b1. Derived twice C this is a steep peak c1 and steep
valley c2. The absolute height of the peaks b1, c1 and c2 depend on small differences in
the first micrometers of the indentation. As such, they are of huge random variation and of
no particular interest. Furthermore, the absolute values of peaks and valleys there depend
hugely on the method and width of smoothing of the original data. As well the resolution
of the load sensor, the displacement sensor as well as their measuring frequency plays
significantly into the absolute values of peaks and valleys in these graphs. No emphasis
should therefore be given to peak and valley values — however, their mere existence and
their placement in time and on the displacement scale are hugely important.
In the representative normal sample, the loading slope at a2 was relative straight. How-
ever, straightness shall never be judged based on a non-derived graph. The nearly straight
a2-section derived into a consistently increasing slope b2, thus proving that a2 increased
its slope permanently. This means that the resistance of the material against penetration
increased the further the probe indented the bone. As mentioned earlier (sec. 2.1) this
is unavoidable, but acceptable — as long as a sufficient number of sufficiently complex
parameters are computed to characterize this behaviour adequately12.
12Basically the principle of Occam’s Razor: Cut away any excess and leave (or introduce) the necessary.
Or as Albert Einstein puts it: “It can scarcely be denied that the supreme goal of all theory is to make
the irreducible basic elements as simple and as few as possible without having to surrender the adequate
representation of a single datum of experience”, from The Herbert Spencer Lecture “On the Method of
Theoretical Physics” held in Oxford, 1933.
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The increasing slope of a2 and b2 derived a second time resulted in the plateau c3 with
absolute values close to zero: ∆
2Fˆ1−4.75N,O1
∆dˆ21−4.75N,O1
≈ 0. This indicated that the stiffness of the first
loading cycle increased, but linearly and not of higher order (see p. 310).
As a measure of how constant the slope increased in a3, the standard deviation σ of the
third derivative in this area c3 should be quite small as well: σx ≈ 0 with x = ∆
2Fˆ1−4.75N,O1
∆dˆ21−4.75N,O1
.
In comparison to the relative high rising slope b2, the neighbouring sample 5 L 5 in E shows
a nearly constant slope at e2.
The phenomenon of non-constant slopes is even more pronounced in the unloading curves
as seen clearly in section b3 as well as in the other samples (E, H). Based on a qualitative
and quantitative curve sketching analysis of the load-displacement derivatives, condensing
all loading slope information into a single LS parameter is bound to lead to some inaccu-
racy. But condensing the even more complex unloading slope information into one single
US parameter seems unjustifiable.
2.3.3. Loading Curve with Humps
The second column (D−F) of Fig. D.5 shows indent 5 L 5. This indent had a major hump
in the first cycle. These humps are suspected to originate from material inconsistencies
and occurred in 6 out of 81 indents (≡ 7.4%) for which the raw data were available. Either
new material grew in layers over older material or there was a cavity in the old material
close to the surface that collapsed during indentation. Graphically this emerges as a single
prolonged hump d1 in the load-displacement curve D. Humps like this may not be obvious
to the human operator. However, an unobtrusive hump still derives mathematically into
specific patterns. Humps leave a deep, long pit at the beginning of the bone contact, seen at
e1 in comparison to b1−b2. The hump is also seen in the second derivative as an unusually
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high peak f1, where it should normally smooth from the first negative peak c2 into a steady
line c3. Whereas most of these characteristics are detectable for an experienced user —
given that the derivative graphs are given — computers recognize patterns only if they are
taught to do so. In order to yield neutral and comparable indicator values for differently
set-up experiments, the data require a normalization over the force range (p. 320) for most
parameter calculations. Suggestions to detect humps are:
• The 1st and 2nd derivative curves should be displayed additionally during the testing
procedure beside a representative, normal graph for comparison. At the moment
only the load-displacement graph is shown with no derivative and no comparison.
• Humps seemed to produce around 3% increased average slopes of normalized data
of the loading of cycle 1: L̂SO1 =
∆Fˆ1−4.75N,O1
∆dˆ1−4.75N,O1
> 1.030. An ideal elastic material
would produce L̂SO1 =
∆Fˆ1−4.75N,O1
∆dˆ1−4.75N,O1
= 1.000. This indicator also increased in many
samples with wave interferences. Thus it can indicate that something on an indent
went wrong, but it is not a very specific indicator for the detection of humps.
• The standard deviation of the first derivative of the loading slope can be calculated.
If humps are present, the standard deviation is usually higher than 20% of the mean
slope. This calculation works both for the raw data slope as for a normalized deriva-
tive: σLS/LS > 20% with LS = ∆Fˆ1−4.75N,O1
∆dˆ1−4.75N,O1
or with LS = ∆F1−4.75N,O1∆d1−4.75N,O1 .
• The 2nd derivative (curvature) is more hump sensitive than the 1st derivative. The
average curvature is negligible for normal curves: kˆ1−4.75N,O1 =
∆2Fˆ1−4.75N,O1
∆dˆ21−4.75N,O1
≈ 0,
while kˆ1−4.75N,O1 > 0.5 indicates humps.
• Humps are characterized with high fluctuations in the 2nd derivative, so the 2nd
derivative standard deviation σk with k =
∆2Fˆ1−4.75N,O1
∆dˆ21−4.75N,O1
gains high values. The
increased curvature mean and the increased curvature standard deviation can be
325
APPENDIX D. APPENDIX TO MICROINDENTATION STUDY
multiplied to one single parameter. The higher the resulting product, the more likely
the individual indent had a hump. This was the most promising method to identify
humps and was therefore named the hump number (see below).
• A different approach for hump detection is the use of integration instead of deriva-
tion. The integral area below the load-displacement curve is calculated at the moment
as the energy dissipation ED. Humps change the load-displacement curve by one
main kink, so they increase the area below the curve. Currently the ED is averaged
over the cycles 1− 20. Humps occur mainly in the first cycle, so a split of the cur-
rent EDO1−20 into an EDO1 and EDO2−20 may be useful. A ratio of EDO1EDO2−20  1.0
indicates an unusually high first cycle ED caused by a hump. This was not tried out,
as ED values were not available for individual cycles and a numerical integration of
the load-displacement data was beyond the scope of this analysis. Nevertheless, if
these parameters would be calculated, they are expected to identify humps.
• Normal indentation curves show linearly increasing slopes with constant, slightly
positive curvatures k. Humps increase the mean curvature (Fig. D.5 f1). If force and
displacement are normalized to ∆F = [1N− 95%Fmax], then a linear slope results
in a constant integral area under the curve of
∫
1
0
Fˆ1−4.75N,O1 ∆dˆ1−4.75N,O1 = 0.5 13.
The lower this integral is below 0.5, the higher the curvature and the higher the
probability for a hump. This parameter was not computed in this work, as it was
seen beyond the scope of this analysis. However, it is proposed to be a useful hump
detection parameter. On the other hand, this integral might not be much more than a
reciprocal representation of the curvature in the normalized graph. So it is expected
to possess approximately the same hump predicting power than a purely curvature-
13The area of a rectangular triangle with catheti of 1.
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derived parameter. The scope of this section was to explore possible parameters, not
to check each of them explicitly for their usability and power of hump detection, as
such, this question cannot be answered here.
• Another proposed hump detecting factor would be the ratio of the two parameters
First Cycle Indentation Distance ID 1st to the Total Indentation Distance T ID. The
closer this ratio is to 1.0 the more likely humps affected the curve. Most curves
with humps showed ID1stT ID > 0.890. While some indents that met this criterion did
not show an obvious hump in their curve. It is presumed that these had newer and
softer tissue layers on their periosteal surface rather than a collapsing structure. As
such, this ratio could be an indicator — but not a very hump specific one. For future
studies, it might be of interest to look at the morphological structure and tissue age
of indents indicated by this ratio, which do not show other hump indicators.
• The loading slope LS1−4.75N,O1 can be extrapolated from the logarithmic fit of the
other cycles LS1−4.75N,O3−20 (p. 317). For first cycle humps, the load-displacement
curve gets considerably flatter and the measured loading slope is lower than predicted
from extrapolation. A high difference LS1−4.75N,O1,predicted− LS1−4.75N,O1,measured
indicates material inhomogeneities, such as humps, even if they are absolutely indis-
cernible to the human eye in derivative charts.
Additionally, the slopes of any cycle can be predicted from the logarithmic trend
data and compared against its measured value to reveal information about inhomo-
geneities in any cycle (e. g. the drop in cycle 15 in D.4). This can be gained by
calculating the standard deviation of the difference of the predicted and measured
slopes σx(O3−20) with x(O3−20) =
∆Fˆ1−4.75N,O3−20,predicted
∆dˆ1−4.75N,O3−20,predicted
− ∆Fˆ1−4.75N,O3−20,measured
∆dˆ1−4.75N,O3−20,measured
for LS and
similarly for US.
327
APPENDIX D. APPENDIX TO MICROINDENTATION STUDY
sample1
potential hump detection parameters graph
ID1st
T ID L̂S σL̂S σL̂S/L̂S kˆ σkˆ
∣∣∣kˆ×σkˆ∣∣∣ hump stiffens
explanation p.327 p.325 p.325 p.325 p.325 p.326 p.328 2 p.324
max. value >0.89 >1.03 >0.2 >20% >0.5 >2.0 >0.5<-0.2
5 L 5 0.902 1.075 0.24 21.8% 0.70 1.30 0.91 yes
17 L 4 0.901 1.308 0.52 39.8% 1.09 3.60 3.91 big
17 L 5 0.891 1.024 0.25 24.6% 0.89 1.69 1.51 big
6 T 2 0.902 1.067 0.28 25.9% 0.88 0.65 0.57 yes
17 T 3 0.887 1.034 0.21 20.3% 0.60 1.06 0.63 yes
6 T 1 0.624 1.055 0.31 29.7% -2.14 6.89 14.73 small
51 T 1 0.843 1.018 0.12 11.8% -0.48 2.60 1.25 long
13 T 1 0.848 1.019 0.15 14.4% -0.37 2.89 1.07 yes
6 L 1 0.896 1.015 0.18 17.9% 0.52 0.70 0.36 small
46 L 1 0.908 1.016 0.16 15.6% 0.46 0.54 0.25 long yes
13 T 3 0.881 1.025 0.16 15.9% 0.37 0.95 0.35 small
17 T 4 0.867 1.013 0.14 13.9% 0.18 1.14 0.20 small
17 L 3 0.869 1.017 0.14 13.2% 0.14 1.37 0.19 small
13 T 2 0.866 1.015 0.14 13.5% 0.03 1.71 0.05 small
indicated (total) 14 8 9 7 11 9 14
correct (hump) 4/5 4 4 5 5 6 3 6 8
correct (stiffens) 3/6 4 1 1 1 3 1 2 7
fp3 (wavy) 3 3 3 1 2 5 6
fp3 (rest) 0 5 0 0 0 0 0 0
fn3 (hump) 4 4 3 3 3 5 2
fn3 (stiffens) 4 6 6 6 4 6 5
Table D.5.: Potential of new parameters to detect humps or severe material stiffening during
the first indentation cycle. All parameters from O1 except T ID. Bold numbers: amount of
indents identified correctly.
1 L: longitudinal testing direction, T: transverse testing direction.
2
∣∣∣kˆ×σkˆ∣∣∣ is the novel parameter hump number (p. 328).
3 fn: false negative, fp: false positive.
4 ID1st/T ID identified 4 indents not listed: 1 with a small hump and 3 which stiffened slightly.
5 ID1st/T ID did indicate 0 indents wrong on bone, but 13 on PMMA.
Hump Number. The most promising parameter for the detection of humps was called the
hump number. The hump number was defined as the absolute value of the product of the
mean of the 2nd derivative times the standard deviation of the 2nd derivative:
hump number=
∣∣∣kˆO1×σkˆO1∣∣∣ with: kˆO1 = ∆2Fˆ1−4.75N,O1∆dˆ21−4.75N,O1 .
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The higher the hump number, the higher the likelihood that an individual indent had a
hump. Indents with humpnumber > 0.5 always showed loading oddities and identified all
indents with major humps in the data set (Table D.5). No false negative indents, with visual
hump but humpnumber < 0.5, were found. On the contrary humpnumber > 0.5 detected
6 false positive indents, however, all 6 indents had severe wave interference and exceeded
the scattered jerk criterion (p. 332) already.
It is strongly advised that one or more of these parameters be included in future versions
of the BioDent™.
Humps may be irritating at first sight, but they can still provide profound scientific value.
The occurrence of humps indicates fast growing tissue, resorption cavities or other voids.
Even if humps cannot — due to their low incidence — be used solely as indicators of
bone condition, they could be used as factors contributing to the overall judgement of bone
strength and disease progress. It is not sure if including hump-skewed parameters into
the statistics is beneficial or not. Either hump presence itself is indicated by one of the
proposed novel indicators and the individual indent is excluded precautionary or they are
not excluded but their averaged parameters are influenced and shifted in a direction to judge
bone strength anyway. This leads to the tragedy of humps: “To be excluded, or not to be
excluded: that is the question14”.
14Freely adapted from Shakespeare, W. ≈1603. The Tragedy of Hamlet.
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2.3.4. Wave Interference
The third column of Fig. D.5 (G–I) shows another abnormal feature: wave interference.
This appeared in 11 out of 81 indents (≡ 13.6%) for which the raw data were available.
Sample 17 L 1 (G–I) is one of the more severe examples, where the wave interference can
be seen already pronounced in the raw load-displacement graph both in the loading (g1)
and the unloading (g2) and throughout all 20 cycles. The hump sample 5 L 5 (Fig. D.5,
D–F) showed a fast frequency pattern of ≈ 160Hz ( f2) with small amplitude, that did not
appear to affect the results. Various explanations for wave interference exist, but a definite
reason has not been identified:
1. Electronic interference. Between the peaks of the interfering wave pattern were
≈ 50 data points. With a testing frequency fnom = 2Hz and a sampling frequency
fsampling = 2000cycle = 4000Hz, this resulted in an overlying frequency ≈ 80Hz. It is
thus unlikely to arise from electronic interference from the 25% slower American
mains frequency of 60 Hz.
2. PID controller’s Eigen frequency. An unfortunate pairing of sample and set-up
stiffness against the PID controller’s Eigen frequencies could potentially lead to
severe interference patterns. However, then this phenomenon should appear on the
majority of similar samples in this set-up, but it would be unlikely to appear on the
PMMA control material due to the stiffness shift. However, 3 of the wave cases
were on a PMMA block. Furthermore, nobody would design a system that regularly
operates in a stiffness range that coincidences with the system’s PID controller15.
Thus, accidental PID controller interference might theoretically cause these patterns,
15Obviously, one can design an unstable control loop. However, the result is likely to be so disastrously
unstable that either a) the user would interfere very quickly and improve something or b) the sample or some
other set-up component will fail.
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but such severe PID controller problems would not be expected to occur in such a
device, neither would it be likely to be close to instability, while never crossing the
line into fatal instability.
3. Superficial dirt. There might be sticky dirt on the tip of the probe, causing these
wavy patterns. However, if the surface stickiness would be enough to produce
measurable effects, it should mainly affect the retraction of the probe but not the
indentation. While the wave patterns here are seen both in the unloading and the
loading. Thus, dirt on the probe tip is unlikely the reason for these waves.
4. In depth dirt. Dirt in the thin space between probe and reference probe could cause
a slip-stick effect. Slip-stick is caused by the difference in static friction and kinetic
friction. However, slip-stick during the unloading with a pulling force on the probe
would very likely still result in movement in one direction. While the wavy inter-
ference in some samples was so severe, that the probe during the unloading pull out
motion of the indenter even moved down the probe. Furthermore, a slip-stick effect
that occurs in the first cycle due to friction between probe and reference probe would
likely change quickly once the dirt in the gap would touch the bone surrounding
media causing some lubricating effect. The wave patterns here are seen throughout
all 20 cycles, as well as appearing for individual samples or in groups of up to 4
samples in a row. Thus, a slip-stick friction effect of dirt inside the reference probe
seems unlikely.
5. Structural vibration. The most likely explanation for these interferences seems to
be from outside the RPI set-up, probably by mechanical vibration of the surrounding
building structure caused by heavy machinery. However, it was not possible to test
this hypothesis as there were no contemporary error recognition algorithms available,
as these patterns only attracted attention in the post-experimental raw data analysis.
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The 1st derivative of the load-displacement curve mˆ = ∆Fˆ
∆dˆ
indicates linear changes of the
slope over time, the 2nd derivative kˆ = ∆
2Fˆ
∆dˆ2
removes linear effects and indicates if the slope
increased quadratic over time. The 3rd derivative removes quadratic slope effects and leaves
disturbances with high jerk, such as overlying (sine-)waves (e. g. i1 & f2 in Fig. D.5). To get
a single indicator parameter for wave disturbance, the standard deviation of the jerk σ jˆ with
jˆ = ∆
3Fˆ
∆dˆ3
was computed. Higher order derivatives are increasingly prone to discontinuity
influences from the original curve (Spivak & Pig, 1995), so the displacement range of the
jerk computation, derived from the previous force range of ∆F = [1N− 95%Fmax] was
reduced by ≈ 12% from each side. Jerk mean values were normally close to zero: jˆ ≈ 0,
more interesting, however, were scattered jerks with high σ jˆ.
Scattered Jerk Criterion
Normal indents had standard deviations of the (normalized) jerk of: σ jˆ = 6 . . .9. The
subgroup of indents with high wave interference on the other hand, always exhibited a
high standard deviation of the jerk: σ jˆ > 15.
Application of this criterion to the data set (n = 81) identified 11 indents, of which 10 had
severe wave interferences (Tab. D.6). The 11th was not a total false positive, but gained its
jerk from a big hump in O1 and was an exclusion candidate already. There was one false
negative sample, that had slight wave patterns but was not detected by this novel criterion.
Due to its excellent ability to indicate wave interference (more then 80% of incidents iden-
tified successfully), the criterion σ jˆ > x was named the scattered jerk criterion. In this
work x = 15 was used successfully to identify most cases of severe wave interference. The
threshold value x of the scattered jerk criterion varies with the specific methods and condi-
tions of the calculation (e. g. smoothing and the normalization range), while the calculation
principle stays the same.
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sample1
wave parameters
graph
jˆ σ jˆ
1
explanation p. 332 p. 332 p. 330
maximum value >15
5 T 1 -5.77 56.86 very wavy
5 T 2 -2.59 26.47 very wavy
5 T 3 -1.82 32.50 very wavy
17 L 1 -2.05 35.13 very wavy
17 T 5 1.14 21.46 very wavy
P1.4 -5.09 46.38 wavy
P2.1 -0.48 32.14 wavy
P2.2 0.34 32.08 wavy
P2.3 -1.26 34.57 wavy
6 T 1 16.13 45.15 small waves2
6 T 2 0.84 11.16 fn wavy
17 L 4 -14.15 73.86 fp not wavy, big hump
indicated (total) 11
correct 10 11
false positive (humps) 1
false positive (rest) 0
false negative (wavy) 1
Table D.6.: Individual microindents with wave behaviour. The scattered jerk criterion
(σ jˆ > 20) successfully identified 10 indents with wave interference (bold numbers), failed
to identify 1 (fn) and identified 1 wrongly (fp) out of a data set of 81 indents. Parameters
were calculated for first cycle.
1 σ jˆ is the novel scattered jerk criterion (p. 332).
2 L: longitudinal testing direction, T: transverse testing direction, P: PMMA.
A significant part of the data sets was affected by wave interference (11 out of 81,≡ 13.6%)
(Tab. D.1), we therefore advise that keeping jerks in mind would significantly increase the
quality of the measured data. The scattered jerk criterion is seen as the most powerful
indicator to identify unwanted periodic interference.
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2.3.5. Force as a Quality Indicator of the PID Controller
The aforementioned jerk can be a quality indicator for issues that presumably arise outside
the RPI. There could be further parameters to identify issues generated by the BioDent™
itself. The main task of a PID controller is to follow a given input curve as closely as
possible. The second task of a correctly set PID controller is not to over-react and overshoot
and cause fluctuations from the requested input curve.
At the moment there is only one parameter to indicate a correct loading and correct fol-
lowing of the desired force curve: the Average Maximum Force Fmax. However, Fmax aver-
ages the force, so positive and negative fluctuations are cancelled out. Fmax indicated, at the
pseudo-load controlled BioDent™ (Sec. 5.4.2), if the probe length was not compensated
correctly for in the load-displacement adjustment table. This can lead to severe disturbance
of the true force from the desired theoretical curve, that the high fluctuations also caused
the averaging Fmax to decrease substantially. Therefore, Fmax can be an indicator of severe
loading issues, but small discrepancies are not detectable.
To create a meaningful parameter to judge the PID influence and effectiveness, a measure
of the deviation should be computed. Any square function of the difference of the real
force against the theoretical force should be effective, for example the standard deviation
σ(Fˆreal−Fˆtheory). This would enable an objective judgement about how well the indentation
force followed the theoretical force. Such a factor can span over all cycles, as inaccuracy
behaviour of the PID controller is not expected to change during different stages of the
test. However, oversteering would be not specifically pronounced in such a factor. Over-
steering usually occurs with high frequencies, so derivatives of the difference of the real
force against the theoretical force ∆(Fˆreal−Fˆtheory)
∆dˆ
should show this well. Again, a single fac-
tor indicating any oversteering could be the standard deviation of this difference series:
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σ(∆(Fˆreal−Fˆtheory)
∆dˆ
). Potentially the standard deviation of the second derivative of the force
differences σ(∆(Fˆreal−Fˆtheory)2
∆dˆ2
) would be an even more favourable parameter due to increased
sensitivity for high frequencies in higher order derivatives. For any derivatives of force
over displacement, it would be advisable to normalize both force and displacement as oth-
erwise the material’s resistance against indentation would influence the absolute values of
the derivatives. The force could get normalized from ∆F = [0N,Fmax] to ∆Fˆ = [0, 1] 16.
The displacement d, however, should get normalized for the stiffness that the PID con-
troller experiences. The stiffness that the PID controller is subjected to is dependent on the
resistance of the material against penetration, the nominal testing force Fnom, the indenta-
tion frequency fnom and, in the case of a software-based PID controller, on the sampling
frequency fsampling. Thus, it is not exactly clear how a normalization before derivation
should be designed, respectively, to which values a normalized force should be derived
with respect to. Deriving the force with respect to the time could work. A different pos-
sibility could be a derivative with respect to the single data points — basically the most
simple numerical derivative: by subtraction of one data point from the previous one. Any
of these suggestions could produce a solid parameter to control the quality and the cor-
rect setting of the PID controller, a parameter independent of material stiffness, testing
frequency, maximum force and sampling frequency.
The PID controller is dependent on the actual force, e. g. it could work fine near Fcur ≈ 0N,
but could produce inconsistent results around the maximum force Fnom. Thus, it should be
considered, splitting PID control parameters into fixed force ranges, for example:
∆Flow=[−∞, 10%×Fnom], ∆Fmedium=[10%, 90%]×Fnom and ∆Fhigh=[90%×Fnom,+∞].
16Normalized force values Fˆ > 1.0 then occur regularly for forces above the maximum force Fmax, this
might initially confuse human operators, but the pure mathematics mentioned here still work.
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The mentioned parameter calculi for a PID controller control are only proposed here but
were not tried out. This was due to the fact that the desired theoretical loads were not
exported beside the real loads in the BioDent™ data set and therefore not available for
computation. However, the BioDent™ software has both these data sets and could calculate
such values. Furthermore, the internal structure of the PID controller is not known so an
independent and comparable parameter describing the quality of the PID controller cannot
be suggested with certainty here. However, it is strongly recommended to introduce a
somehow normalized parameter to enable human end-users and the machine itself to judge
on erroneous PID performance to interfere and improve the situation.
2.4. The Energy Dissipation ED is Unreasonable
The parameter Energy Dissipation ED in this application was defined as the area under
the force-displacement curve. As such ED was supposed to result in something similar to
toughness measurements from established mechanical tests. Unfortunately, this is wrong17.
2.4.1. What is Dissipated Energy?
The term energy in physics is associated with the energy unit Joule (J) 18. In fracture mecha-
nics, however, the term “energy” is not measured in an expected physical energy unit in
Nm. This is due to the linguistic inaccuracy of not mentioning to what that energy is nor-
malized. Any fracture mechanics parameter, related to strength or toughness, including
fracture energies, are normalized to a dimension of length, area or volume.
Table D.7 lists common measures of strength and toughness.
17“Science is the belief in the ignorance of experts.” (Feynman, 1969)
18Respectively 1Nm = 1J.
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parameter unit includes normalized to destruction
ED=
∫
dT ID
0
F dd N·m T ID - , 1 undefined
σultimate =Fmax/A N/mm2 Fmax: max. load A: sample area 100%, 2
ε f =
l f−l0
l0
m/m l f : failure length l0: effective length 100%
H = Y ∗ F/A N/mm2 Y : form factor, 3 F : indentation load small, 5
A: indent area, 4
HRC=100− h0.002mm - h: indent depth
load: F = 1373N
small, 5δtip = 120◦
ac =W/A Nm/m2 W : failure energy A: sample area, 6 100%
γwo f =
∫
ε f
0
σ dε0
σ = F/A
A: sample areaN/m2 ε = d/l0 l0: effective length
100%
ε f : failure strain
KI = Yσ
√
pia N/m3/2 σ =
F/A A: sample area
infinitesimal
Y : form factor
√
a :
√
crack length/2
GIc = JIc = K2I/E
A: sample area
N/m KI
√
a :
√
crack length/2 infinitesimal
E: Young’s modulus
Table D.7.: Measures of strength and toughness. ED: Energy dissipation from RPI tests.
σultimate: ultimate strength. ε f : failure strain. H: Hardness. HRC: Hardness Rockwell
Cone. ac: Impact toughness or impact strength from Charpy impact test. γwo f : work of
fracture. KI: stress intensity factor, fracture mode I (p. 212). GIc: critical strain energy
release rate to grow a thin crack in fracture mode I. JIc: J-integral. ED is the only para-
meter of strength or toughness that is not normalized to any dimension of the damage.
1 Tip geometry is constant. Indent area increases with T ID, which is not normalized for.
2 Equals 100% destruction in a force controlled test.
3 For example: the form factor for Vickers Hardness is Y = 0.1891.
4 Requires optical measuring of the indent area A. A can be calculated from the indent
depth and the tip geometry (e. g. in nanoindentation).
5 The T ID is most similar to H and HRC.
6 Normalized to the cross-sectional area sometimes to the thickness at the notch.
337
APPENDIX D. APPENDIX TO MICROINDENTATION STUDY
2.4.2. The Issues with ED
The ED suffers from a fundamental mistake. Toughness and strength related parameters are
based on area normalized stresses σ = F/A, complete failure of the sample (ε f , σultimate,
ac, γwo f ), damage area A or failure depth h (in H, HRC) or on the crack length 2a (in
KI , JIc). ED does not include any normalization to a stressed area, volume or depth and
therefore also lacks the vital base for comparison. The RPI damages some amount of
material however, the ED does not include the amount of damage.
The design mistake of the ED can be explained easily: Toughness parameters are related
to the area under the loading curve, but they are not the same. The γwo f is even defined as
the area under the stress-strain curve, but stress and strain are hard to compute for the RPI.
The volume of destruction increases non-linearly due to the conical probe geometry.
The demonstrated lack of sense and sensitivity of the ED is indicated also in the literature:
not a single RPI publication mentioned significant ED values. In fact, ED never got any
attention, while it was a standard computed output parameter. Hereby, I propose that ED
values were never mentioned and discussed in the published literature because ED never
gained statistical significance or because the statistically significant relations could not be
explained (Feynman, 1974).
One issue of the current ED parameter gets apparent in a simple example. High toughness
is related to high toughness parameter values19. In a sample with a hump (Fig. D.5 D)
due to a weak structure, the loading curve stretches towards higher displacement. A hump
therefore increases the area under the force-displacement curve and — if the rest of the
19For example, KIc of concrete is ≈ 100× lower than from steel. Based on personal experience it is much
more difficult to destroy the same amount of steel than of concrete.
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curve stays similar — subsequently increases the ED and not, as assumed, decreases the
ED. Indeed for half of the hump samples (p. 328) the ED increased by up to +50%.
In a second example, we imagine an indentation force Fnom increased from 5N to 6N. A
higher force value would increase the ED as the area under the force-displacement curve.
How could an increase in ED, caused by indentation force, be interpreted?
1. The sample is tougher, because tougher materials show higher toughness values.
2. The sample is weaker, because weakening humps cause ED increase.
3. The ED change means nothing at all. Toughness is a property of the material in itself
and should be widely independent from changes in the measurement settings.
Unfortunately for the ED, the third interpretation is most reasonable.
2.4.3. Toughness Parameter Suggestions
The current ED is an insufficient parameter due to the lack of normalization to the amount
of damage. Computing toughness parameters, like KI , GI and γwo f (p. 337), is linked to
issues inherent to reference point indentation itself. The main issues and potential solutions
for novel toughness parameters are:
• Unknown amount of damage. A fundamental issue of toughness measurement via
RPI testing is the lack of a clear indicator for the amount of destruction at any given
time point. KI and GI incorporate the crack length 2a, however, RPI does not provide
one such parameter. A proxy parameter for crack length could be:
1. Indentation Distance Increase IDI. IDI measures the depth difference from
Fmax,O1 to Fmax,O20 and excludes the first loading to Fmax,O1.
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2. Total Indentation Distance TID. T ID takes the damage during the first cycle
loading into account, that the IDI does not. However, the T ID also includes
soft tissue of the periosteum and could be prone to non-bone influences.
3. Novel parameter that includes stiffness. The T ID includes the last cycle
unloading distance USO20×Fnom, which originates from elastic recoiling rather
than from crack propagation (Fig. 5.4). The IDI on the other hand, both
neglects O1 damage and falsely includes O20 elastic recoiling. The distance
of crack propagation may be more accurately described by a recoiling free new
parameter Plastic Deformation Depth that would
be T ID based: PDDT ID = T ID− FnomUSO20
or IDI based20: PDDIDI = IDI− FnomUSO20 +
Fnom
LSO20
and a toughness parameter: KIc,RPI = Yσ
√
pi×PDD/2
with the form factor Y depending on the RPI technique and the probe geometry.
4. Unknown strain ε . It is impossible to define a nominal strain ε in RPI testing,
due to the complex destruction situation and the lack of a defined strained vol-
ume. Furthermore, there is no complete failure of entire samples so the failure
strain ε f is undefined. An energy integral, based on the complete failure, similar
to γwo f =
∫
ε f
0
σ dε is not possible for RPI. Any RPI derived toughness para-
meters must be normalized to infinitely small crack progression rather than a
counting sum up to the non-existing full sample failure.
• Unknown real stress. The real stresses in RPI are non-trivial due to the conical
indenter. However, RPI does not even use an approximation to convert forces Fcur
into stresses σcur. Solution approaches could be:
20Note that PDDT ID and PDDIDI result in comparable but not identical values. To limit O1 soft tissue
influences, LSO1 for PDDIDI may be calculated in a smaller force range ∆F = [50%,95%]×Fnom (p. 310).
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1. Interestingly, Sneddon (1965) developed an analytical solution for the contact
of a rigid, friction-free, conical indenter and an elastic half-space. Test probe
tip angle δ = 90◦ (p. 187), current indentation depth T IDcur and current force
Fcur result in the real contact radius as: rcontact = 2/pi · tan(δ/2) ·T IDcur; the
real, current, contact area: Acur = r2contact×pi; the indented material’s stiffness:
E = pi2 tan(δ/2) ·
Fcur
T ID2cur
and the contact stress distribution in dependence of the
radius r as: p(r) =− E ·T IDcur
pi rcontact(1−ν2) · ln
(
rcontact
r +
√( rcontact
r
)
2−1
)
.
2. Oliver & Pharr (1992; 2004) formulated the theoretical background of nanoin-
dentation, that would be applicable to RPI as well.
3. An analytical solution for the real stressed area may suffice well. For more
detailed investigations into the complex damage patterns (Fig. 5.3) finite ele-
ment modelling (FEM) could be useful.
Most indentation techniques use sharp tips, while the tip of the BioDent™ is
rounded, so the above solutions will require modifications.
• Fracture initiation and fracture progression. Toughness values KIc can be calcu-
lated for the damage initiation period O1− 3 (Fig. 2.2) separately from KI for the
propagation period O4−20.
• Logarithmic increase in LS or US as toughness proxy. The increase of LS and US
provide insight into crack propagation (p. 317). Once initiated, the crack propagation
is predictable during the later cycles (Fig. D.3 & D.4). An analytical solution for this
effect is lacking.
Despite some uncertainties, designing novel toughness-related parameters is imaginable.
Which analytical solution is most sensible remains to be proven in future work.
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Normalizing the force values Fcur by the effective area Acur to the effective compres-
sion stress σcur is both achievable and possible. A benefit of stress values compared to
force values is, that the loading curves are easier to interpret. The “stiffness” LS and US
increased both with the indentation depth and the force (Fig. D.5 B). However, as the mate-
rial evidently gets more and more destroyed, a “stiffness” should decrease. The stiffness
increase of the F-d-curve is an illusion of the ignored indentation area Acur that increases
with the square of the indentation depth T ID. In a stress-based σ -d-loading-curve the
decrease in stiffness is a measure of the damage.
Changing the loading curve from F-d to σ -d will have consequences on most sections
of this appendix, the associated chapter 5, as well as on the entire BioDent™ device, its
software and any of its results. Furthermore, the design and validation of novel toughness
parameters require attention as well. All these implications will require effort, but will be
useful.
The difference between the realization of the existence of flaws in ED and other RPI para-
meters compares to the presentation of a sensible, novel, toughness related parameter like:
“Errors, like straws, upon the surface flow;
He who would search for pearls, must dive below.”21
Unfortunately, the complete development and validation of an analytical solution resulting
in the best possible, novel, sensible, useful, RPI based toughness parameter is beyond the
depth of this study.
21Dryden, J. 1677. All for Love.
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2.5. Potential of Novel RPI Parameters
All the above mentioned novel parameters and improvements of existing parameters show
great promise to improve the value of the BioDent™ instrument significantly for research
and for clinical use. As this was not discovered before, a patent should be filed. It fulfils
all requirements of patentability:
1. It is novel. Nobody else did it before. Otherwise it would be either a) included in
the BioDent™’s software or b) published recently.
2. It is useful, applicable and saleable. The device is on the market, the market is
growing, increased sensible data from each test are highly valuable. Indicators of
measurement quality and of occurring errors in real-time are vital.
3. It is inventive and non-obvious. According to the European Patent Convention
(EPC) Article 52(1), patents require an inventive step and must not be obvious to
a person skilled in the state of the art. This can be proven simply by the fact that
world-wide there have been some estimated 30−50 scientists and engineers working
on and with this machine and yet none of them came up with these ideas in the last
5 years, which indicates that the ideas here may not be trivial.
However, the European Patent Convention mentions in Article 52(2) EPC that “discoveries,
scientific theories and mathematical methods” are not patentable. As such, any patent on
these subjects may not be legally filed in Europe. However, as the American patent law
covers a wider range of subjects — including software patents22 — a patent might be
feasible there.
22However, Donald Knuth (2002) states “I am against patents on things that any student should be
expected to discover. There have been an awful lot of software patents in the U.S. for ideas that are com-
pletely trivial, and that bothers me a lot.”
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Much more helpful, flexible and trustful for the end user side, however, would be an Open
Source solution. For example the entire output parameter computation can be programmed
in MatLab and compiled into executable (.exe) files that can be run from within the Bio-
Dent™ software but also independently.
Any of the above mentioned ideas and concepts, developments and improvements regar-
ding reference point indentation testing may be actually practically useful — independent
of any claims or the way of claims toward their content. As well these ideas should be
treated independently from any of the scientific results in this work23. All technical sug-
gestions above are strongly recommended for any future developments on the BioDent™
device itself and for any further RPI experiments.
23Feynman (1974) referred to early rat experiments in mazes, which showed few clear results. Young
(1937) discovered that rats orient and find food behind specific doors on a corridor by the look of the door,
the smell of the food, the light arrangement of the laboratory and the sound of the flooring. “He discovered
all the things you have to do to discover something about rats.” However, his work was not considered in
subsequence research, “because he didn’t discover anything about the rats.”
Thus, the analytical content of this chapter cannot and must not be mixed up with the resulting data from the
initial experiment on animal tissue.
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